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Summary 
Decades have passed since the realisation that a protein’s amino acid sequence can 
contain all the information required to form a complex three-dimensional fold. Until 
recently, these encoded structures were thought to be crucial determinants of 
protein function. Much effort was directed to fully understand the mechanisms 
behind how and why proteins fold, with natively unfolded proteins thought to be 
experimental artefacts. Today, the field of natively unfolded – or so-called 
intrinsically disordered – proteins, is rapidly developing. Protein disorder content 
has been positively correlated with organismal complexity, with over thirty percent 
of eukaryotic proteins predicted to contain disordered regions. However, the 
biophysical consequences of disorder are yet to be fully determined. With the aim 
of addressing some of the outstanding questions, the work described in this thesis 
focuses on the relevance of structure within disordered proteins.  
  
Whilst populating a variety of conformations in isolation, a subset of disordered 
proteins can fold upon binding to a partner macromolecule. This folded state may 
be present within the ensemble of conformations sampled by the unbound protein, 
opening the question of what comes first: folding or binding? Protein engineering 
techniques were employed to alter the level of residual ‘bound-like’ structure within 
the free conformational ensemble, and the consequences on coupled folding and 
binding reactions were investigated. Resultant changes in the rate of association 
are easily imaginable; yet, this work demonstrates that the majority of the 
observed changes in binding affinity were due to alterations in the rate of 
dissociation, thus altering the lifetime of the bound complex. 
  
Promiscuous binding is a touted advantage of being disordered. If many disordered 
proteins, each with their own conformational ensemble, can bind and fold to the 
same partner, then where is the folding component encoded? Does the partner 
protein template the folding reaction? Or, is the folding information contained within 
the disordered protein sequence? Utilising phi-value analysis on the BCL-2 family 
of proteins, residues in the disordered sequence were probed to ascertain which 
form contacts at the transition state of the reaction. Comparison with phi-value 
analyses of alternative pairs – sharing either the ordered or disordered protein – 
provides insight into the encoding of these interactions. In the context of a 
bimolecular reaction, the amino acid sequence of the disordered protein was shown 
to determine the interactions within the transition state. Thus, analogous to the 
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discovery from decades’ past, it is the sequence of the protein that folds which 
encodes its pathway, even when binding is a prerequisite. 
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Chapter 1   
 
1 Introduction 
 
1.1 Human Genome Project 
Deoxyribonucleic acid (DNA): words that many people may recognise, perhaps 
without grasping the biological importance or function that the term entails. 
Enrolled in a media storm, DNA shot to prominence at the start of the 21st century. 
Scientists from around the world were both collaborating and competing to publish 
the sequence of nucleotides that represent the human instruction manual. Within 
the same week in 2001, both an academic conglomerate and a private company 
presented their findings (International Human Genome Sequencing Consortium, 
2001; Venter et al., 2001). The race was over. The draft of the human genome was 
published.  
 
Such was the perceived importance of the human genome project, Presidents and 
Prime Ministers had, 8-months before publication of the papers, pre-emptively 
hailed the benefits of knowing humans’ genetic code. The perceived advantages 
are as a result of DNA’s significance in biology. DNA is a polynucleotide, consisting 
of 4 nucleotide bases; adenosine (a), thymine (t), guanine (g) and cytosine (c). 
When read in groups of three, these nucleotides contain the coding information for 
an amino acid residue (e.g. ccc encodes proline). The name attached to these 
groups of three nucleotides, a codon, references the data storing ability of DNA. 
However, on its own, a codon only provides information for a single amino acid. 
The real power of DNA comes through combining codons into genes. Genes are a 
series of codons that encode multiple, covalently linked amino acids. These amino 
acid polymers, termed proteins, are key players in biology.  
 
Much of the hype surrounding the Human Genome Project related to the promise 
that it would revolutionise medicine. Diseases can contain a genetic aspect, where 
differences in the nucleotide sequence from one individual to another can either 
directly cause, or make one more susceptible to, a specific illness. For example, in 
the gene for the cystic fibrosis transmembrane conductance regulator (CFTR), 
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deletion of a single codon can cause the disease, cystic fibrosis (Kerem et al., 1989; 
Riordan et al., 1989; Rommens et al., 1989). However, knowledge of the genetic 
causes does not automatically result in the disease being cured. The true potential 
of the Human Genome Project related to identifying which proteins were involved 
in disease, and how they differed from the healthy population. This point is 
illustrated by returning to the cystic fibrosis example mentioned earlier. Rather 
than directly causing the disease, the codon deletion in the CFTR gene results in 
the deletion of an amino acid (phenylalanine) at position 508. This leads to higher 
rates of degradation, effectively meaning that the protein is no longer present 
(O’Sullivan and Freedman, 2009), and the protein function is lost. Thus, while DNA 
provides the starting point for what has gone wrong, understanding how and why 
the protein function has changed is required in order to fully understand the disease 
biology. 
 
1.2 Amino Acids 
Given the requirement for codons, the 4 DNA nucleotide bases could encode a 
maximum of 64 amino acids (43). If this were the case, then the potential for 
problematic changes would be vast: mutation of a single nucleotide would result in 
a different amino acid, potentially altering the function of the protein. Instead, 
biology utilises just 20 amino acids, allowing several codons to encode the same 
residue. Based on their chemical characteristics, amino acids can be divided into 
different groups (Figure 1.1): non-polar; aromatic; polar; negatively charged; and 
positively charged. 
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Figure 1.1 Amino Acid Structures and Properties. 
The full name, three letter and single letter codes are shown for each of the 20 
standard amino acids. Amino acid side chains from the alpha-carbon vary in size 
and property. For the charged residues, approximate pKa values are shown, and 
the side chain charge of the majority species at pH 7.0 is indicated. Structures were 
constructed using ChemDraw Professional (version 16.0).  
 
To form a protein, the carboxyl group of one amino acid undergoes a condensation 
reaction with the amino group of another residue. The resultant peptide bond (ω) 
is planar and has a relatively fixed angle of either 180° (trans) or 0° (cis) (Figure 
1.2). Steric clashes between the side chains, and high energy barriers limit the 
population of peptide bonds found in cis, with more than 99% typically observed in 
the trans conformation (Stewart et al., 1990). At least 2 rotatable bonds are 
present in each amino acid – the Cα-C (psi torsion angle, ψ) and the N-Cα (phi 
torsion angle, φ) bonds. Additional rotational bonds are provided by the various 
amino acid side chains (Figure 1.1).  
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Figure 1.2 Peptide Bond. 
A tripeptide with the first peptide bond (ω) shown in either trans (A) or cis (B). The 
phi (φ) and psi (ψ) torsional angles are also indicated. R indicates amino acid side 
chains. Structures were constructed using ChemDraw Professional (version 16.0). 
 
1.3 Forces that Fold 
In biology, proteins are typically found in solution. Interactions between the protein 
and solvent can alter the phi and psi angles, changing the conformation of the 
protein. Depending on the characteristics of the side chain and the solvent, these 
interactions can either be favourable or unfavourable. Forces between amino acids 
can also be attractive or repulsive, bringing some residues close in space, while 
keeping others far apart. Consequently, rather than maintaining their inherent 
flexibility and existing as one-dimensional strings of amino acids, proteins can 
undergo spontaneous folding into three-dimensional structures.  
 
 
 
Figure 1.3 Proteins can Fold From a 1-Dimensional Amino Acid Sequence 
into a 3-Dimensional Structure. 
The amino acid sequence for the B1 domain of Protein G (GB1) is shown in both a 
linear, unfolded and folded form. Structures were generated using PyMOL (version 
1.7.2.1, Schrödinger), with the folded structure based on PDB code: 3GB1. For 
clarity, only the backbone carbon (grey), nitrogen (blue) and oxygen (red) are 
shown.  
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Spontaneous, reversible folding of the amino acid chain indicates that the folded 
state must be thermodynamically favoured over the unfolded state. Analysis of 
multiple proteins reveals that this difference in Gibbs free energy typically ranges 
from approximately 2 – 10 kcal mol-1 (Maxwell et al., 2005). To put this into 
context, a single hydrogen bond contributes an energy of around 1 – 5 kcal mol-1 
(Fersht et al., 1985). Proteins are, therefore, only marginally stable and all forces, 
even those with small energy contributions, can have a significant influence on 
protein stability.  
 
1.3.1 Hydrogen Bonding  
Hydrogen bonds form between a donor, hydrogen, and an electronegative acceptor 
group. Each amino acid has a backbone hydrogen bond acceptor, the carbonyl 
group, and all but proline have a donor, amide N-H group. Further hydrogen 
bonding capabilities can also be provided in a side chain specific manner. At first 
glance, it would appear that the ability of the amino acids to form intramolecular 
hydrogen bonds should produce a highly stable protein. However, the solvent also 
has to be taken into account (Dill, 1990; Hunter, 2004). For proteins, this is 
predominantly water (H2O). By either donating its hydrogen or accepting through 
its oxygen, water is able to satisfy the amino acid hydrogen bonds. As the bonds 
can be satisfied by either water or another amino acid, there is little change in free 
energy upon formation of intramolecular amino acid hydrogen bonds. While 
hydrogen bonds are therefore not the principal determinant of protein stability, 
they do provide some distinct advantages for the formation of protein structure. 
Firstly, hydrogen bonds can be formed between amino acids in a manner that 
produces a specific structure. This both allows specificity in the conformation of the 
protein fold, and contributes to the second benefit of intra-protein hydrogen bonds: 
they can form cooperatively. Establishing a single hydrogen bond can bring other 
donor and acceptor groups closer in space, promoting the formation of subsequent 
intra-protein hydrogen bonds. 
 
1.3.2 van der Waals 
Orbiting electrons can shift towards one side of an atom, setting up a transient 
charge. Nearby atoms may be either attracted to, or repulsed from, this charge, 
creating an electrostatic force known as van der Waals. The strength of van der 
Waals interactions is related to the distance between interacting atoms (Roth et al., 
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1996). As 2 atoms become closer in space, the influence on each other’s electron 
orbit increases, causing an increase in electron density shift and a rise in the van 
der Waals force. This force can be attractive, but once the distance between the 
two atoms becomes so small that the electron orbits start to overlap, the force 
between the atoms becomes repulsive. When a protein folds, the interior of the 
protein typically becomes tightly packed. The reduced distances between atoms 
results in an enhanced van der Waals interaction force. Consequently, van der 
Waals forces promote protein folding (Pace et al., 2014).    
  
1.3.3 Electrostatics 
Ionisable side chains are present in a subset of amino acids (Figure 1.1). Depending 
upon the pH, these ionisable groups either gain or lose a proton. Interactions 
between these residues and other charged groups can be either attractive (opposite 
charge) or repulsive (same charge). Compared with hydrogen bonds and van der 
Waals forces, which are both also electrostatic in nature, the force between charged 
groups functions over relatively large distances. Bringing together oppositely 
charged residues would therefore be expected to contribute a large driving force 
for folding. However, the solvent again needs to be taken into account. Oxygen’s 
electronegativity creates a dipole, with oxygen having a net negative charge and 
hydrogen a net positive charge. In addition to being responsible for the ability of 
water to hydrogen bond (Chapter 1.3.1), the dipole also allows water to interact 
with charged amino acid groups. Consequently, electrostatic interactions may not 
offer a significant driving force for folding, as there is little change in free energy 
between forming charge-charge interactions with water or within the protein chain. 
However, electrostatic forces can play a role in setting up the correct protein 
structure. Burial of either an unsatisfied hydrogen bond or an unpaired charge 
group in the core of the protein fold comes with a large energy penalty: in the 
unfolded state the charge/hydrogen bond can interact with water, whereas in the 
folded state, the bond is broken and the free energy contribution is lost. An 
unpaired charge is therefore likely to be found on the surface the protein, where it 
can interact with water. Through this interaction, charged amino acids on solvent 
exposed surfaces provide the added benefit of improving the protein’s solubility.    
 
Introduction| 7 
 
1.3.4 The Hydrophobic Effect 
Compared to the other forces mentioned above, the hydrophobic effect is the main 
driving force for protein folding (Dill, 1990; Pace et al., 2014). Many of the amino 
acid side chains are hydrophobic, containing only carbons and hydrogens (Figure 
1.1), and are unable to form hydrogen bonds with solvent. When the hydrophobic 
groups are solvent exposed, this creates an energetic penalty. The source of this 
penalty is the subject of much debate (Ball, 2011). One hypothesis, supported by 
recent experiments (Camilloni et al., 2016), states this penalty is a result of 
reduced solvent entropy due to water molecules maximising their hydrogen 
bonding by ordering themselves around the hydrophobic residue. The second 
hypothesis suggests that the hydrophobic groups disrupt the solvent’s hydrogen 
bonding network (Lum et al., 1999), creating an enthalpic penalty. Either way, 
packing hydrophobic side chains into the protein core removes the interaction with 
the solvent and the corresponding energetic penalty. Burial of hydrophobic residues 
is thus associated with a significant gain in free energy, promoting the 3-
dimensional folded version of the protein over the 1-dimensional chain (Figure 1.3).  
 
1.3.5 Disulphide Bonds 
Containing a thiol group, the side chains of 2 cysteine residues can couple, forming 
a covalent, disulphide bond. To form this interaction, the 2 cysteines need to be 
close in space. Consequently, it is perhaps more likely for a native disulphide bond 
to form when the protein is folded, as residues that may be far apart in the unfolded 
state are brought together. It is easy to assume that the formation of this bond 
once the protein folds provides a significant enthalpy gain. However, if the protein 
unfolds after bond formation, the disulphide is still formed and there is no 
significant difference in enthalpy between the two states. Instead, the stabilising 
influence of disulphide bonds is due to the entropic effect on the unfolded state. 
The bringing together of two residues which were far apart in the unfolded protein 
carries an entropic cost. This cost is already paid in the folded state, as the 2 
cysteine residues are brought close in space by other interactions that contribute 
to the folding of the protein. Thus, disulphide bond formation has an entropic cost 
to the unfolded state, not the folded state, resulting in a net stabilisation of the 
folded protein. There is a caveat - not all disulphide bonds stabilise the folded 
protein. Disulphide formation can create strain in the folded structure, disrupting 
other native interactions, or can stabilise the unfolded state by increasing 
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intramolecular interactions (Clarke et al., 2000). Although some of the proteins 
investigated in this thesis contain cysteine residues, none of the proteins contained 
native disulphide bonds.  
 
1.4 Protein Structure 
Proteins can experience various levels of structure. The most basic structure is one 
that all proteins have – the covalent linking of amino acids in a 1-dimensional chain. 
Known as the primary structure, this is effectively the sequence of amino acids and 
is traditionally referenced from the amino acid with the free amino group (N-
terminus). Whether a protein forms further levels of structure is dependent on the 
influence the exerted forces have on the rotatable backbone phi and psi angles. 
However, not all torsion angles are equal. This inequality is superbly demonstrated 
by the Ramachandran Plot (Figure 1.4), which illustrates the favoured phi and psi 
angles, and the regions that are inaccessible due to steric clashes (Ramachandran 
et al., 1963).   
 
 
 
Figure 1.4 Ramachandran Plot Demonstrating the φ and ψ Angles for a 
Typical Amino Acid. 
Due to steric clashes, the phi (φ) and psi (ψ) torsion angles for a typical amino acid 
only sample a subset of conformations (lines). Analysis of protein structures 
indicates that amino acids (black points) typically fall within distinct favoured 
regions (interior lines). These regions represent different secondary structures: 
alpha-helix (α); beta-sheet (β); and left handed alpha-helix (αL). The plot was 
adapted from Lovell et al (Lovell et al., 2003) and indicates the allowed and 
observed phi and psi angles for all amino acids, except proline and glycine.    
φ
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Except proline, all amino acids contain a hydrogen bond donor, the amide 
hydrogen, and an acceptor, the carbonyl group. Given the restrictions on the phi 
and psi angles, intramolecular hydrogen bonds are typically satisfied in one of two 
ways. Firstly, the carboxyl of one amino acid can interact with the amide hydrogen 
that is 3 – 4 residues ahead in sequence (Figure 1.5). This creates a helical 
structure, with a full turn occurring either every 3 residues (310-helix), or every 3.6 
residues (α-helix). Hydrogen bonds can also be satisfied by interacting with 
residues that are further away in sequence. For example, if a turn is introduced in 
the amino acid chain, then the amide hydrogen of one residue can interact with the 
carboxyl of another. This type of structure is named β-sheet and is relatively more 
extended than the 310- or α-helix. Due to the differing nature of their hydrogen 
bond patterns, both helices and β-sheets exhibit distinct phi and psi angles (Figure 
1.4). Compared to the random coil-like primary structure, these torsion angles are 
relatively fixed. Thus, being more ordered versions of the primary structure, both 
β-sheets and helices represent the second level of protein structure (secondary 
structure).     
  
 
Figure 1.5 Protein Secondary Structure.   
Restrictions on torsion angles and hydrogen bonding patterns cause amino acids to 
be structured in 1 of 2 ways. In an α-helix (A), the amide hydrogens bond with the 
carboxyl groups that is 4 residues towards the N-terminus. For β-sheets (B), a turn 
in the polypeptide chain allows hydrogen bonding between the carboxyl groups and 
amide hydrogens of residues that are relatively separated in sequence. To aid the 
eye, a single hydrogen bond is indicated with a dashed line, but in both cases, the 
alignment of the chain allows multiple hydrogen bonds to form. For clarity, only the 
A
B
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backbone carbon (grey), nitrogen (blue) and oxygen (red) atoms are shown. 
Structures were generated using PyMOL (version 1.7.2.1, Schrödinger). 
When the secondary structure elements interact, protein tertiary structure is 
formed (Figure 1.6). This folding is the highest level of structure achieved by 
monomeric proteins and is driven by interactions between the amino acid side 
chains (see Chapter 1.3 for a description of the forces involved).  
 
 
 
Figure 1.6 Visual Representation of Protein Tertiary Structure. 
(A)When GB1 folds, the secondary structural elements of a single α-helix and a four 
strand β-sheet come together. (B) Showing all atoms indicates that the folded 
structure is tightly packed, with the side chains of each secondary structure 
element interacting. (C) To ease comparison between different protein folds, 
structures can be presented in a cartoon manner, showing only the arrangement 
of the secondary structure elements. Structures were produced using PyMOL 
(version 1.7.2.1, Schrödinger) and are based on PDB code: 3GB1. 
 
1.5 Structure-Function Paradigm 
The human genome encodes more than 20,000 genes (International Human 
Genome Sequencing Consortium, 2004). Proteins from almost half of these are 
expressed in every cell (Uhlen et al., 2015), with approximately 1 million proteins 
present in every fL (Milo, 2013). A key question arises from this observation – how 
do proteins carry out specific functions and avoid non-specific interactions with each 
other?  
 
When a protein folds, it displays a 3-dimensional surface to its environment. 
Through positioning specific amino acids in specific places on the surface, proteins 
are able to present a unique interface. For example, residue side chains in the 
active site of enzymes are typically highly conserved (Bartlett et al., 2002), creating 
a specific interaction surface. Analogous to a lock and key (Fischer, 1894), this 
A B C
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specificity ensures that only the correct substrate (the key) can fit into and be 
catalysed by the enzyme’s active site (the lock). Problems arise when proteins lose 
their unique 3-dimensional surface – misfolded or unfolded proteins can stick 
together forming toxic aggregates or amyloids (Dobson, 2003). Thus, through 
enabling the precise 3-dimensional localisation of specific amino acids, tertiary 
structure allows proteins to function specifically, minimise non-specific interactions 
and reduce the potential for aggregation.  
 
The link between structure and function led to the development of the structure-
function paradigm, which states that in order to function, a protein must have 
tertiary structure. Given the acclaimed importance for protein function, studies of 
how and why proteins fold were of critical importance.  
 
1.6 Studies of Protein Folding  
From a purely statistical standpoint, it seems incredible that a protein could fold 
into a specific structure simply by chance. As demonstrated by the Ramachandran 
plot (Figure 1.4), each amino acid can occupy a variety of states. Considering a 
protein of 101 amino acids, each with just three possible configurations, this 
provides a total of 5 x 1047 (3100) different combinations. Thus, as stated by 
Levinthal, even if the rate of exchange between these configurations occurred at a 
rate of 1013 s-1, it would take 1027 years to sample all possible states (Zwanzig et 
al., 1992). Given that this is longer than the age of the universe, protein folding 
clearly cannot be due to a purely random sampling of all possible bond angles. 
Instead, proteins are funnelled to their final conformation (Onuchic and Wolynes, 
2004). Imagine two amino acids that are distant in the unfolded chain, but close in 
space in the folded structure. If these two amino acids interact in the unfolded 
state, due to Brownian motion, they are more likely to have a lower free energy 
than the interaction of two residues that do not form native interactions. This 
interaction is therefore more likely to persist and allow other native-like interactions 
to form (Dobson, 2003). Hence, rather than sampling all possible conformations, 
the amino acid chain only needs to sample enough to form stabilising interactions, 
ultimately providing directionality towards the native state.    
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1.6.1 Phi-Value Analysis 
Anfinsen’s experiment demonstrated that all of the information required to correctly 
fold a protein was contained within the amino acid chain (Anfinsen et al., 1961). 
Given that proteins fold by forming contacts between residues, another question is 
provoked: are all amino acids equally involved in the folding process? If not, which 
ones are the crucial, fold encoding residues? The involvement of residues in either 
the unfolded or folded state can be easily addressed by equilibrium structural 
studies. However, probing the folding process is a little more problematic. One 
technique, named phi-value (φ-value) analysis, is able to determine amino acid 
interactions in the relatively short lived, reaction transition state (Matouschek et 
al., 1989). The transition state is the point of highest free energy on the reaction 
coordinate and, for a 2-state process, reaching the transition state is the rate 
limiting step for either folding or unfolding. To gain insight into the transition state, 
φ-value analysis utilises mutagenesis, kinetic and equilibrium experiments. For 
example, imagine a leucine residue that forms all its native-like interactions in the 
transition state. If the leucine side chain was shortened by mutation (e.g. to 
alanine), the side chain interactions in both the transition and folded state would 
be lost. This would destabilise the folded protein and the transition state by the 
same amount. On the other hand, if the leucine was only making interactions in 
the folded state, mutation to alanine would only destabilise the folded protein, not 
the transition state. There is also a scenario between these extremes – the leucine 
can make some, but not all, of its native-like interactions in the transition state. Or 
the leucine could make all of its native interactions, but with a lower energy than 
in the folded state. In these cases, mutation to alanine would destabilise the 
transition state to a lesser amount than the folded state (Figure 1.7).  
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Figure 1.7 Free Energy Diagrams for the Folding of a Protein and the 
Possible Influence of Mutation.   
For a protein that is predominantly folded at equilibrium, the folded (native; N) 
state of the protein is lower in energy than the unfolded (denatured; D) state. The 
difference between the two (ΔGD-N) can be measured by equilibrium chemical 
denaturation studies and represents the free energy of unfolding. The rate of 
protein folding (kf) and unfolding (ku) are related to the height of the energy barrier 
between D and the transition state (ΔG‡-D), and N and the transition state (ΔG‡-N), 
respectively. The folding rates can be measured through kinetic chemical 
denaturation experiments. Examples for the possible effects of mutation (blue, 
dashed lines) are shown when the residue makes all its native interactions in the 
transition state (2nd from the left, φ =1); some native interactions in the transition 
state (2nd from the right, φ = 0.5); or no native interactions in the transition state 
(right, φ = 0). ΔΔG values are added for illustrative purposes. A description of the 
calculation for ΔΔG and φ-values is given below.  
 
The ΔΔG values for the mutation are calculated as follows (Equations 1.1, 1.2, 1.3): 
 
 ΔΔ"#$% = 	∆"#$%)* − ∆"#$%,-.																													(1.1) 
 
 
where ΔGD-NWT is the ΔG of unfolding for wild-type and ΔGD-NMut is the ΔG of 
unfolding for the mutant protein 
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ΔΔ"#$‡ = 	01ln 45674589:                         (1.2) 
  
where R is the gas constant, T is the temperature in kelvin, kfWT is the folding rate 
of the wild-type protein and kfMut is the folding rate of the mutant protein 
 
 ΔΔ"‡$% = 	−01ln 49674989:																																							(1.3) 
 
 
where R is the gas constant, T is the temperature in kelvin, kuWT is the unfolding 
rate of the wild-type protein and kuMut is the unfolding rate of the mutant protein. 
 
Normalisation of the changes in ΔΔG provides a φ-value (Equation 1.4): 
 
 φ = 	 ∆∆<=>‡∆∆<=>? 		Or	φ = 	1 − ∆∆<‡>?∆∆<=>?                    (1.4) 
 
 
Thus, the φ-value provides information on how the interactions of the mutated 
residue compare in the transition state and the folded (native) state. If the mutated 
residue makes all of its native interactions in the transition state, a φ-value of 1 is 
achieved. If no native interactions are formed then a φ-value of 0 is observed. A 
φ-value between 0 and 1 can also occur when the residue makes some of the native 
interactions in the transition state, or all of its native interactions, but with a lower 
energy than in the folded state. 
 
A picture of the transition state can therefore be built up by producing multiple φ-
values. Allowing the residues that encode the folding process to be identified.  
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1.6.1.1 Assumptions of Phi-Value Analysis 
When performing or interpreting a phi-value analysis, it is important to remember 
the basic assumptions of the technique (Fersht et al., 1992). (1) The mutations 
should not introduce new interactions in either the transition state or the folded 
state. Otherwise, the calculated ΔΔG values would be a composite of the 
destabilising effects, due to the loss of the WT residue interaction, and the new 
interactions introduced by the mutation. (2) Mutation does not alter the pathway 
of folding. If it did, the reported phi-value would not be representative of the WT 
transition state. (3) Neither the folded or unfolded state structure should be 
significantly altered by the mutation. (4) Through taking the ratio of the WT and 
mutant folding rates in Equations 1.1, 1.2 and 1.3, the pre-exponential factor of 
the Arrhenius equation can be cancelled. The implicit assumption, therefore, is that 
the pre-exponential factor is not altered by mutation.  
 
Assumption 1 can be tested by performing multiple mutations. For example, the 
phi values obtained from mutating an isoleucine to a valine can be compared to the 
phi-values obtained when mutating the same isoleucine to an alanine. If the valine 
introduced new interactions, these would be expected to be different or lost in the 
shorter side chain containing alanine. Consequently, the ratio of the ΔΔG values 
and the determined phi-value would differ. Alternatively, if no new interactions 
were introduced by the mutation, both valine and alanine would provide the same 
phi-value. The second assumption can also be tested by this method or by mutation 
of an additional, distinct residue. If the additional mutation shifts the folding 
pathway, the determined phi-value will differ. Whereas, an identical phi-value 
should be obtained when in the presence of the WT or mutated background, if the 
pathway is not altered by mutation. Assumption 3 can be assessed using 
equilibrium structural techniques, such as NMR.     
 
1.6.1.2 Caveats of Phi-Value Analysis 
Through providing the ability to explore protein transition states, phi-value analysis 
has proved a key method for studying protein folding. However, its use has not 
been without controversy (Cho and Raleigh, 2006; de los Rios et al., 2006; Gianni 
and Jemth, 2014; Naganathan and Muñoz, 2010; Ozkan et al., 2001; Sánchez and 
Kiefhaber, 2003). Much of the debate has surrounded the sensitivity and accuracy 
of phi values. Due to the use of ratios, it has been argued that small errors in either 
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the numerator or denominator can lead to large errors in phi. This is particularly 
problematic when the mutation provides little destabilisation. Phi-value analysis, 
therefore, should be pursued with a few caveats. Firstly, the mutation should 
provide a ΔΔGD-N of >0.6 kcal mol-1. Secondly, to prevent large scale changes in 
transition state structure, conservative mutations should be utilised. Finally, given 
the potential for error in an individual calculation, phi-values should be interpreted 
as groups of values at multiple positions, rather than interpreting a single value at 
a single position. When these caveats are employed, the method can generate 
reliable transition state information, providing insight into protein folding pathways 
and mechanisms (Fersht and Sato, 2004; Gianni and Jemth, 2014).  
 
1.7 Intrinsically Disordered Proteins 
A consequence of the structure function paradigm is that to fully understand a 
protein’s function, a detailed knowledge of its structure is required. Since 1958, 
when the first protein structure was published (Kendrew et al., 1960, 1958), over 
120,000 protein structures have been deposited in the Protein Data Bank (PDB). 
Along the way, some proteins were found that lacked structure, but these were 
generally considered experimental artefacts or rare exceptions.  
 
At the end of the 20th century it started to become clear that unstructured proteins 
were not irrelevant (Wright and Dyson, 1999). Rather than folding to well-defined 
three-dimensional structures in physiological conditions, unstructured proteins can 
remain unstructured in the crowded environment of the cell (Binolfi et al., 2012; 
Theillet et al., 2016). Given that the fold of a protein is encoded within its amino 
acid sequence (Anfinsen, 1973), the sequence of unfolded proteins must encode 
their structure-lacking nature. Compared to folded proteins, unfolded proteins 
typically contain an excess of proline and charged residues (Romero et al., 2001; 
Theillet et al., 2014; Uversky et al., 2000). Combined with the relative lack of bulky 
hydrophobic residues, both the secondary structure propensity and the hydrophobic 
driving force for folding are reduced. Identification of sequence bias in unfolded 
proteins indicates that they are not merely unstable folded proteins, but proteins 
that are encoded to lack structure. In line with this idea, they have been termed 
intrinsically disordered proteins (IDPs) (Dunker et al., 2001; Schlessinger et al., 
2011).   
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Capitalising on the sequence bias of IDPs, bioinformatic analysis sought to ascertain 
the prominence of disorder in biology. Remarkably, predictors indicated that 
disordered proteins were not just rare exceptions of the structure function 
paradigm. Over 30% of eukaryotic proteins are expected to contain intrinsically 
disordered regions (IDRs) of >30 amino acids in length (Peng et al., 2013; Ward 
et al., 2004). Perhaps unsurprisingly, given the ‘lock and key hypothesis’ (Fischer, 
1894), enzymes typically lack disordered regions. Instead, protein disorder is found 
predominantly in signalling and transcription processes (Ward et al., 2004).  
 
The ability of populations to adapt to their environment is a crucial benefit of protein 
evolution. However, whilst evolution can provide increased fitness, mutations in 
protein sequences can also be detrimental. In folded proteins, mutations in the core 
can have large effects on protein stability (Tokuriki et al., 2007), and can ultimately 
result in disease (Yue et al., 2005). Consequently, there is a strong evolutionary 
pressure to maintain the position and identity of amino acids that contribute to the 
thermodynamic structural stability (Mirny and Shakhnovich, 1999). Disordered 
proteins are not under the same evolutionary pressure as, by definition, they do 
not have a fold. This allows IDPs to tolerate more mutations, making them more 
amenable to evolution (Chen et al., 2006). Yet, despite the relatively rapid rate of 
mutation, the disordered nature of IDP sequences is conserved (Chen et al., 2006), 
indicating important functional benefits to disorder beyond the ability to tolerate 
mutation.  
 
Lacking structure, amino acid side chains in IDPs are typically more accessible than 
in folded proteins, making them more amenable to post-translational modifications 
(Bah and Forman-Kay, 2016). This can have a crucial impact on function. For 
example, the IDP 4E-BP2 suppresses cap-dependent mRNA translation by binding 
to the eukaryotic translation initiation factor 4E (eIF4E). Phosphorylation of the 4E-
BP2 induces folding and sequestering of the interaction motif, reducing binding 
affinity and promoting translation (Bah et al., 2015).  
 
The ability to undergo weak, but highly specific interactions is another touted 
functional advantage of disorder (Chen, 2012; Zhou, 2012). Fast binding and 
unbinding rates could be of particular functional use in transcriptional processes, 
where the ability to respond quickly to changes in conditions is important 
(Shammas, 2017). However, while complexes involving disordered proteins bind 
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less tightly on average, the span of affinities for complexes involving disordered or 
purely folded proteins is similar (Shammas et al., 2012). Additionally, while the 
association of complexes involving disordered proteins can be remarkably fast 
(Shammas et al., 2013), rapid binding and unbinding rates can also be achieved 
by folded proteins (Schreiber and Fersht, 1996; Shammas et al., 2012). 
 
Due to their roles in important cellular processes, IDPs require tight regulatory 
mechanisms (Babu et al., 2011). Compared to their folded counterparts, disordered 
proteins typically tend to have an increased number of ubiquitination sites (Edwards 
et al., 2009) and higher rates of protein degradation (Tompa et al., 2008). 
Combined with an enhanced rate of mRNA degradation, this maintains low cellular 
concentration of IDPs (Edwards et al., 2009). Problems occur when these control 
mechanisms fail: aberrant expression levels and half-lives of IDPs are associated 
with multiple diseases, including neurodegeneration and cancer (Uversky et al., 
2008). However, as with every generality, it should be noted that this is not the 
case for all IDPs. Some IDPs are expressed at high levels and perform their function 
without causing issue (Edwards et al., 2009).  
 
1.7.1 Coupled Folding and Binding 
An essential aspect of signalling and transcription processes is the ability of proteins 
to interact with other molecules. Disordered regions are over-represented in these 
processes (Ward et al., 2004), suggesting that they may convey specific 
advantages over folded proteins. Upon interacting with a partner macromolecule, 
a subset of IDPs fold to a well-defined 3-dimensional structure (Dyson and Wright, 
2002). A potential advantage for IDPs over folded proteins is structural plasticity, 
which allows the same sequence to form different conformations when bound. For 
example, the disordered C-terminal domain of p53 can bind as a strand (Avalos et 
al., 2002), a helix (Rustandi et al., 2000) or a coil (Lowe et al., 2002; Mujtaba et 
al., 2004) (Figure 1.8).  
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Figure 1.8 p53 Folds and Binds to Many Different Conformations. 
Structure of the disordered C-terminal domain of p53 when bound to (A) CBP 
Bromodomain (PDB code: 1JSP); (B) Sir2 (PDB code: 1MA3); (C) CyclinA (PDB 
code: 1H26); and (D) S100B(ββ) (PDB code:1DT7). Residues of p53 that are 
present in all structures are shown in purple, additional residues are shown in 
lavender. The binding partners are indicated in grey. Structures were produced 
using PyMOL (version 1.7.2.1, Schrödinger). 
 
IDPs can sample elements of secondary structure, existing as ensembles of multiple 
conformations. Within the ensemble, the disordered protein may sample a structure 
that resembles the bound state. Mechanistically, this raises a pertinent question. 
Is the structure required and formed before binding? Or does the IDP bind and then 
fold? These 2 scenarios are referred to as conformational selection, and induced fit, 
respectively (Figure 1.9).     
 
A B
C D
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Figure 1.9 Potential Mechanisms for Coupled Folding and Binding. 
There are 2 conceivable extremes for IDPs that fold and bind. Firstly, in the induced 
fit mechanism (top), any conformation within the IDP ensemble is able to bind to 
its partner and subsequently fold – IDP folding occurs after binding. Secondly, in 
the conformational selection mechanism (bottom), some IDP molecules within the 
ensemble may sample a structure that resembles the bound state. Only these 
molecules are able to bind to their partner – IDP folding occurs before binding. 
Between these two extremes, a third mechanism is also possible. Binding to the 
partner could require the IDP to contain some structure. After binding in a partially 
folded conformation, the IDP would then fold to the final bound structure. Thus, 
resembling a mixed conformational selection and induced fit mechanism. 
Structures were produced using PyMOL (version 1.7.2.1, Schrödinger). 
 
Induced Fit
Conformational Selection
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1.8 Aims of this Thesis 
At the time that the work described in this thesis began (2014), the prevalence of 
IDPs in biology had already been recognised for more than a decade (Ward et al., 
2004; Wright and Dyson, 1999). Disorder brings with it a few issues - the exposed 
nature of IDPs can promote aggregation and aberrant regulation can result in 
disease (Babu et al., 2011). Given these complications, the prominence of IDPs and 
IDRs in signalling and transcription processes indicates that they may have 
significant advantages over folded proteins. Several benefits had been proposed 
(Chen, 2012); however, few had been experimentally determined. Debates 
surrounded the relevance of ‘bound-like’ structure within IDPs that could undergo 
coupled folding and binding. Highly cited work claimed that pre-formed structure 
gave a functional advantage (Fuxreiter et al., 2004), but, if so, why have disorder 
at all?  
 
This thesis aims to answer some of the outstanding questions. Specifically, (1) how 
does altering the level of residual ‘bound-like’ structure alter coupled folding and 
binding reactions? (2) Are non-contacting residues just bystanders, joining 
together the interacting residues? Or do they influence coupled folding and binding 
reactions? (3) Finally, how do reactions involving the folding and binding of an IDP 
compare to the unimolecular folding of a protein? Where is the folding information 
encoded? These questions were addressed using equilibrium, kinetic and structural 
methods.  
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Chapter 2  
 
2 Kinetics and Thermodynamics of Folding and 
Binding 
 
This thesis examines the population of molecules (proteins) in different states 
under a given set of conditions, and how those populations change when the 
conditions are altered. Thermodynamics provides a mathematical framework to 
predict whether a reaction, such as a protein changing state from unfolded to 
folded, will occur.  
 
2.1 Entropy, Enthalpy and Gibbs Free Energy 
As described by the second law of thermodynamics, a reaction will occur 
spontaneously if it results in an increase in the entropy of the universe. This does 
not mean that the reaction itself must be associated with an increase in entropy. 
Instead, the reaction could lead to an increase in the entropy of the surroundings, 
as shown in Equation 2.1: 
 
 ∆C-DE = 	∆CFGF +	∆CF-I                   (2.1) 
 
 
where ∆Suni is the change in entropy of the universe, ∆Ssys is the change in entropy 
of the system where the reaction is taking place (e.g. the protein solution), and 
∆Ssur is the change in entropy of everything else.   
 
The change in entropy of the surroundings can be calculated by dividing the energy 
change of the reaction by the temperature, as shown in Equation 2.2: 
 
  ∆CF-I = ∆JK9LM                         (2.2) 
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where T is the temperature in kelvin and ∆qsur is the change in the energy of the 
system that is transferred as heat to the surroundings (i.e. the energy transferred 
as heat from the protein solution to the surroundings as the protein folds). 
 
As a protein folds, the nature and number of intramolecular and intermolecular 
interactions are altered, resulting in a change in the internal energy of the system. 
Some of this energy may expand or contract the volume of the protein solution, 
while the rest is transferred as heat. Thus, in a situation where the volume of the 
protein solution can change upon the protein folding, the total change in the energy 
of the system is not equal to the energy transferred as heat. As shown in Equation 
2.3, by considering both components, enthalpy quantifies the energy transferred 
as heat to or from the system: 
 
 ∆NFGF = 	∆OFGF + P∆QFGF                              (2.3) 
 
 
where ∆Hsys is the change in enthalpy of the system, ∆Usys is the change in internal 
energy of the system, p is the pressure exerted on the system (assumed to be 
constant) and ∆Vsys is the change in volume of the system.  
 
Under reversible conditions, the energy transferred to the solution as heat (∆Hsys) 
is equal and opposite to the energy transferred as heat from the surroundings 
(Equation 2.4): 
 
 ∆NF-I = 	−∆NFGF	                               (2.4) 
 
 
The negative enthalpy change of the system (i.e. the energy transferred to the 
surroundings as heat) can therefore be substituted into Equation 2.2, giving 
Equation 2.5:  
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∆CF-I = $∆RKSKM                                          (2.5) 
 
 
Substituting Equation 2.5 into Equation 2.1 gives Equation 2.6: 
 
 ∆C-DE = 	∆CFGF +	$∆RKSKM                                (2.6) 
 
 
Multiplying Equation 2.6 through by -T gives Equation 2.7.  
 
 
 −T∆C-DE = 	−1∆CFGF +	∆NFGF                          (2.7) 
 
 
This equation is known as the Gibbs function, or the Gibbs free energy (Equation 
2.8), and is named after Josiah Willard Gibbs. As the Gibbs free energy (G) relates 
to the entropy and enthalpy of the system, the subscripts can be dropped.  
 
 ∆" = ∆N − 1∆S                                       (2.8) 
 
 
Assuming a constant temperature and pressure, the Gibbs free energy relates the 
change in entropy of the universe to the change in entropy and enthalpy of the 
system. Thus, any reaction that has a negative change in the Gibbs free energy 
(∆G) will result in an increase in the entropy of the universe. Reactions associated 
with a negative ∆G will therefore take place spontaneously. Enthalpy has units of 
kilojoule per mole (kJ mol-1), entropy has units of joule per kelvin (JK-1) and Gibbs 
free energy has units of kJ mol-1. In protein folding studies, joules are typically 
replaced by calories. The 2 units can be inter-converted using a factor of 1 joule 
being equal to 4.18 calories.   
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2.2 Populations at Equilibrium 
A reaction will occur spontaneously if it is associated with a negative change in the 
Gibbs free energy. However, as the reaction proceeds, the number of reactants 
reduces and the number of products increases. For a reversible reaction such as a 
protein folding, the reaction proceeds in both the forward (folding) and reverse 
(unfolding direction), as shown in Equation 2.9:      
 
 D ⇌ N                                    (2.9) 
 
 
Where D is the unfolded (denatured) state and N is the folded (native) state. 
 
The reaction of unfolded protein (D) forming folded protein (N) proceeds until the 
forward flux is equal to the reverse flux. At this point, the reaction has reached 
equilibrium. Taking the concentration ratio of the 2 species at equilibrium provides 
a new parameter, the equilibrium constant, Keq. For example, for a protein folding, 
Keq can be calculated using Equation 2.10: 
 
 YZ[ = []][_]                                           (2.10) 
 
 
where [N] is the concentration of native, folded protein and [D] is the concentration 
of denatured, unfolded protein. 
 
This thesis also considers the folding and binding reactions of IDPs with structured 
partner proteins. In these cases, the reactions are defined by Equation 2.11. Keq of 
these reactions can be described either in the forward direction (Ka) (Equation 
2.12), or more commonly, in the reverse direction (Kd) (Equation 2.13):  
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A + B	 ⇌ C                                (2.11) 
 Yc = [d]e f 	                                (2.12) 
 Yg = e fd                                 (2.13) 
 
 
where [A] is the concentration of protein A, [B] is the concentration of protein B 
and [C] is the concentration of the complex formed between proteins A and B. The 
concentrations are in units of molar (M). It is for this reason that the dissociation 
constant (Kd; units of M) is more convenient and easier to interpret than the 
association constant (Ka; units of M-1). 
 
As the equilibrium constant is the ratio of products over reactants, it provides 
information relating to the position of the equilibrium i.e. the amount of product vs 
the amount of reactant. In the case of the equilibrium dissociation constant (Kd), 
lower numbers indicate a high affinity complex, where the product (the complex) 
is favoured over the reactants. Equation 2.13 provides another piece of 
information: when [A] equals Kd, [B] is equal to [C]. Thus, the Kd is the 
concentration of A required to form a complex with 50% of the molecules of protein 
B.   
 
The equilibrium constant for a reaction can be converted into a difference in Gibbs 
free energy between the products and reactants using Equation 2.14: 
 
 ∆" = 	−01lnY                           (2.14) 
 
where R is the ideal gas constant (8.31 J K-1 mol-1), T is the temperature in kelvin 
and K is the equilibrium constant for the reaction.  
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Hence, as well as indicating whether a reaction is spontaneous, the Gibbs free 
energy describes the position of the equilibrium: the more negative the value of 
∆G, the larger the ratio of product(s) vs reactant(s).  
 
2.2.1 Measuring K 
Proteins can contain the naturally fluorescent amino acids, tyrosine and tryptophan. 
When these fluorescent amino acids change environment, for example, 
transitioning from solvent exposed into a hydrophobic core during protein folding, 
the fluorescence intensity and/or the emission wavelength can shift. Consequently, 
intrinsic fluorescence can be used as a proxy for determining whether the protein 
is in an unfolded or folded state.  
 
Folded proteins typically have a Gibbs free energy difference of 2 – 10 kcal.mol-1 
between the unfolded and folded state (Maxwell et al., 2005). Consequently, the 
concentration of folded protein may be several orders of magnitude greater than 
the concentration of unfolded protein (~2 x 107 excess for 10 kcal.mol-1). This can 
make it difficult to measure the concentration of denatured protein, and therefore 
K (Equation 2.10), under physiological conditions. To overcome this obstacle, 
difference in Gibbs free energy between the unfolded and folded protein can be 
reduced by adding chemical denaturants. As the observed unfolded state is induced 
by denaturant, it is often referred to as the denatured state. It has been shown 
empirically that the difference in Gibbs free energy is generally linearly related to 
the concentration of denaturant (Fersht, 1999), as show in Equation 2.15: 
 
 ∆"#$% = 	∆"#$%hij − k[Den]                   (2.15)  
 
 
where ∆GD-N is the Gibss free energy difference between the denatured and native 
state under the experimental conditions, ∆"#$%hij is the free energy difference in 
buffer, m is a constant and [Den] is the concentration of denaturant. 
 
Through altering the ratio of unfolded, denatured protein to folded, native protein, 
the equilibrium constant for that specific experimental condition can be ascertained 
more accurately. Calculating ∆GD-N at multiple denaturant concentrations allows the 
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m-value to be determined.  The Gibbs free energy difference between denatured 
and native states in buffer (∆"#$%hij) can then be determined by multiplying the m-
value by the concentration of denaturant required to equally populate both the 
denatured and native state (∆GD-N = 0). 
 
For bimolecular reactions, measuring K can be a little easier. As the formation of 
the complex requires both proteins, the concentration of the free and bound 
proteins can be altered by changing the concentration of one of the protein 
partners.  
 
2.3 Reaction Rates 
For a reversible reaction, such as those described in Equations 2.9 and 2.11, the 
flux of the forward and reverse reactions can be described by reaction rate 
constants, k. For protein folding, these can be termed kf, the rate constant for 
folding, and ku, the rate constant for unfolding. To distinguish from this 
terminology, the reaction rates for a 2-state bimolecular reaction are referred to as 
the association rate constant, kon (the rate of complex formation) and the 
dissociation rate constant, koff (the rate of complex dissociation).  
 
When a protein can only exist in 2-states, either natively folded or unfolded 
(denatured), the change in concentration of denatured protein with time is 
described by Equation 2.16:  
 
 n[]]no = p- q 	−	pr[s]                         (2.16) 
 
 
where [N] is the concentration of natively folded protein, ku is the rate constant for 
unfolding, [D] is the concentration of denatured protein and kf is the rate constant 
for folding.  
 
At equilibrium, the change in concentration of native and denatured protein is 
equal. Therefore, as shown in Equations 2.17 and 2.18, the equilibrium constant 
for a 2-state unimolecular reaction is equal to the ratio of the kinetic rates: 
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 0 = 	p- q 	−	pr[s]                         (2.17) 
 Y = 	 []][_] = 4945                             (2.18) 
 
When an extra protein molecule is involved, such as in IDP coupled folding and 
binding reactions, the rate equation becomes a little more complex. Rather than 
following first order reaction kinetics, the rate of complex formation for a reversible 
bimolecular reaction is dependent on the concentration of both proteins. 
Consequently, for the reaction scheme shown in Equation 2.11 – where proteins A 
and B react to form the complex, C – the change in the concentration of the protein 
A with time is described by Equation 2.19:      
 
 n[e]no = purr v − puD w x                       (2.19) 
 
 
where [C] is the concentration of complex, [A] is the concentration of protein A, 
[B] is the concentration of protein B, kon is the association rate constant for the 
reaction and koff is the dissociation rate constant for the reaction. 
 
Again, at equilibrium the change in concentration of protein A with time is 0. 
Therefore, as shown in Equations 2.20 and 2.21, the equilibrium constant is equal 
to the ratio of the kinetic rates: 
 
 0 = purr v − puD w x                       (2.20)   
 Yg = 	 e f[d] = 	 4y554z{                           (2.21)                     
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2.3.1 Measuring k 
When a protein is transferred into conditions that favour the unfolded state, for 
example, by rapidly mixing the protein with a chemical denaturant, the change in 
fluorescence with time can be followed. The change in fluorescence is described by 
an exponential function and can be derived from the rate law, as shown in Equations 
2.22, 2.23, 2.24 and 2.25. First, as the reaction is 2-state, the concentration of 
native protein can be replaced by the concentration of denatured protein at time 0, 
minus the concentration of denatured protein at time t. 
 
 n[]]no = p-( s } − s )	−	pr[s]                       (2.22) 
 
The equation can then be rearranged to give;   
 n[]]no + 	 p-+	pr s = p- s }                      (2.23) 
 
integration then gives; 
 s = 	 4~ ] 4~Ä4Å + 	ve($4~Ä4Å)o                      (2.24) 
 
which is equivalent to a single exponential function:  
 s = 	ÇrEDcÉ + ∆Çe($4yÑK)o                      (2.25) 
 
 
where Ffinal is the fluorescence at the end of the reaction, ∆F is the amplitude of the 
fluorescence change, kobs is the observed rate constant (ku + kf) and t is time.  
 
 
As bimolecular reactions are dependent on the concentration of both individual 
proteins, integration of the rate law becomes a little more complex. For example, 
Equations 2.26, 2.27, 2.28 and 2.29 show the model used by Shammas et al. 
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(2013) to fit the association kinetic data for a protein (A) binding to a different 
protein (B) under reversible conditions; 
 
 Ç = Ç} +	∆Ç (Ö$Ü)(á$Z àâyäã )å ç>àçÄà Z àâyäã $á                      (2.26) 
 
 
where b is equal to; 
 é = − Yn + 1 + è w                        (2.27) 
 
z is equal to; 
 ê = 	 Ynå + 2 1 + è Yg w + èå − 2è + 1 [w]å          (2.28) 
 
x is equal to: 
 è = 	 [f][e]                                  (2.29) 
 
and [A] is the concentration of protein A and [B] is the concentration of protein B.  
 
This model describes data obtained from experiments where the two proteins are 
mixed at near equimolar concentrations. When the concentration of one protein is 
in significant excess over the concentration of the other, then the model can be 
simplified. For example, if protein B is in a 10-fold concentration excess over protein 
A, then a maximum of 10% of protein B will go into complex (assuming a 1:1 
stoichiometric ratio). The concentration of protein B is therefore effectively constant 
and can be combined into the association rate constant, as shown in Equation 2.30: 
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n[e]no = purr v − p′uD w                        (2.30) 
 
where k’on is equal to kon multiplied by [B]. 
 
Equation 2.30 resembles 2.16 and the reaction can be described by an exponential 
function (Equation 2.25). Maintaining one of the proteins at a ten-fold concentration 
excess over the other protein therefore results in the reaction following pseudo-
first order kinetics.   
 
2.3.2 Determining ∆∆G from kinetics 
Reactions rates are related to the difference in free energy between the transition 
state and the 2 ground states (e.g. folded or denatured protein). A conversion 
between reaction rates and free energy barriers is provided by the Arrhenius 
equation, as shown in Equations 2.31 and 2.32: 
 
  pr = we ∆ì=>‡îï       or      ∆"#$‡ = 01 lnpr − lnw            (2.31) 
 pñ = we >∆ì‡>?îï     or   ∆"‡$% = −01 lnp- − lnw            (2.32)       
 
where ∆GD-‡ is the difference in free energy between the transition state and the 
denatured state, ∆G‡-N is the difference in free energy between the native state and 
the transition state, R is the ideal gas constant, T is the temperature in kelvin, kf is 
the rate constant for folding, ku is the rate constant for unfolding and A is a 
constant.  
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The pre-exponential factor A relates to the reaction rate at infinite temperature, 
i.e. when the exponent tends to 0. This cannot be directly determined from a simple 
kinetic experiment. However, when calculating ∆∆G‡-N or ∆∆GD-‡ for a mutant, the 
pre-exponential factor is assumed to be equal and can be cancelled, giving 
Equations 1.2 and 1.3, which are reproduced here for clarity: 
 ΔΔ"#$‡ = 	01ln 45674589:                                                 (1.2) 
 ΔΔ"‡$% = 	−01ln 49674989:                        (1.3) 
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Chapter 3  
 
3 Materials and Methods 
 
3.1 Buffers and Reagents 
All stock buffers were prepared volumetrically, filter sterilised through 0.22 µM 
cellulose acetate filters (Sartorius Stedim Biotech), and stored at 25°C. Biophysical 
buffer used in investigating helix-flanking prolines was 100 mM sodium phosphate 
with 0.05% tween 20 at pH 7.4. All experiments with BCL-2-like or BH3-containing 
proteins were performed with a biophysical buffer consisting of 50 mM sodium 
phosphate with 0.05% Tween 20 at pH 7.0. 
 
Ultrapure deionised water: Deionised water (ddH2O), defined as having a resistivity 
of 18.2 MΩ•cm at 25°C, was obtained from water purifiers and used in the 
preparation of all buffers, broths and reagents, unless otherwise stated. 
 
Lysogeny broth (LB): Media containing 10 g/L tryptone, 5 g/L yeast extract and 10 
g/L NaCl (all MP Biomedicals) was prepared and autoclaved at 121°C for at least 
20 minutes.  
 
2x yeast extract and tryptone broth (2x YT): Media containing 16 g/L Tryptone, 10 
g/L yeast extract and 5 g/L NaCl (all MP Biomedicals) was prepared and autoclaved 
at 121°C for at least 20 minutes.  
 
Imidazole: A 1 M (34.04 g/L) stock was prepared. 
 
Phosphate buffered saline (PBS), pH 7.4: A 20x stock was prepared containing 162 
mM (28.82 g/L) disodium hydrogen phosphate dihydrate (Na2HPO4 2H2O), 38 mM 
(5.93 g/L for the dihydrate) sodium dihydrogen phosphate dihydrate (NaH2PO4 
2H2O), 54 mM (4.03 g/L) potassium chloride (KCl) and 2.73 M (159.54 g/L) sodium 
chloride (NaCl). 
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PBS imidazole buffer: 1x PBS with 25 mM or 500mM imidazole was prepared by 
dilution of the 20x PBS and 1M imidazole stock buffers. 
 
Phosphate buffer, pH 7.4: A 100 mM stock solution was prepared containing 81 mM 
(14.42 g/L for the dihydrate) disodium hydrogen phosphate dihydrate (Na2HPO4 
2H2O) and 19 mM (2.96 g/L) sodium dihydrogen phosphate dihydrate (NaH2PO4 
2H2O). 
 
Biophysical 100 mM phosphate tween buffer, pH 7.4: Tween® 20 (Fisher) was 
added to the 100 mM phosphate buffer stock to give a final tween concentration of 
0.05% (500 µL per L of phosphate buffer).  
 
Biophysical 50 mM phosphate tween buffer, pH 7.0: A 50 mM buffer was prepared 
containing 29.7 mM disodium hydrogen phosphate dihydrate (Na2HPO4 2H2O, 5.29 
g/L), 20.3 mM sodium dihydrogen phosphate dihydrate (NaH2PO4 2H2O, 3.17 g/L) 
and 500 µL of Tween® 20 (Fisher) per 1 L of phosphate buffer.  
 
Tris(hydroxymethyl)aminomethane (TRIS) buffer, pH 7.0: A 200 mM, 10x stock, 
was prepared containing 16 mM (1.94 g/L) TRIS base and 183 mM (28.8 g/L) TRIS 
hydrochloride. 
 
TRIS ion exchange buffer, pH 7.0: 1x TRIS, by dilution of the 10x TRIS stock, was 
prepared containing 0 or 500mM (29.22 g/L) or 1M (58.44 g/L) NaCl. 
 
TRIS buffer, pH 8: A 100 mM stock, was prepared containing 39 mM (4.72 g/L) 
TRIS base and 60 mM (9.46 g/L) TRIS hydrochloride. 
 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid ion exchange buffer (HEPES), 
pH 7.5: a 10 mM buffer containing 5.7 mM (1.36 g/L) of HEPES free acid 
(C8H18N2O4S) and 4.2 mM (1.09 g/L) of HEPES sodium salt (C8H17N2NaO4S) was 
prepared. For the 10 mM HEPES pH 7.5 1 M NaCl buffer, 58.44 g/L of NaCl was 
added.  
 
Factor Xa cleavage buffer: A 20 mM pH 8.0, 50 mM NaCl, 5 mM CaCl2 buffer was 
prepared by dilution of the 100 mM TRIS pH 8.0 stock and addition of 2.92 g/L of 
NaCl and 0.74 g/L of CaCl2. 
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TEV cleavage buffer: A 10 mM TRIS pH 8.0, 150 mM NaCl buffer was prepared by 
dilution of the 10x TRIS stock and addition of 8.77 g/L of NaCl. 
 
M9 Salts: A 10x stock was prepared containing 423 mM disodium hydrogen 
phosphate dihydrate (Na2HPO4 2H2O, 75.3 g/L), 172 potassium phosphate dibasic 
(HK2O4P, 30 g/L) and 85.6 mM NaCl (5 g/L). The stock was adjusted to pH 7.4 by 
titration with NaOH.  
 
M9 Minimal Media: 1 L of minimal growth media was prepared containing 1 x M9 
salts (100 mL of 10x M9 salts), 2 mM MgS04 (2 mL of 1 M stock) 0.1 mM CaCl2 (2 
mL of 50 mM stock), 10 µM FeCl3 (1 mL of 10 mM stock), 1 µg/mL of Vitamin B1 
(400 µL of 5 mg/mL stock), 1 g of 15N ammonium chloride and 2 g of 13C glucose. 
The pH was adjusted to 7.4 by titration with HCl.   
 
Alexa Fluor® 594 C5 maleimide dye (Life Technologies): An 11 mM stock was 
prepared in DMSO, flash frozen in liquid Nitrogen (N2) and stored in 10 µL aliquots 
at – 80°C. 
 
Ampicillin (Fisher Scientific): A 100 mg/mL stock solution was prepared, filter 
sterilised through 0.22 µM polyethersulfone membrane (PEM) filters (Millex), and 
stored in 1 mL aliquots at – 20°C. 
 
Isopropyl β-D-thiogalactoside (IPTG) (Thermo Scientific): A 1M (238.3 g/L) stock 
was prepared, filter sterilised through 0.22 µM PEM filters (Millex), and stored at - 
20°C in 400 µL aliquots.  
 
Thrombin (Sigma): A stock of 1 unit/µL was prepared, filter sterilised filter sterilised 
through 0.22 µM PEM filters (Millex), and stored in 200 µL aliquots at – 20°C. 
 
TEV protease: tobacco etch virus (TEV) protease was expressed and purified in the 
lab by Tristan Kwan, according to a slightly modified version of an optimised 
protocol (Blommel and Fox, 2007). TEV was stored at –20°C in 20 mM TRIS pH 
7.5, 125 mM NaCl, 2mM DTT, 2 mM EDTA and and 50% (v/v) glycerol. 
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Dithiothreitol (DTT) (Fisher Scientific): A 1 M stock solution (154.24 g/L) was 
prepared in biophysical 50 mM phosphate tween buffer, filter sterilised through 
0.22 µM polyethersulfone membrane (PEM) filters (Millex), and stored in 0.25 mL 
aliquots at – 20°C. 
 
3.2 Escherichia Coli Cells 
Three strains of Escherichia coli (E. coli) cells were used in this work. XL1-Blue cells 
(genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F ́ proAB 
lacIqZ∆M15 Tn10 (Tetr)]) were used for site directed mutagenesis. These cells were 
utilised as they are deficient in endonuclease (endA), and consequently, produce 
good quality miniprep DNA. For protein expression and purification, C41 (genotype: 
F– ompT gal dcm hsdSB(rB-mB-) (DE3)) or C41 (DE3) pLysS (F– ompT gal dcm 
hsdSB(rB-mB-) (DE3) pLysS (Cmr)) cells were used. C41 and C41 pLysS cells are 
derived from BL21 (DE3) cells. Compared to BL21 cells, they contain two mutations 
in the LacUV5 promoter, which helps to improve the expression of toxic proteins 
(Miroux and Walker, 1996; Rosano and Ceccarelli, 2014).   
 
3.3 Generation of CaCl2 Competent Cells 
E. coli cells were incubated, shaking, at 37°C overnight in 5 mL of Lysogeny broth 
(LB). Under sterile conditions, 1 mL of overnight culture was added to 100 mL of 
LB. Cells were incubated at 37°C, shaking, until the optical density at 600 nm 
(OD600) reached 0.3 – 0.5: when the cells were placed on ice for at least 20 minutes. 
After splitting the volume into two 50 mL conical tubes, the cells were pelleted by 
centrifugation at 3,000 rpm (1962 x g) for 10 minutes at 4°C. Pellets were re-
suspended in 10 mL of 100 mM CaCl2 15% glycerol (v/v) before leaving on ice for 
20 minutes. After pelleting again, the supernatant was discarded and the cells were 
re-suspended in 2 mL of 100 mM CaCl2 15% glycerol (v/v). Cells were aliquoted, 
flash frozen in liquid N2 and stored at – 80°C.  
 
3.4 Transformation into Competent Cells 
Unless stated otherwise, all transformations were carried out as follows. Plasmid 
Deoxyribonucleic acid (DNA) was mixed with CaCl2 competent E. coli cells and left 
on ice for 10 minutes. Incorporation of DNA was achieved by heat shock at 42°C 
for 45 seconds, before placing on ice for 2 minutes. Cells were incubated in 900 µL 
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of 2x YT for 45 minutes, shaking, at 37°C. After pelleting the cells, the supernatant 
was removed and the cells re-suspended in 50 – 100 µL of 2x YT, before spreading 
onto a 2x YT agar plate containing 0.1 mg/mL ampicillin and incubating overnight 
at 37°C. 
 
3.5 Mutagenesis 
Mutants were constructed from wild type (WT) plasmid templates using site-
directed mutagenesis. Primers were designed to be more than 30 residues in 
length, begin and end in at least one G or C and contain the nucleotides to be 
mutated in approximately the middle of the sequence. Mutation reaction mixtures 
consisted of 2.5 µL of 10 µM forward and reverse primer mix, 5µl of 2mM 
nucleotides (Fermentas), 1µL of at least 50 ng/µL plasmid DNA template, 5 µL of 
10 x Pfu reaction buffer MgCl2 (ThermoScientific), 1 µL of Pfu Turbo polymerase 
(ThermoScientific) and 35.5 µL of ddH2O. Mutation reactions consisted of 15 cycles 
(95°C for 1 minute, 50°C for 1 minute and 72°C for 7 minutes) and were performed 
using a PTC-100 programmable thermal controller (Bio-Rad). Parental methylated 
DNA template was digested by incubation with 10 units of Dpn1 for at least 30 
minutes at 37°C. Plasmids (10 µL) were transformed into XL1-blue cells (100 µL). 
Single colonies were selected from 2x YT agar plates and incubated at 37°C 
overnight in 2x YT broth containing 0.1 mg/mL ampicillin. Plasmid DNA was isolated 
and purified using a QIAprep Spin Miniprep Kit (Qiagen), following manufacturer’s 
instructions: briefly, cells were lysed, ribonucleic acid (RNA) was degraded, and 
proteins were denatured. Cell debris was precipitated and soluble plasmid DNA 
bound onto a silica membrane. After washing, the DNA was eluted in ddH2O. 
Isolated plasmid DNA was sent for sequencing (Beckman Coulter) to confirm 
successful mutagenesis.    
 
3.6 Protein Expression and Purification 
Unless otherwise stated in the subsections below, all proteins and peptides were 
expressed and purified as follows. Plasmid DNA was transformed into C41 (DE3) or 
C41 (DE3) pLysS E. coli cells, as described above. Protein transcription was typically 
under the control of a T7 promoter: C41 (DE3) and C41 (DE3) pLysS cells are 
engineered to be able to express T7 polymerase, which binds to the T7 promoter, 
leading to transcription. Protein expression during cell growth was inhibited by the 
lac repressor, which binds to the lac operon and prevents T7 polymerase from being 
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produced. Cells were grown, shaking, at 37°C to an OD600 of 0.4 - 0.6 in 2x YT or 
LB with 100 µg/mL of ampicillin. Protein expression was then induced by addition 
of IPTG to a final concentration of 0.1 or 1 mM: IPTG binds to the lac repressor, 
which disrupts its interaction with the lac operon, leading to T7 polymerase 
production and transcription of plasmid DNA. Cells were harvested by centrifugation 
at 5,000 revolutions per minute (rpm) for 45 minutes using a SLC4000 rotor 
(Sorvall). Cell pellets were flash frozen in liquid N2 and stored at – 80°C. Cells were 
lysed on ice using an XL-2020 sonicator (Misonix). Sonication consisted of 3 
minutes pulsing, which was split into 15 second (s) pulses separated by 45 s rest. 
Cell sonicate was pelleted by centrifugation at 18,000 rpm for 45 minutes using a 
SS34 rotor (Thermo Scientific). Sonicate supernatants were filtered through 0.45 
and 0.22 µm PEM filters (Millex) before affinity purification: all recombinantly 
expressed proteins contained a hexahistadine tag sequence (HisTag) or glutathione 
S-transferase tag sequence (GST Tag) N-terminal to the protein. Protein purity was 
assessed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE). After the first purification of a new protein, a sample was sent for analysis 
by mass spectrometry (Department of Chemistry, University of Cambridge) to 
confirm the identity of the purified product. Specific expression and purification 
procedures for each of the proteins and peptides are listed below.  
 
3.6.1 CBP KIX  
The gene for the kinase-inducible domain interacting domain (KIX) of mouse 
CREB-binding protein (CBP) (Uniprot P45481, residues 586 – 672) had previously 
been cloned into a modified version of the pRSET A vector, which contained a 
HisTag N-terminal to CPB KIX, by Dr Sarah Shammas. A single C41 colony was 
added to 5 mL of 2x YT with 100 µg/mL ampicillin and left shaking at 37°C 
overnight. Each 5 mL starter culture was used to inoculate 1L of 2x YT. After 
induction, cells were incubated, shaking, for four hours at 37°C before harvesting. 
Cells were thawed and re-suspended in PBS 25 mM imidazole before sonication. 
Sonicate supernatants were loaded onto a 5 mL HisTrap™ HP column (GE 
Healthcare) using an ÄKTA fast protein liquid chromatography (FPLC) (Amersham 
Biosciences). CBP KIX was eluted from the column using a linear gradient of PBS 
imidazole from 25 to 500 mM over 50 mL. Peak elution was observed at 
approximately 400 mM imidazole. CBP KIX fractions were pooled and incubated 
with 200 units of thrombin overnight at room temperature. Finally, cleaved KIX was 
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loaded onto a HiLoad™ 26/600 Superdex™ 75 pg gel filtration column that had 
been pre-equilibrated in 100 mM sodium phosphate buffer, pH 7.4. Purified KIX 
protein (Figure 3.1) was stored at 4°C. 
 
 
 
Figure 3.1 Amino Acid Sequence for Recombinant CBP KIX. 
CBP KIX consisted of 89 amino acids: glycine and serine at the N-terminus (black), 
as remnants of thrombin cleavage, and residues 586 – 672 of CBP (blue) (Uniprot 
P45481).  	
3.6.2 c-MYB 
The transactivation domain (TAD) of mouse c-MYB (Uniprot P06876, residues 275 
– 327) was expressed as a GB1 fusion protein. The fusion protein gene had 
previously been cloned into a modified version of the pRSET A vector, which 
contained a HisTag N-terminal to GB1, by Dr Sarah Shammas. A scrape of C41 cells 
was added to 5 mL of 2x YT with 100 µg/mL ampicillin and left shaking at 37°C for 
2 hours. Each 5 mL starter culture was used to inoculate 1 L of 2x YT. After induction 
with 0.1 mM IPTG, cells were incubated overnight, shaking, at 18°C, before 
harvesting. Cells were thawed and re-suspended in PBS 25 mM imidazole before 
sonication. Sonicated supernatants were incubated with 3.5 mL of nickel agarose 
resin (Agarose Bead Technologies) for at least 1 hour at 4°C. Resin was washed 
three times with PBS 25mM imidazole and twice with 20mM TRIS pH 7 10mM 
imidazole, before incubating overnight at room temperature with 100 units of 
thrombin. Cleaved c-MYB was loaded onto a 5 mL HiTrap™ Q HP ion exchange 
column (GE healthcare) using an ÄKTA FPLC (Amersham Biosciences). A TRIS ion 
exchange buffer linear gradient of 0 to 300 mM NaCl over 50 mL was used to elute 
bound c-MYB. Peak elution was observed at approximately 110 mM NaCl. Finally, 
c-MYB was loaded onto a HiLoad™ 26/600 Superdex™ 75 gel filtration column that 
had been pre-equilibrated in 100 mM sodium phosphate buffer, pH 7.4. Purified c-
MYB peptides (Figure 3.2) were stored at 4°C or aliquoted, flash frozen in liquid N2 
and kept at – 80°C. 
 
GSGVRKGWHEHVTQDLRSHLVHKLVQAIFPTPDPAALKDRRMENLVAYAKKVEGDM
YESANSRDEYYHLLAEKIYKIQKELEEKRRSRL
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Figure 3.2 Amino Acid Sequence for Recombinant c-MYB Peptides. 
c-MYB consisted of 55 amino acids: glycine and serine at the N-terminus (grey) as 
remnants of thrombin cleavage and residues 275 to 327 of c-MYB (red) (Uniprot 
P06876). Mutated residues are highlighted. The positions of mutated residues are 
shown relative to the peptide investigated in this work. In the context of full length 
c-MYB, the alanine mutations represent residues P289, and P289 and P316. The 
highlighted cysteine was either modified with an Alexa Fluor dye (Chapter 3.9), or 
mutated to an alanine to avoid disulphide bond formation. 
 
3.6.3 PUMA 
Residues 127 – 161 of mouse PUMA (UniProt Q99ML1) were expressed as a GB1 
fusion protein. Residue I144 of PUMA was mutated to an alanine to reduce peptide 
self-association (Rogers et al., 2014b) (Figure 3.3). The fusion protein gene had 
previously been cloned into a modified version of the pRSET A vector, which 
contained a HisTag N-terminal to GB1, by Dr Joseph Rogers.  
 
 
 
Figure 3.3 Amino Acid Sequence for Recombinant PUMA 35. 
The 35-amino acid PUMA peptide was expressed as a GB1-fusion protein. PUMA 
was cleaved from GB1 using Factor Xa, which leaves no additional residues N-
terminal to the cleavage site. An I144A mutation (red) was included to reduce 
peptide oligomerisation. The sequence represents residues 127 – 161 of mouse 
PUMA (UniProt Q99ML1). 
 
After induction with 1 mM IPTG, cells were grown in LB overnight at 18°C. Cell 
pellets were resuspended in PBS 25 mM imidazole and sonicated. Sonicate 
supernatant was incubated with Ni2+-agarose resin (1.25 mL per L of culture) 
(Agarose Bead Technologies) for 1 hour at 4°C. Unbound protein was removed by 
washing twice with PBS 25 mM imidazole and once with Factor Xa cleavage buffer. 
WT: GSPAAAAIQRHYNDEDPEKEKRIKELELLLMSTENELKGQQVLPTQ
NHTCSYPGW
P17A: GSPAAAAIQRHYNDEDAEKEKRIKELELLLMSTENELKGQQVLPTQ
NHTCSYPGW
P17/44A: GSPAAAAIQRHYNDEDAEKEKRIKELELLLMSTENELKGQQVLATQ
NHTCSYPGW
WT BID: SESQEEIIHNIARHLAQIGDEMDHNIQPTLVRQLA
PUMA 35: RVEEEEWAREIGAQLRRAADDLNAQYERRRQEEQH
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Resin was resuspended in Factor Xa cleavage buffer and incubated overnight at 
room temperature with 20 µg of Factor Xa (New England Biolabs): the fusion 
protein contained a Factor Xa cleavage site between GB1 and PUMA. Resin 
supernatant was loaded onto a 5 mL HiTrap™ Q HP ion exchange column (GE 
healthcare) using an ÄKTA FPLC (Amersham Biosciences). A TRIS pH 7 ion 
exchange buffer gradient of 0 – 250 mM NaCl over 90 mL was used to elute bound 
PUMA. Peak elution of PUMA was observed at approximately 135 mM NaCl. 
Fractions that appeared pure by SDS-PAGE were pooled and loaded onto a HiLoad™ 
26/600 Superdex™ 30 pg gel filtration column. The column was pre-equilibrated in 
50 mM biophysical sodium phosphate buffer, pH 7.0. Purified PUMA was aliquoted, 
flash frozen in liquid N2 and stored at – 80°C. 
 
3.6.4 MCL-1 
Residues 152 – 308 of mouse MCL-1 (UniProt P97287) had been previously cloned 
into a modified version of the pRSET A vector, which contained a HisTag N-terminal 
to MCL-1, by Dr Joseph Rogers.  
 
 
 
Figure 3.4 Amino Acid Sequence for Recombinant Mouse MCL-1. 
The protein sequence for MCL-1 is shown in grey. Additional glycine and serine 
residues (black) at the N-terminus are not part of the WT sequence, but are 
remnants from thrombin cleavage. The MCL-1 sequence studied in this work 
therefore contained these two extra residues. The N-terminal portion of MCL-1 is 
does not form part of the BCL-2 fold, but contains multiple post-translational 
modification sites (Germain and Duronio, 2007; Thomas et al., 2010), while the C-
terminal portion of the protein contains a trans-membrane domain. Therefore, a 
truncated version of MCl-1, with the first 151 and the final 23 residues removed, 
was investigated in this work.        
 
After induction with 1 mM IPTG, C41 pLysS cells were grown overnight in LB at 
18°C. Cell pellets were resuspended in PBS 25 mM imidazole and sonicated. 
Sonicate supernatant was incubated with Ni2+-agarose resin (1.25 mL per L of 
culture) (Agarose Bead Technologies) for 1 hour at 4°C. Unbound protein was 
removed by washing three times with PBS 25 mM imidazole. To elute bound 
GSEDDLYRQSLEIISRYLREQATGSKDSKPLGEAGAAGRRALETLRRVGDGVQRNH
ETAFQGMLRKLDIKNEGDVKSFSRVMVHVFKDGVTNWGRIVTLISFGAFVAKHLKS
VNQESFIEPLAETITDVLVRTKRDWLVKQRGWDGFVEFFHVQDLEGG
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protein, resin was resuspended in PBS 500 mM imidazole, which had been pH 
corrected to 7.5: the addition of imidazole raised the pH, taking it close to the 
estimated isoelectric point (PI) of MCL-1 (8.23). At the PI, a protein has no net 
charge, potentially increasing the likelihood that the protein will precipitate. 
 
EDTA (4 mM final) was added to the eluted protein solution – the presence of Ni2+ 
can cause chelation of proteins with HisTags, resulting in aggregation and 
precipitation. EDTA binds to the nickel, preventing the HisTag chelation. To reduce 
the concentration of imidazole, the protein was buffer exchanged using 5 kDa 
molecular weight cut off (MWCO) Vivaspin centrifuge concentrators (Sartorius). 
Once the concentration of imidazole was reduced to ~ 50 mM, 600 units of thrombin 
were added to cleave the HisTag overnight at room temperature. Uncleaved protein 
was removed by incubation with Ni2+-agarose resin. Before adding the protein to 
the resin, 4 mM CaCl2 was added to sequester the free EDTA: free EDTA would bind 
to the Ni2+, stripping the resin and reducing the ability of the HisTag to bind. 
Cleaved protein was collected from the resin supernatant. At this stage, purification 
of MCL-1 could be achieved by proceeding straight to size exclusion 
chromatography; however, some MCL-1 fractions contained an impurity of around 
8 kDa (assessed by SDS-PAGE). These fractions were eluted at the start of the 
main MCL-1 elution peak (~ 175 mL) and appeared as a shoulder on the 
chromatogram. The earlier elution volume indicates that the 8 kDa protein was 
likely interacting with MCL-1, producing a protein species of larger size. To remove 
this contaminant, an ion-exchange step was included before gel filtration. Cleaved 
protein was loaded onto a 5 mL HiTrap™ SP HP ion exchange column (GE 
healthcare) using an ÄKTA FPLC (Amersham Biosciences). HEPES ion exchange 
buffer linear gradients of 0 – 9% over 20 mL, 9 – 13% over 25 mL and 13 – 20% 
over 20 mL was used to elute bound MCL-1. MCL-1 elution began at 100 mM NaCl 
(10%), with peak elution observed at 120 mM NaCl. Some MCL-1 also co-eluted 
with the 8 kDa protein at approximately 130 mM NaCl, but the majority of MCL-1 
was separated from the impurity. Pure MCL-1 (assessed by SDS-PAGE) was loaded 
onto a HiLoad™ 26/600 Superdex™ 75 gel filtration column, which had been pre-
equilibrated in 50 mM biophysical sodium phosphate buffer. 
 
Purified MCL-1 was either stored at 4°C, or buffer exchanged into ddH2O using 
HiTrap desalting columns (GE Healthcare) and lyophilised.  
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3.6.5 A1 
The pGEX-4T-3 plasmid containing the sequence for mouse A1 was kindly donated 
by Bonsu Ku (Korea Research Institute of Bioscience and Biotechnology). The 
plasmid was a slightly modified version of pGEX-4T-3, containing a tobacco etch 
virus (TEV) protease site, instead of the usual thrombin cleavage site. Unlike the 
pRSET A plasmids used in the majority of this work, transcription of A1 was under 
the control of a tac promotor. tac combines the strength of the tryptophan (trp) 
promoter and the lac promotors’ ability to be induced by lactose (Rosano and 
Ceccarelli, 2014). Therefore, protein transcription can be directly induced by the 
addition of IPTG, without the requirement of T7 polymerase – transcription occurs 
via E.coli RNA polymerase.  
 
After induction with 1 mM IPTG, cells were grown in LB overnight at 24°C. Cell 
pellets were resuspended in PBS. A1 was expressed as a GST-fusion protein, and 
sonicate supernatant was incubated with glutathione sepharose 4B (GE Healthcare) 
for 4 hours at 4°C. Bound protein was washed once with PBS and twice with TEV 
cleavage buffer. After resuspending in TEV cleavage buffer, EDTA and DTT were 
added to a final concentration of 2 mM and 10 mM, respectively. A1 was left 
overnight, rolling at room temperature, with approximately 5 µM of TEV protease.  
Cleaved A1 was loaded onto a 5 mL HiTrap™ Q HP ion exchange column (GE 
healthcare) using an ÄKTA FPLC (Amersham Biosciences). A TRIS ion exchange 
buffer linear gradient of 0 – 23% over 60 mLs was used to elute bound A1. Elution 
was typically observed at approximately 100 mM NaCl (10%). After ion-exchange, 
A1 generally appeared pure by SDS-PAGE. As a final purification step, and to 
exchange the protein into biophysical buffer, A1 was loaded onto a HiLoad™ 26/600 
Superdex™ 75 gel filtration column.  
 
Purified mouse A1 consisted of residues 1-152 (Uniprot Q07440) with P104K and 
C113S mutations (Figure 3.5). This matched the sequence used by Smits et al to 
solve the structure of A1:PUMA and A1:BID (Smits et al., 2008). The 20 residue C-
terminal transmembrane domain was not included in the expressed protein. 
Purified A1 was stored at 4°C.  
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Figure 3.5 Amino Acid Sequence for Recombinant Mouse A1. 
The protein sequence for WT A1 (UniProt Q07440) is shown in green. Additional 
glycine and serine residues (black) at the N-terminus are not part of the WT 
sequence, but are remnants from TEV cleavage. The A1 sequence studied in this 
work therefore contained these two extra residues.        
 
3.6.6 BCL-XL 
The pPROEX HTa plasmid containing the sequence for mouse BCL-XL was kindly 
donated by Bonsu Ku (Korea Research Institute of Bioscience and Biotechnology). 
Similar to the pGEX-4T-3 plasmid used in the expression of A1 (see Chapter 3.6.5), 
the pPROEX HTa plasmid does not contain a T7 promoter. Instead, protein 
transcription is under the control of a trc promoter. trc is based on the tac promoter, 
but contains one additional base in the linker between the trp and lac promoter 
segments (Brosius et al., 1985). Protein transcription is therefore induced by IPTG, 
and facilitated by E.coli RNA polymerase.  
 
BCL-XL was expressed and purified to determine its suitability as an alternative 
PUMA binding partner. As A1 was chosen instead of BCL-XL, the expression and 
purification of BCL-XL was not optimised. The protocol used to produce pure BCL-XL 
is described below.  
 
After induction with 0.1 mM IPTG, cells were grown overnight at 18°C. Cell pellets 
were reuspended in PBS 25 mM imidazole. BCL-XL was expressed with an N-
-terminal HisTag. Sonicate supernatant was incubated with Ni2+-agarose resin 
(1.25 mL per L of culture) (Agarose Bead Technologies) for 1 hour at 4°C. Unbound 
protein was removed by washing twice with PBS 25 mM imidazole and twice with 
50 mM biophysical sodium phosphate buffer. Addition of 350 mM imidazole eluted 
protein from the resin. Overnight incubation at room temperature with 
approximately 5 µM of TEV protease and 5 mM DTT resulted in partial cleavage of 
the N-terminal HisTag. Size exclusion chromatography, using HiLoad™ 26/600 
Superdex™ 75 gel filtration column that had been pre-equilibrated in 50 mM 
biophysical sodium phosphate buffer, did not separate the HisTag linked, and 
GSMAESELMHIHSLAEHYLQYVLQVPAFESAPSQACRVLQRVAFSVQKEVEKNLKS
YLDDFHVESIDTARIIFNQVMEKEFEDGIINWGRIVTIFAFGGVLLKKLKQEQIAL
DVSAYKQVSSFVAEFIMNNTGEWIRQNGGWEDGFIKKFEPKS
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cleaved BCL-XL. HisTag linked protein was removed by incubation with 
Ni2+-agarose resin for 45 mins at room temperature. Pure BCL-XL was isolated from 
the resin supernatant.       
 
Compared to the sequence of mouse BCL-XL (UniProt Q64373, residues 1 – 42 and 
84 – 196), purified BCL-XL differed by a single mutation, A84S. The structure of 
BCL:XL (PDB 2M04) contains 5 further differences to the purified protein, an 
insertion (S43, which is an alanine in the mouse sequence) and 4 mutations (E40G, 
S84E, S168A and D193E). The disordered loop between helices 1 and 2 (residues 
43 – 83) and 37 C-terminal residues were not included in the expressed protein 
(Figure 3.6). Purified BCL-XL was stored at 4°C.  
 
 
 
Figure 3.6 Amino Acid Sequence for Recombinant Mouse BCL-XL. 
The protein sequence for BCL-XL is shown in orange. Additional glycine and 
histidine residues (black) at the N-terminus are not part of the WT sequence, but 
are remnants from TEV cleavage. The BCL-XL sequence studied in this work 
therefore contains these two extra residues. A disordered loop between residues 
42 and 84, and the C-terminal transmembrane domain, were not included in the 
expressed protein.         
 
3.7 Synthesised Peptides 
 
3.7.1 MLL 
MLL peptides were purchased from Biomatik (Canada) and synthesised with either 
a free, or fluorescein isothiocyanate (FITC) labelled, N–terminus (Figure 3.7). FITC 
is a fluorescent dye and was added to aid kinetic and thermodynamic analysis.  
 
GHMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEETESAVKQALREAGD
EFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALC
VESVDKEMQVLVSRIASWMATYLNDHLEPWIQENGGWDTFVDLYG
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Figure 3.7 Chemical Structure of FITC. 
The structure of fluorescein isothiocyanate (FITC) when attached to the N-terminus 
of peptides. The nitrogen-peptide bond indicates the N-terminal end of the attached 
peptide sequence. When conjugated to the peptide, FITC contributes an additional 
charge of approximately – 1.8 at pH 7 (the pKa for formation of the anion and 
dianion are 4.31 and 6.43, respectively) (Sjöback et al., 1995). The structure of 
FITC was constructed using ChemDraw Professional (version 16.0). 
Mouse WT MLL consisted of 31 amino acids: residues 2834 - 2865 (Uniprot P55200) 
with residue C2837 removed to avoid disulphide bond formation. This sequence is 
identical to the human version (Uniprot Q03164, residues 2838 – 2896 with C2841 
removed). Single and double mutants of MLL were also purchased (P2854A; 
P2842A and P2854A; and L2841A) (Figure 3.8). In this work, we refer to these 
mutations relative to their position in the 31-residue peptide (P9A, P9/21A and 
L8A). 
 
 
 
Figure 3.8 Amino Acid Sequences for WT and Mutant MLL Peptides. 
Peptides contained either a free, or fluorescein isothiocyanate labelled, N–terminus. 
The sequence for MLL WT is shown in orange. Mutated residues are highlighted. 
The positions of mutated residues are shown relative to the peptide investigated in 
this work. In the context of full length MLL, the alanine mutations represent 
residues P2854, P2842 and P2854, and L2841. 
 
OO O
O
HN C
S
O
H
N Peptide
WT: SDDGNILPSDIMDFVLKNTPSMQALGESPES
P21A: SDDGNILPSDIMDFVLKNTASMQALGESPES
P9/21A: SDDGNILASDIMDFVLKNTASMQALGESPES
L8A: SDDGNIAPSDIMDFVLKNTPSMQALGESPES
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Peptides arrived as trifluroacetate salts and were reconstituted in biophysical 100 
mM phosphate Tween buffer. Left over peptides were aliquoted, flash frozen in 
liquid N2 and stored at - 80°C.  
 
3.7.2 PUMA Shuffles 
PUMA shuffles were based on the sequence of PUMA 34 (residues 128 – 161, 
UniProt Q99ML1). Sequences contained an M144I mutation to match the sequence 
used to solve the NMR structure of PUMA:MCL-1 (Day et al., 2008) and the work 
of Dr Joe Rogers (Rogers et al., 2013). The aim of this work was to create various 
residual structure profiles of PUMA 34 by moving the relative position of the 
residues. As only the position of the residue is altered, the overall sequence 
composition remains the same. Effects on the kinetics and thermodynamics of the 
shuffled peptides binding to MCL-1 would then be monitored. Clearly, altering the 
position of contacting residues could lead to a significant destabilisation of the 
bound complex. Therefore, 7 hydrophobic interface residues were kept constant 
(W133, I137, L141, I144, A145, L148 and Y152) (Figure 3.9). The choice of these 
7 residues was a balance between maintaining the key contacts, while leaving 
enough residues to shuffle.     
   
 
Figure 3.9 Amino Acid Sequences for PUMA 34 Shuffles. 
Residues of WT PUMA 34 were shuffled in an attempt to create various residual 
structure profiles (BH – broken helix; MSH – middle spanning helix; NTH – N-
terminal helix; CTH – C-terminal helix; LSH – low stability helix). Two versions of 
each design were purchased. The position of 7 PUMA:MCL-1 interface residues were 
kept constant in all designs (blue). Peptides were N-terminally acetylated and C-
terminally amidated.  
WT: VEEEEWAREIGAQLRRIADDLNAQYERRRQEEQH
BH1: EVDEEWQARIQRALQGIAEDLNARYRERRQEEEH
BH2: EVDEEWARGIRAQLQRIAEDLNARYRERQEEQEH
MSH1: EGREEWEEDIAQVLARIAHQLRENYERREDAQRQ
MSH2: ERDEEWREDIEEALAVIARQLNQQYGQRERRAEH
NTH1: EVEEEWARGIRARLQRIAEDLNARYERQQDEQEH
NTH2: GEVDEWAQRIRAQLHRIAEDLNEAYRREREQEQE
CTH1: EVEEQWQAQIEAGLREIADDLNARYRRRHRQEEE
CTH2: EVDERWEARIQEALQGIAEDLNAEYRRRRQEQEH
LSH1: VREEEWERAIRGQLREIAQDLNQDYRERAAEQEH
LSH2: RVEEGWAQRIEQRLEAIADDLNREYAERRQQEEH
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This work was performed in collaboration with Prof. Rohit Pappu’s group (University 
of Washington in St. Louis). Tyler Harmon, a PhD student in Prof. Pappu’s lab, 
generated the shuffle sequences using their algorithm, GADIS (Harmon et al., 
2016). In essence, the Genetic Algorithm for Design of Intrinsic secondary 
Structure (GADIS) first creates shuffled sequences. Input parameters are the 
peptide sequence, the position of immutable residues and the target helicity profile. 
The shuffled sequences are then simulated, yielding conformational ensembles. 
Comparison with the target helicity profile provides an objective score. Based on 
this score, sequences are chosen, reshuffled, simulated and scored. Sequences are 
selected once they go through two generations without improving their score. 
Figure 3.9 represents the shuffled sequences of PUMA 34 generated by GADIS. For 
reasons described in Chapter 5.3, 5 additional peptides were designed. Briefly, 
these consisted of 3 shuffles with 19 PUMA residues fixed, and 2 shuffles based on 
single site swaps of WT and CTH1 (Figure 3.10).  
 
 
 
Figure 3.10 Amino Acid Sequences for Additional PUMA 34 Shuffles. 
On a background of CTH 1, a glycine was swapped with a glutamic acid (red), 
returning the glycine to the position occupied in WT PUMA (CTH G Swap). A 
glutamic acid (red) was swapped into the same position in the context of the WT 
PUMA 34 sequence, at the expense of glycine (WT G Swap). Keeping 19 residues 
in their WT positions (blue), 3 conservative swaps were designed. A contact map 
analysis (Sobolev et al., 2005) of the PUMA:MCL-1 NMR structure (PDB:2ROC) was 
used to determine the residues kept constant. The 19 residues identified all had a 
contact area of 11 Å or greater.   
 
N-terminal acetylated and C-terminal amidated peptides were purchased from 
WatsonBio (Texas, US). Peptides arrived as trifluroacetate salts and were 
reconstituted in biophysical 50 mM phosphate Tween buffer. To ensure the removal 
CTH 1: EVEEQWQAQIEAGLREIADDLNARYRRRHRQEEE
CTH G Swap: EVEEQWQAQIGAELREIADDLNARYRRRHRQEEE
WT G Swap: VEGEEWAREIEAQLRRIADDLNAQYERRRQEEQH
WT: VEEEEWAREIGAQLRRIADDLNAQYERRRQEEQH
Conservative 1: EQEEEWAREIGAQLRRIADDLNAQYERRRQEEQH
Conservative 2: EVQEQWAREIGEQLREIADELNRAYEQRRREDAH
Conservative 3: EREEEWAREIGRQLRDIADHLNQVYEARRAEEQQ
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of residual salts, peptides were buffer exchanged into biophysical 50 mM phosphate 
Tween buffer using 5 mL Hitrap™ desalting columns (GE Healthcare).  
 
3.7.3 BIM, BIK and PUMA Core Swaps 
To assess the impact of non-contacting residues on the kinetics and 
thermodynamics of PUMA binding to MCL-1, variants of mouse PUMA containing 
either WT PUMA, BIM or BIK amino acids were designed. As for the PUMA 34 
conservative shuffles (Figure 3.10), the 19 residues of PUMA that contact MCL-1 
were kept constant. The remaining 16 PUMA residues were swapped with residues 
from BIM (UniProt O54918) or BIK (UniProt O70337).  
 
 
 
Figure 3.11 Amino Acid Sequences for PUMA Core Swaps. 
Oligomerisation problems had been observed with the PUMA 34 shuffles (Chapter 
5.3.1). To reduce the propensity of the peptide to self-associate, an I144A mutation 
(Rogers et al., 2014b) was included in the design of these peptides. Differences in 
net charge between PUMA and the swap peptides could alter long-range 
electrostatic interactions with MCL-1, causing a change in the association rate 
constant. Therefore, PUMA 35, which contains an additional arginine at the N-
terminus, was used as the template sequence. This allowed the PUMA, BIK-swap 
and BIM-swap to maintain estimated net charges of approximately – 3. Based on 
the number of positively and negatively charged residues, BIM and BIK have 
estimated net charges of – 3 and – 1, respectively. To avoid disulphide bond 
formation, 3 cysteine residues in BIK were mutated to alanine (C44A, C57A and 
C65A). PUMA residues are shown in blue, swapped residues are indicated in black.  
 
N-terminal acetylated and C-terminal amidated peptides were purchased from 
WatsonBio (Texas, US). Peptides arrived as trifluroacetate salts and were 
reconstituted in biophysical 50 mM phosphate Tween buffer. To ensure the removal 
of residual salts, peptides were buffer exchanged into biophysical 50 mM phosphate 
Tween buffer using 5 mL HiTrap™ desalting columns (GE Healthcare). 
BIK: LMEAVEGRNQVALRLAAIGDEMDLALRSPRLVQLP 
BIK Swap: LMEAEEWAREIGLQLRAAADELNLAYESRRLVQLP 
PUMA: RVEEEEWAREIGAQLRRAADDLNAQYERRRQEEQH
BIM Swap: EPEDERWAREIGQQLRRAADELNETYERRRFANDY 
BIM: EPEDLRPEIRIAQELRRIGDEFNETYTRRVFANDY
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3.7.4 PUMA TAMRA Peptides 
Variants of residues 127 – 161 of mouse PUMA (UniProt Q99ML1) were purchased 
from Biomatik (Canada) (Figure 3.12).  
 
 
 
Figure 3.12 Amino Acid Sequences for Synthesised PUMA TAMRA Peptides. 
The sequence for WT PUMA 35 is shown in blue. Compared to PUMA 34, PUMA 35 
contains an additional arginine at the N-terminus and an I144A mutation. These 
two changes were shown to reduce the self-association propensity of PUMA 34. 
(Rogers et al., 2014b) Investigated mutations are highlighted in black. Peptides 
were synthesised with fluorescent dye, TAMRA, attached to the N-terminus via a 
peptide bond.   
 
As discussed in Chapter 8, a fluorescent dye was required to follow the binding of 
PUMA to the BCL-2 like protein, A1. Dissociation of PUMA from MCL-1, another BCL-
2 like protein, had been shown previously to be relatively slow (koff = 0.0013 ± 
0.0009 s-1) (Rogers et al., 2014a). With this rate, measuring 10 half-lives would 
require monitoring the reaction for approximately 5,000 s. Over such timescales, 
fluorophores may photo-bleach. A balance between price and photo-stability 
WT: RVEEEEWAREIGAQLRRAADDLNAQYERRRQEEQH
E132A: RVEEEAWAREIGAQLRRAADDLNAQYERRRQEEQH
E132G: RVEEEGWAREIGAQLRRAADDLNAQYERRRQEEQH
W133F: RVEEEEFAREIGAQLRRAADDLNAQYERRRQEEQH
E136A: RVEEEEWARAIGAQLRRAADDLNAQYERRRQEEQH
E136G: RVEEEEWARGIGAQLRRAADDLNAQYERRRQEEQH
I137A: RVEEEEWAREAGAQLRRAADDLNAQYERRRQEEQH
A139G: RVEEEEWAREIGGQLRRAADDLNAQYERRRQEEQH
L141A: RVEEEEWAREIGAQARRAADDLNAQYERRRQEEQH
R143A: RVEEEEWAREIGAQLRAAADDLNAQYERRRQEEQH
R143G: RVEEEEWAREIGAQLRGAADDLNAQYERRRQEEQH
D147A: RVEEEEWAREIGAQLRRAADALNAQYERRRQEEQH
D147G: RVEEEEWAREIGAQLRRAADGLNAQYERRRQEEQH
L148A: RVEEEEWAREIGAQLRRAADDANAQYERRRQEEQH
A150G: RVEEEEWAREIGAQLRRAADDLNGQYERRRQEEQH
Y152A: RVEEEEWAREIGAQLRRAADDLNAQAERRRQEEQH
R154A: RVEEEEWAREIGAQLRRAADDLNAQYEARRQEEQH
R154G: RVEEEEWAREIGAQLRRAADDLNAQYEGRRQEEQH
A139G A150G: RVEEEEWAREIGGQLRRAADDLNGQYERRRQEEQH
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(Dempsey et al., 2011) therefore led to 5-Carboxytetramethylrhodamine (TAMRA) 
(Figure 3.13) being chosen as a good candidate for this work.  
 
 
Figure 3.13 Chemical Structure of TAMRA. 
The structure of 5-Carboxytetramethylrhodamine (TAMRA) when attached to the 
N-terminus of peptides. The nitrogen-peptide bond indicates the N-terminal end of 
the attached peptide sequence. Conjugation of TAMRA does not change the net 
charge of the peptide. ChemDraw Professional (version 16.0) was used to construct 
the structure of TAMRA.  
 
The 35 amino acid peptides were N-terminally labelled with TAMRA. Peptides 
arrived as trifluroacetate salts and were reconstituted in biophysical 50 mM 
phosphate Tween buffer. Left over peptides were aliquoted, flash frozen in liquid 
N2 and stored at - 80°C.  
 
3.7.5 BID 
Residues 76 – 110 of mouse BID (UniProt P70444) were purchased from Biomatik 
(Canada) (Figure 3.14).  
 
 
 
Figure 3.14 Amino Acid Sequence of WT BID. 
The peptide was synthesised with a fluorescent dye, TAMRA, attached to the N-
terminus via a peptide bond.  
 
To allow comparison with PUMA TAMRA, the 35-amino acid peptide was N-
terminally labelled with the fluorescent dye, TAMRA (Figure 3.13). The peptide 
O
C
CO N
H
O
O
N(CH3)2(CH3)2N
Peptide
WT BID: SESQEEIIHNIARHLAQIGDEMDHNIQPTLVRQLA 
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arrived as a trifluroacetate salts and was reconstituted in biophysical 50 mM 
phosphate Tween buffer. Left over peptide was aliquoted, flash frozen in liquid N2 
and stored at - 80°C.  
 
3.8 Isotopically Labelled Proteins 
 
3.8.1 c-MYB 
Expression and purification of 13C 15N isotopically labelled c-MYB was performed by 
Dr Wade Borcherds, a post-doc in Dr Gary Daughdrill’s lab (University of South 
Florida). Except for a couple of nuances, it was carried in the same manner as non-
isotopically-labelled c-MYB (Chapter 3.6.2). Firstly, to avoid disulphide bond 
formation, the cysteine at position 50 (C322 in the full-length protein) was mutated 
to an alanine. Secondly, to produce isotopically labelled protein, C41 DE3 
Escherichia coli cells were grown to an OD600 of 0.4 – 0.6 at 37°C in minimal media 
containing M9 salts and 100 mg/L ampicillin, with 13C D-glucose and 15N ammonium 
chloride (Cambridge Isotope Labortories) as the sole carbon and nitrogen sources. 
 
3.8.2 MLL 
Residues 2834 - 2865 (Uniprot P55200) with residue C2837 removed to avoid 
disulphide bond formation were expressed as a GB1 fusion protein. The fusion 
protein gene had previously been cloned into a modified version of the pRSET A 
vector, which contained a HisTag N-terminal to GB1, by Dr Sarah Shammas.  
 
C41 DE3 Escherichia coli cells were grown to an OD600 of 0.4-0.6 at 37°C in 
minimal media containing M9 salts and 100 mg/L ampicillin, with 13C D-glucose 
and 15N ammonium chloride (Cambridge Isotope Labortories) as the sole carbon 
and nitrogen sources. Protein expression was induced by addition of 1 mM 
isopropyl-beta-D-thiogalactopyranoside (IPTG). After incubating for 4 hours at 
37°C, cells were harvested by centrifugation. Cells were re-suspended in PBS, 25 
mM imidazole, sonicated and centrifuged. His-GB1-MLL was purified from the 
soluble fraction by affinity chromatography using a 5 mL HisTrap column (GE 
Healthcare Life Sciences). Bound protein was eluted using a linear gradient of PBS 
0 - 500 mM imidazole over 50 mL: elution began at approximately 50 mM 
imidiazole. To reduce the ionic strength, protein was diluted 5-fold before loading 
onto a HiTrap Q HP ion exchange column (GE Healthcare Life Sciences). His-GB1-
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MLL was separated from truncated versions using a linear gradient of 20 mM TRIS 
pH 7.0, 1 M NaCl (0 – 300 mM NaCl over 50 mL). Full length His-GB1- MLL eluted 
at ~ 200 mM NaCl. His-GB1-MLL was bound to Ni2+ agarose resin and exchanged 
into 100 mM sodium phosphate pH 7.4. MLL was cleaved from His-GB1 by overnight 
incubation with 100 units of thrombin. Thrombin was removed from the sample by 
filtration using a 20 kDa cut-off filter (GE Healthcare Life Sciences), with the flow 
through containing MLL. The identity and purity of MLL were confirmed by mass 
spectrometry (Department of Chemistry, University of Cambridge, UK) and amino 
acid analysis (Department of Biochemistry, University of Cambridge, UK). 
 
3.9  Protein and Peptide Dye Labelling 
To reduce disulphide bonds between cysteine residues, purified peptides were 
incubated with 1 mM tris(2-carboxyethyl)phosphine) (TCEP) for at least 30 minutes 
at 37°C. Alexa Fluor® 594 C5 maleimide dye (Life Technologies) was added to the 
peptides at molar a ratio of 1.4:1 and the solution left covered, rolling at room 
temperature for 2 hours. The solution was diluted with ddH2O to reduce the ionic 
strength and β-mercaptoethanol was added to a final concentration of 10 mM to 
quench the reaction. Labelled peptide was separated from unlabelled peptide and 
free dye by ion exchange: the solution was loaded onto a HiTrap Q ion exchange 
column (GE healthcare) and separated using TRIS pH 7 ion exchange buffer with a 
gradient of 0 to 1M NaCl over 90 mL. Purified labelled peptides were exchanged in 
biophysical phosphate buffer using a HiTrap desalting column (GE Healthcare).  
Labelled peptides were stored at 4°C or aliquoted, flash frozen in liquid N2 and kept 
at –80°C. 
 
3.10  Protein and Peptide Concentration Determination 
Knowledge of accurate protein concentrations is crucial when conducting a 
biophysical analysis of bimolecular interactions, due to the concentration dependent 
nature of the reaction. Substantial care was therefore taken throughout this work 
to ensure that protein concentrations were determined as accurately as possible. 
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Protein and peptide stock concentrations were typically determined using a Cary 
60 UV-Vis spectrophotometer (Agilent Technologies) and the Beer – Lambert Law, 
as shown in Equation 3.1: 
 
 
     w = 	óòô     (3.1) 
 
where A is the absorbance at a specific wavelength, ε is the extinction coefficient 
at that wavelength, c is the concentration and l is the path length.  
 
Before calculating the concentration, a buffer absorbance reading was subtracted 
from all protein and peptide absorbance scans. When necessary, protein and 
peptide stocks were diluted with buffer to achieve an absorbance reading of 
between 0.1 and 1 absorbance units. 
 
3.10.1  Extinction Coefficients 
Protein absorbance at 280 nm is predominantly due to the presence of tryptophan, 
tyrosine and cystine residues. Estimates of a protein’s extinction coefficient can 
thus be calculated by multiplying the number of tryptophan, tyrosine and cystine 
residues by their molar extinction coefficients (5500 M-1 cm-1 for tryptophan, 1490 
M-1 cm-1 for tyrosine and 125 M-1 cm-1 for cystine) (Pace et al., 1995). However, 
this approach does not take into account the positioning or context of these 
residues and, therefore, does not necessarily yield an extinction coefficient that is 
accurate enough to determine the true protein concentration. For example, the 
predicted extinction coefficient for the folded BCL-2 protein, A1, is 22460 M-1 cm-1, 
compared to the experimentally determined value of 24200 M-1 cm-1. Ergo, use of 
the predicted extinction coefficient would lead to an overestimation of the 
concentration of A1 by more than 7%. 
 
Proteins can also be associated with other chromophores. For example, to aid in 
biophysical analysis, many of the proteins and peptides in this work were labelled 
with fluorescent dyes. As they are designed to absorb and fluoresce light, these 
chromophores typically have large extinction coefficients, which can be utilised to 
determine protein concentrations. Many of the dyes also absorb partially at 280 
nm, precluding the use of extinction coefficients that are calculated purely from the 
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amino acid content. As described in the subsections below, several methods were 
consequently employed to confirm extinction coefficients and protein 
concentrations. 
 
3.10.1.1 CBP KIX 
An extinction coefficient of 12,009 M-1 cm-1, which had been previously determined 
by Dr Sarah Shammas (Shammas et al., 2013) using the method of Gill von Hippel 
(Gill and von Hippel, 1989), was used for CBP KIX. 
 
3.10.1.2 MLL and c-MYB 
The extinction coefficient of 8,480 M-1 cm-1 at 280 nm for unlabelled c-Myb was 
estimated using the number of tryptophan, tyrosine and cystine residues and their 
respective determined extinction coefficients (Pace et al., 1995). For peptides 
labelled with a dye, the extinction coefficient of the dye was used: extinction 
coefficients for Alexa Fluor® 594 labelled c-Myb and FITC labelled MLL were 92,000 
M-1 cm-1 at 593 nm and 75,000 M-1 cm-1 at 493 nm, respectively. Determined 
protein concentrations were checked by amino acid analysis (Department of 
Biochemistry, University of Cambridge), which provides an estimate that is 
suggested to be within 5% of the actual concentration. 
 
3.10.1.3 MCL-1 and PUMA 35 
Dr Joseph Rogers had previously determined the extinction coefficients for MCL-1 
(Rogers et al., 2013) and PUMA 35 (Rogers et al., 2014a) through comparison of 
the absorbance at 280 nm with the concentration determined from amino acid 
analysis. These extinction coefficients of 22157 M-1 cm-1 and 7113 M-1 cm-1 for MCL-
1 and PUMA 35, respectively, were used in this work.  
 
3.10.1.4 PUMA Shuffles and Core Swaps 
Samples of each stock solution were weighed to ascertain an accurate volume. 
Concentrations were then determined by amino acid analysis (Department of 
Biochemistry, University of Cambridge).   
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3.10.1.5 PUMA-TAMRA and BID-TAMRA Peptides 
Solutions of WT and mutant PUMA and BID TAMRA peptides were scanned using a 
Cary 60 UV-Vis spectrophotometer (Agilent Technologies). An absorbance peak at 
555 nm was observed and buffer subtracted. A range of stock dilutions were 
generated to produce values from 0.1 to 1 absorbance units. Samples of the 
scanned stocks were sent for amino acid analysis (Department of Biochemistry, 
University of Cambridge). Extinction coefficients were calculated from the gradient 
of the straight line fit of the absorbance at 555 nm verses the concentration from 
amino acid analysis (Figure 3.15). For PUMA-TAMRA, several of the mutants 
displayed a propensity to oligomerise at concentrations within the micro molar 
range (see Chapter 8.1.3). Oligomerisation was found to influence the absorbance 
at 555 nm and, consequently, oligomerising peptides were not included in the 
determination of the extinction coefficient. Values of 83,000 ± 1,000 M-1 cm-1 and 
85,000 ± 1,000 M-1 cm-1 at 555 nm were established and utilised for PUMA-TAMRA 
and BID-TAMRA, respectively. 
 
 
Figure 3.15 Extinction Coefficient for TAMRA labelled Peptides. 
Samples of PUMA-TAMRA and BID-TAMRA peptides were scanned and the 
absorbance at 555 nm was recorded and buffer subtracted (A555). Concentrations 
for the samples were determined by amino acid analysis (AAA). Gradients of the 
straight-line fits gave extinction coefficients of 83,000 ± 1,000 M-1 cm-1 for PUMA-
TAMRA (A) and 85,000 ± 1,000 M-1 cm-1 for BID-TAMRA (B). For fitting, the 
intercept was fixed to 0 — when no protein is present, the absorbance should be 
equal to the absorbance of the buffer. The reported errors represent the error of 
the fit.  
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3.10.1.6 A1 
A1 was expressed and purified on several occasions during this work. To 
experimentally determine an extinction coefficient for A1, a buffer subtracted 
absorbance at 280 nm was obtained. Concentrations for a number of the scanned 
solutions were ascertained from amino acid analysis (Department of Biochemistry, 
University of Cambridge). A straight-line fit of the absorbance at 280 versus the 
concentration provided an extinction coefficient of 24,200 ± 200 M-1 cm-1 (Figure 
3.16). This extinction coefficient was then utilised for the remaining preparations 
that had not been sent for amino acid analysis.  
 
   
 
Figure 3.16 A1 Extinction Coefficient 
Samples of A1 were scanned and the absorbance at 280 nm was recorded and 
buffer subtracted (A280). Concentrations for the various A1 preparations were 
determined by amino acid analysis (AAA). An extinction coefficient of 24,200 ± 200 
M-1 cm-1 was obtained from the gradient of the straight-line fit. When no protein is 
present, the absorbance should be equal to the absorbance of the buffer; therefore, 
the intercept of the fit was fixed to a value of 0. The reported error represents the 
error of the fit. 
 
3.10.1.7 BCL-XL 
The folded BCL-2 like protein, BCL-XL, was expressed and purified to test its 
suitability as an alternative to MCL-1. After initial experiments, A1 was chosen for 
further study, resulting in little biophysical analysis being pursued with BCL-XL. An 
experimentally determined extinction coefficient was, therefore, not acquired. 
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Instead, extinction coefficients were simply calculated by multiplying the number 
of tryptophan, tyrosine and cystine residues by their molar extinction coefficients. 
 
3.11 Circular Dichroism 
Circular dichroism (CD) experiments were performed using Applied Photophysics 
Chirascan spectrometers. To ensure accurate concentrations, dilutions of stock 
solutions were produced by weight. Spectra obtained with buffer were subtracted 
from the protein spectra. 
 
The millidegrees (mdeg) signal obtained from far-UV CD is related to the number 
of peptide bonds, and the secondary structure of the protein. Thus, the raw 
millidegrees signal from one protein of a given length and concentration cannot be 
directly compared to the signal obtained with another protein of different length 
and/or concentration. To allow comparison, the CD signal must be converted to 
mean residual ellipticity (MRE), which takes into account the protein concentration, 
cuvette path length and the number of amino acids (aa). This conversion was 
achieved using Equation 3.2 and gives the MRE with units of degrees cm2 dmol-1.  
 
 MRE = ù#	FEûDcÉ	 ünZûá}	×	°uD°ZD.Ic.EuD	 , 	×	¢c.£	ÉZDû.£	 °ü 	×	Du.ur	cc              (3.2) 
 
 
 
The path length is included in Equation 3.2 due to the relationship between the 
number of peptide bonds and the observed CD signal: at the same concentration, 
a longer path length cuvette would result in the polarised light interacting with 
more protein molecules. Thus, giving a greater mdeg signal. However, increasing 
the path length leads to a higher background absorbance. The reduced amount of 
transmitted light can be offset by enhancing the detector voltage. Although, this 
comes at the cost of greater signal noise. For the Applied Photophysics instruments 
utilised in this work, a detector voltage of 800 V was the recommended maximum. 
A delicate balance of protein concentration and path length is therefore required to 
optimise the signal to noise ratio. Details for the CD settings employed are listed in 
the subsections below.  
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3.11.1 MLL, c-MYB and CBP KIX 
Association of CBP KIX to its intrinsically disordered partners was known to be rapid 
(Shammas et al., 2013). Experiments with CBP KIX were therefore performed at 
low temperatures (10°C for c-Myb:KIX and 5°C for MLL:KIX). Cuvettes of 1 or 2 
mm path lengths were utilised. Settings were 1 nm bandwidth and 5 s adaptive 
sampling. The mean average of three technical repeats was used to calculate 
helicity estimates.   
 
3.11.2 MCL-1, PUMA Shuffles and Core Swaps 
PUMA 34, the template for the PUMA shuffles, self-associates in the micro-molar 
range. Upon oligomerising, PUMA 34 gains helical structure, producing an estimated 
helicity that is concentration dependent (Rogers et al., 2013). To ensure that the 
calculated helicities were concentration independent and representative of the 
monomeric peptide, at least 3 concentrations (typically 2.5, 5 and 10 µM) were 
compared. MCL-1 samples were scanned at a concentration of 5 µM.  A 2 mm 
cuvette was utilised to ensure that recorded signals achieved a reasonable signal 
to background ratio. Settings were 1 nm bandwidth, 25°C and 15 s adaptive 
sampling. For each concentration of peptide and MCL-1, two samples were 
independently prepared and scanned. Estimated helicities were calculated from the 
mean of the highest concentration samples that showed no concentration 
dependence. 
 
3.11.3 A1 
A1 contains a single cysteine. To prevent disulphide-bond formation, a reducing 
agent (10 mM DTT) was added. Somewhat problematically, DTT absorbs in the far-
UV region, increasing the background absorbance. A 0.2 mm cuvette was therefore 
used to allow enough light to reach the detector. Settings were 1 nm bandwidth, 
25°C and 5 s adaptive sampling. A ten-fold concentration range (4, 10, 20, 30 and 
40 µM) was compared to check for self-association. 
 
3.11.4 PUMA TAMRA Peptides 
Addition of an arginine at the N-terminus in PUMA 35 and an I144A mutation had 
reduced the self-association problems observed with PUMA 34.(Rogers et al., 
2014b; Rogers et al., 2013) However, the addition of TAMRA, a hydrophobic dye, 
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resulted in the formation of PUMA 35 oligomers. Low concentrations of PUMA-
TAMRA peptides (typically 0.5 and 1 µM) were consequently scanned using a 
cuvette of 1 cm path length. Use of this cuvette resulted in an increased background 
absorbance. To prevent the detector voltage exceeding 800 V, scans were stopped 
at 200 nm. Settings were 2 nm bandwidth, 25°C and 15 s adaptive sampling. All 
peptides were reconstituted and scanned on the same day. Peptide concentrations 
were determined from amino acid analysis (Department of Biochemistry, University 
of Cambridge). Helicity estimates were calculated from the highest concentration 
sample that showed no concentration dependence. 
 
3.11.5 Coupled Folding and Binding 
Upon binding, a subset of IDPs are known to fold into a well-defined structure. This 
folding and binding reaction can be probed using CD. Spectra for near equimolar 
concentrations of each individual sample were collected. The mean of the two 
individual sample spectra was calculated and converted to MRE: this represents the 
MRE spectrum expected if no change in structure occurred upon binding. A mixture 
of the two samples was produced in a 1:1 volume ratio and scanned. The difference 
between the observed spectrum and the mean of the individual spectra is related 
to the amount of structural change and the proportion of protein in complex. 
Therefore, to allow comparison of the structure formation upon binding, the 
difference spectra were multiplied by the fraction of protein in complex.   
 
The concentration of complex was estimated using Equation 3.3: 
 
 
wx = e 	•	 f •¶ß$	 e 	•	 f •¶ß $® e få 																									(3.3) 
 
 
where [A] is the total concentration of protein A, [B] is the total concentration of 
protein B and Kd is the dissociation constant for the reaction.  
 
The fraction bound was then calculated by dividing the concentration of complex 
([AB]) by the total amount of either protein A or protein B.  
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3.11.6 Estimation of Helical Content 
Helical content was estimated from the MRE value at 222 nm using the method of 
Muñoz and Serrano (Muñoz and Serrano, 1995). Their method is described below. 
 
The expected MRE for a fully helical protein at 0°C is given by Equation 3.4: 
 
 Helix}°ù = 	−	39,500 1 − å.±≤≥                                (3.4) 
 
 
where Helix0°C is the expected MRE for a full helix at 0°C and n is the number of 
amino acids. 
 
The MRE values for a random coil at a certain temperature is determined using 
Equation 3.5: 
 
 MREùuEÉ = 400 − 45µ																																										(3.5) 
 
 
where 400 is the MRE at 222 nm for a random coil at 0°C and t is the temperature 
in degrees Celsius. 
Equation 3.6 gives the MRE for a full a-helix at a specific temperature.: 
 
 MREhZÉE∂ = Helix}°d + 100µ                     (3.6) 
 
 
where Helix0°C is given by Equation 3.4 and t is the temperature in degrees Celsius. 
 
Muñoz and Serrano’s method then estimates the helicity using Equation 3.7: 
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%Helix = á}}á• (8∏πiii>8∏π∫ªºΩæ)(8∏πøyΩº>8∏πiii)        (3.7) 
 
 
where MRE222 is the measured mean residual ellipticity at 222 nm, MRECoil is given 
by Equation 3.5 and MREHelix is given by Equation 3.6. 
 
3.12 Nuclear Magnetic Resonance 
The nuclear magnetic resonance (NMR) data presented in Chapter 4 was collected 
in collaboration with Dr Gary Daughdrill’s Lab (University of South Florida, US). 
Isotopically labelled MLL protein was expressed, purified and shipped to Dr 
Daughdrill. Expression and purification of 13C 15N c-MYB was performed in Florida 
by Dr Wade Borcherds, a post-doc in Dr Daughdrill’s lab. Dr Borcherds and Dr 
Daughdrill performed the NMR experiments. Dr Borcherds, Dr Daughdrill and I 
analysed the data.  
 
NMR experiments were performed on a Varian VNMRS 800 MHz spectrometer 
equipped with a triple resonance pulse field Z-axis gradient cold probe. To make 
the amide 1H and 15N as well as 13Ca, 13Cb and 13CO resonance assignments, 
sensitivity enhanced 1H-15N HSQC and three-dimensional HNCACB and HNCO 
experiments were performed on uniformly 15N and 13C-labelled samples. All NMR 
spectra were processed with NVFx and analysed using nmrViewJ software (Johnson, 
2004; Johnson and Blevins, 1994). The 1H carrier frequency was set on 4,4-
dimethyl-4-silapentane-1-sulfonic acid (DSS) and used as the reference frequency 
(Markley et al., 1998). Secondary chemical shift values were calculated by 
subtracting the residue specific random coil chemical shifts in the neighbour-
corrected IDP chemical shift library (ncIDP), from the measured chemical shifts 
(Tamiola et al., 2010). Secondary structure populations were calculated with the 
δ2D method, using the measured proton, nitrogen, and alpha, beta, and carbonyl 
carbon chemical shifts (Camilloni et al., 2012). Overall helicity was calculated as 
the mean of the per residue δ2D helical population estimates. 
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3.12.1 c-MYB 
NMR experiments for c-MYB and its proline to alanine mutants were performed with 
200 µM of uniformly 15N- and 13C-labelled samples at both 10°C and 25°C. 
Experiments were carried out in 90% H2O/10% D2O, 50mM sodium phosphate 
buffer with 50 mM NaCl, 1mM EDTA, 0.02% NaN3, at pH 6.8. For WT c-MYB, 
processing and analysis of the HNCACB data resulted in 48 non-proline, amide 1H, 
15N, 13Ca and 48 13Cb resonance assignments plus 4 proline 13Ca and 13Cβ resonance 
assignments. 47 13CO resonance assignments were made using the HNCO data. For 
P17/44A c-MYB, 46 non-proline, amide 1H, 15N, 13Ca and 43 13Cb resonance 
assignments plus 2 13Cα and 2 13Cβ proline resonance assignments were made using 
the HNCACB data and 46 13CO resonance assignments were made using the HNCO 
data. 
 
3.12.2 MLL 
NMR experiments for WT MLL and MLL P9/21A were performed at 10°C using 
sample concentrations of 160 µM, and 155 µM, respectively. Experiments were 
carried out in 90% H2O/10% D2O, 50mM sodium phosphate buffer with 50mM NaCl, 
1mM EDTA, 0.02% NaN3, at pH 6.8. For WT MLL, processing and analysis of the 
HNCACB data resulted in 28 non-proline, amide 1H, 15N, 13Ca and 26 13Cb resonance 
assignments plus 3 proline 13Ca and 13Cb resonance assignments. Using the HNCO 
data, 27 13CO resonance assignments were made. For mutant MLL, processing and 
analysis of the HNCACB data resulted in 30 non-proline, amide 1H, 15N, 13Ca and 28 
13Cb resonance assignments plus 1 proline 13Ca and 13Cb resonance assignments. 29 
13CO resonance assignments were made using the HNCO data.  
 
3.13 Association Kinetics 
Protein solutions were rapidly mixed using Applied Photophysics SX18 or SX20 
stopped-flow spectrometers. Temperature was maintained at 10°C for c-MYB, 5°C 
for MLL and 25°C for BCL-2 family experiments. Depending on the fluorophore, 
excitation wavelengths of 593 nm (a594-c-MYB, Chapter 4), 493 nm (FITC-MLL, 
Chapter 4), 280 nm (PUMA:MCL, Chapters 5 and 6) and 555 nm (TAMRA-Peptides, 
Chapters 7 and 8) were utilised. To reduce the detection of scattered light, long-
pass filters were employed between the cell and photomultiplier tube: 515 nm for 
FITC-MLL, 610 nm for a594-c-MYB, 320 nm for PUMA:MCL-1 and 570 nm for 
TAMRA-labelled peptides. Depending on the photobleaching propensity of the 
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proteins and the timescale of the reaction, slit widths were set to either 1 or 2 mm. 
Except for MLL P9/21A and L8A (See Chapter 3.15), fluorescence traces were 
collected and averaged before analysis. Data within the deadtime of mixing (the 
first 1 ms) were removed before fitting.  
 
3.13.1 Pseudo-First-Order Association Kinetics 
Solutions were prepared such that the concentration of one protein was at least 
10-fold higher than the concentration of the partner. To ensure optimal signal to 
noise, the protein that had the lower relative fluorescence was used in excess (KIX 
for Chapter 4 and the BCL-2 folded partner for Chapters 7 and 8). For each 
concentration of excess protein, the mean trace was fit to a single exponential 
decay function (Equation 2.25)  to extract the observed rate of reaching the new 
equilibrium (kobs). kobs is equal to Equation 3.8: 
 
 pu¿F = puD w +	purr                            (3.8) 
 
 
where [A] is the concentration of protein in excess, kon is the association rate 
constant and koff is the dissociation rate constant. 
 
Therefore, the gradient from the straight line fit of kobs vs the concentration of 
excess protein was used to determine kon.  
 
3.13.2 Association Kinetics for PUMA Shuffles and Core Swaps 
Association kinetics were monitored by following the change in intrinsic tryptophan 
fluorescence upon binding. MCL-1 (0.2 μM) was rapidly mixed with various 
concentrations of PUMA (0.2 – 1 μM). The voltage applied to the photomultiplier 
tube was kept constant for an individual peptide and the data for all concentrations 
were collected on the same day. Traces for each concentration were averaged 
(mean), before fitting to a reversible biomolecular association model (Equation 
2.26), to determine the kon. When the Kd fell within a suitable range (>~1 nM), the 
Kd could also be reliably determined from this model. All concentrations were 
globally fit using ProFit (Quantum Soft), with the kon, Kd and fluorescence change 
shared. The starting fluorescence was fit individually for each concentration, while 
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the concentration of MCL-1 and the PUMA to MCL-1 ratio were fixed. For peptides 
that oligomerised, a linear term was added to the model.    
 
3.14 Dissociation Kinetics 
Depending upon the observed reaction rate, dissociation kinetics were monitored 
using either Applied Photophysics SX18 or SX20 stopped-flow spectrometers (kobs 
typically > 0.03 s-1), or a Cary Eclipse fluorescence spectrophotometer 
(fluorimeter) (Varian) (kobs typically < 0.03 s-1). A pre-formed complex of 
peptide:partner was mixed with various concentrations of a peptide competitor. To 
extract the kobs, the change in fluorescence upon formation of the new equilibrium 
was monitored, averaged (mean) and fit to a single exponential decay function 
(Equation 2.25). The determined kobs depended on the ratio of competitor to 
complex ratio: at low ratios, the new equilibrium can contain some peptide:partner 
complex, and kobs represents the koff plus a component of kon. Whereas, at high 
concentration ratios of competitor, there is effectively no peptide:partner complex 
reformation and kobs represents koff. 
 
3.14.1 MLL:KIX and c-MYB:KIX 
Temperatures were maintained at 10°C for c–MYB:KIX and 5°C for MLL:KIX. The 
lower temperatures were required to follow the fast observed rates of c-Myb:KIX 
and MLL:KIX. Excitation wavelengths of 493 nm and 594 nm were used in 
conjunction with 515 and 615 nm long pass filters for FITC-MLL and Alexa594-c-
MYB labelled peptides, respectively. Dye-labelled peptide (0.25 – 0.5 μM) was pre-
equilibrated with 1 – 2.5 μM of KIX and mixed in a 1:1 volume ratio with various 
concentrations (0 – 50 μM) of unlabeled c-MYB. Unlabelled c-Myb contained a C50A 
mutation (C322 in the full-length protein) to prevent disulphide bond formation. 
Data within the dead-time of mixing (the first 1 ms) were removed before fitting.  
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To extract the koff, the concentration of competitor was plotted against kobs and 
fitted to Equation 3.9: 
 
 pu¿F = purr + 	puD partner áá• [ƒy≈∆ª:Ω:yL]«»(ƒy≈∆ª:Ω:yL)            (3.9) 
 
 
where [competitor] is the concentration of competing peptide and Kd(competitor) is the 
equilibrium dissociation constant for the interaction between the competitor and 
partner protein.  
 
3.14.2 BCL-2 Family    
Temperature was maintained at 25°C. Depending on the fluorophore, 
excitation/emission wavelengths of 340/360 or 320/360 nm (intrinsic tryptophan), 
and 555/575 nm (TAMRA) were utilised. For reactions monitored on the fluorimeter, 
excitation and emission slit widths were typically 2.5 nm and 10 nm, respectively. 
A 320 nm long-pass filter was employed in stopped-flow. For some PUMA-TAMRA 
mutants, changes in fluorescence intensity were small. Binding kinetics for these 
mutants were consequently followed by monitoring the change in fluorescence 
anisotropy, or the change in fluorescence intensity when exciting with and detecting 
vertically polarised light: the fluorimeter did not have the ability to monitor two 
fluorescence channels simultaneously. Therefore, fluorescence was monitored only 
in the VV channel and anisotropy was not calculated.  
 
Peptides (1 – 5 μM) were pre-equilibrated with equimolar amounts of partner and 
mixed with various concentrations of unlabelled PUMA 35 WT or PUMA 
W133F/N149A. PUMA W133F/N149A was required for reactions that were following 
changes in intrinsic tryptophan fluorescence: this mutant had lower intrinsic 
fluorescence (W133F) and contained a mutation that was shown by Dr Joe Rogers 
to have a negligible fluorescence intensity change upon binding MCL-1 (Rogers et 
al., 2014b). For mixing, a 1:9 or 1:10 volume ratio of complex to competitor was 
used for the fluorimeter and stopped-flow, respectively. For reactions monitored on 
the fluorimeter, samples were manually mixed before returning to the fluorimeter, 
which had been left recording. Consequently, the start of the reaction was missed. 
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To account for this, the time between adding the competitor and returning to the 
fluorimeter was recorded, and the reaction timescale adjusted accordingly. At least 
three points, where no dependence of concentration of competitor on kobs was 
observed, were averaged (mean) to ascertain the koff: when a sufficiently high 
concentration of competitor is used, the kobs becomes equal to koff.    
 
3.15 Fitting of MLL P9/21A and L8A Binding Kinetics 
For reasons described in Chapter 4, the observed binding rates for MLL were fast 
and displayed small amplitudes. Under these conditions, it proved challenging to 
extract consistent rates from the mean trace. Consequently, Dr Sarah Shammas 
and I developed a different fitting method.    
 
Between 60 and 120 traces were collected for each concentration of excess partner 
protein/peptide. Each trace was individually fit to a single-exponential decay 
function (Equation 2.25). The individual rate constants obtained for single traces 
(at each concentration of excess partner protein) were plotted as histograms and 
fit to a Gaussian function (Equation 3.10) to extract an average rate: 
 
 … è = 	 Z∂¢ $ À>Ã iiÕŒ åœ                       (3.10) 
 
where a is a scaling constant, µ is the mean, and σ is the standard deviation.  
To assist Gaussian fitting, only individual fitted rates between 0 and 1000 s−1 were 
included: rates below 0 s−1 have no physical meaning, and rates above 1000 s−1 
cannot be feasibly detected with the stopped-flow setup used to collect these data. 
To uncover and minimize any potential dependence of the extracted rate on the 
chosen bin size, 10 bin sizes (from 5 to 50 in increments of 5) were used to generate 
histograms. kobs was determined as the mean µ over all bin sizes. kon was obtained 
from the gradient of the straight line fit of kobs versus partner protein concentration.  
 
Dissociation kobs values at each concentration of excess competing peptide were 
determined using the Gaussian fitting method described above. koff was then 
obtained by taking the mean of dissociation kobs at different concentrations of out-
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competitor: at high concentrations of competitor, there is effectively no complex 
reformation and kobs represents koff.  
 
These described data analyses for MLL P9/20A and L8A were performed using a 
bespoke script created in Mathematica, written by Dr Sarah Shammas.  
 
3.16 Equilibrium Binding Affinities 
Changes in fluorescence anisotropy were monitored using Cary Eclipse fluorescence 
spectrophotometers (Varian), equipped with a manual polariser accessory. 
Temperature was maintained at 10°C for c-MYB, 5°C for MLL and 25°C for BCL-2 
family experiments. Depending on the fluorophore, excitation/emission 
wavelengths of 593/625 nm (a594-c-MYB, Chapter 4), 493/515 nm (FITC-MLL, 
Chapter 4), and 555/575 nm (TAMRA-Peptides, Chapters 7 and 8) were utilised. 
Excitation and emission slit widths were typically 2.5 nm and 10 nm, respectively.  
 
The fluorescence intensity in vertically and horizontally polarised channels is used 
to calculate the anisotropy. Therefore, to take into account the ability of the 
fluorimeter to detect vertically and horizontally polarised light, a correction factor 
has to be included. This is known as the G factor, and was calculated using Equation 
3.11: 
 
 " = –∫—–∫∫                                 (3.11) 
 
 
where IHH is the fluorescence intensity when using horizontal excitation and 
emission polarisers, and IHV is the fluorescence intensity when using horizontal 
excitation and vertical emission polarisers. 
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Accounting for the G factor, the anisotropy (R) can then be calculated from Equation 
3.12: 
 
 0 = 	 –——$<–—∫–——•å<–—∫																																																	(3.12) 
 
 
where IVV is the fluorescence intensity when using vertical excitation and emission 
polarisers, and IVH is the fluorescence intensity when using vertical excitation and 
horizontal emission polarisers. 
 
When dye-labelled peptide binds to its partner protein, the rate of tumbling can 
change, due to the change in the relative size of the peptide. As the rate of tumbling 
decreases, there is an increase in the amount of light emitted in the plane that was 
used to excite of the dye (i.e. Ivv). However, a change in the fluorescence intensity, 
as well as the anisotropy, can also observed upon binding. In these cases, the 
observed changes in IVV are composites of the change in quantum yield/quenching 
of the dye and the change in the tumbling. This can result in deviations between 
the calculated anisotropy and the true anisotropy, which influence the determined 
binding affinity. Dandliker et al provide a method to correct for the change in 
fluorescence intensity upon binding (Dandliker et al., 1981), which can be 
computed using Equation 3.13: 
 
 
 0cn“ = 	 À”	×	‘5‘Ñ	×	’Ñ•’5á•	À”	×	‘5‘Ñ                       (3.13) 
 
 
where Radj is the adjusted anisotropy, Q is the measured fluorescence intensity, R 
is the measured anisotropy, x is the difference between the measured anisotropy 
and anisotropy of the free peptide, and y is the difference between the anisotropy 
of the bound peptide and the measured anisotropy. The subscripts f and b indicate 
Materials and Methods| 71 
 
that the value is measured for the free or bound peptide, respectively. The total 
fluorescence intensity of the free (Qf) and bound (Qb) peptide was calculated using 
Equation 3.14: 
 
 ÷ = ◊ÿÿ + 2◊ÿh                             (3.14) 
 
 
3.16.1 Saturation Binding 
Dye-labelled peptides were incubated with varying concentrations of partner 
protein, protected from light, for at least 10 half-lives (calculated from the koff). 
Samples were transferred to a temperature equilibrated fluorescence cuvette and 
placed into a temperature controlled sample-handling unit. The fluorescence 
intensity in each plane was calculated from the mean of three repeats. After 
calculation of the anisotropy, the equilibrium binding dissociation constant (Kd) was 
determined using Equation 3.15: 
 
 0cn“ = 0r + ∆0 ¶»• e • f $ ¶»• e • f i$® e få e 																			(3.15) 
 
where [A] is the concentration of dye-labelled peptide, [B] is the concentration of 
partner protein, Rf is the anisotropy of the free peptide and ΔR is the difference 
between the free and bound peptide anisotropies.  
 
3.16.2 Competition Binding 
PUMA-TAMRA A139G A150G (300 nM) was incubated with 300 nM of MCL-1 and 
various concentrations of competing peptides. The PUMA A139G A150G mutant was 
chosen as the Kd could be independently determined from both kinetics and 
saturation binding experiments. The fluorescence intensity in each plane was 
calculated from the mean of three repeats. To obtain the midpoint of the binding 
isotherm, the total fluorescence, calculated using Equation 3.14, was fit to a four-
parameter logistic Hill equation (Equation 3.16): 
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÷ = ÷r +	 ∆Ÿá• [øy≈∆ª:Ω:yL]⁄ø¤ >∫Ωºº‹ºy∆ª 																																 (3.16) 
 
 
where IC50 is the midpoint of the binding isotherm, [competitor] is the 
concentration of competing peptide and HillSlope is the steepness of the curve.  
 
If the Kd of the labelled peptide is known, then the IC50 can be converted to a 
relative binding affinity (Ki). Ki values for the competing peptides were calculated 
using the method of Nikolovska-Coleska et al. (Nikolovska-Coleska et al., 2004), 
which is summarised in Equation 3.17: 
 
 Y› = –¤fi¤«»Äfl«»Ä‡                               (3.17) 
 
 
where I50 is the concentration of free inhibitor at 50% inhibition, L50 is the 
concentration of the free labelled ligand at 50% inhibition, P0 is the concentration 
of free protein when no competitor is present, and Kd is the dissociation constant 
for the Labelled-peptide:partner complex. 
 
3.17 Equilibrium Folding Stability 
Dilutions of the chemical denaturants, urea or guanidine hydrochloride (GdmCl), 
were produced using a Microlab 500 liquid processor (Hamilton Company). Protein 
was incubated at 25°C with the chemical denaturant for at least 2 hours. For A1 
and BCL-XL, 10 mM DTT was included, to prevent the formation of disulphide 
bonds. Protein unfolding was monitored either by following the change in intrinsic 
tryptophan/tyrosine fluorescence (LS55 luminescence spectrometer - Perkin Elmer, 
or Cary Eclipse spectrophotometer - Varian), or by monitoring the change in CD 
mdeg signal at 222 nm (Applied Photophysics Chirascan). Samples were 
transferred to a 10 mm by 4 mm cuvette, utilising the 10 mm path length for 
excitation in fluorescence, and the 4 mm path length for absorbance in CD. For 
fluorescence, a scan from 300 – 400 nm was performed with an excitation 
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wavelength of 280 nm and slit widths of 10 nm. Settings for CD were typically 2 
nm bandwidth, 15 s trace with 500 points.  
 
3.18 Data Analysis 
Data were typically fit using Kaleidagraph (version 4.1, Synergy). Analysis of MLL 
P9/21A and L8A binding kinetics was achieved using Mathematica (Wolfram). 
Association kinetics for PUMA shuffles and core swaps were analysed using ProFit 
(version 6.2.16, Quantum Soft).  
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Chapter 4  
 
4 Conserved Helix-Flanking Prolines in IDPs 
 
The script used to analyse MLL P9/21A and MLL L8A was written by Dr Sarah 
Shammas. Dr Gary Daughdrill and Dr Wade Borcherds performed NMR 
experiments. Dr Sarah Shammas performed and analysed p53 kinetic experiments. 
 
4.1 Structural Features of Prolines 
Being the only imino acid, proline is unique amongst the residues that make up 
protein sequences. Instead of the usual bonds to 2 carbons, and a hydrogen, the 
backbone nitrogen of proline is bonded to 2 alkyl carbons and the carbonyl from 
the previous amino acid, forming a cyclic structure (Figure 4.1). This lack of a 
backbone amide hydrogen prevents proline from forming hydrogen bonds that are 
required to stabilise both α-helical and β-sheet secondary structures. Additional 
effects of the rigid, bulky pyrrolidine ring influence both the phi and psi angles of 
proline and the backbone geometry of the preceding residue (MacArthur and 
Thornton, 1991). Thus, both prolines and residues preceding prolines, exhibit 
atypical Ramachandran plots (MacArthur and Thornton, 1991; Ramachandran et 
al., 1963; Theillet et al., 2014). Compared to the other 19 naturally occurring amino 
acids, these distinct structural features of proline typically result in destabilisation 
of protein secondary structure.  
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Figure 4.1 Chemical Structure of Amino and Imino Acids in Cis and Trans. 
More than 99% of amino acids occur in trans (A) rather than cis (B). Proline has a 
smaller difference in free energy between the trans (C) and cis (D) forms, resulting 
in up to 20% occurring the cis conformation (Joseph et al., 2012; Theillet et al., 
2014). This has an important influence on the local structure: trans isoforms result 
in extended conformations, whereas cis isoforms favour turn-like structures.  
 
4.2 Position of Prolines 
Due to its destabilising effects, prolines are relatively rarely found in the middle of 
α-helicies or β-sheets. However, when prolines are located in these positions, they 
can confer specific functions. For example, the presence of prolines in helical 
transmembrane segments of membrane channels, transporters and receptors has 
been observed to occur with relatively high frequency (Deber et al., 1986). While 
the exact physiochemical reasons for the presence of all these prolines are not fully 
understood, they have been shown to be crucial for the correct voltage gating of 
the connexin 26 channel (Suchyna et al., 1993). Furthermore, it has been 
suggested that the ability of prolines to undergo cis/trans isomerisation could be a 
means of regulating channel opening and closing (Williams and Deber, 1991).  
 
Inclusion of proline in the middle of an α-helix can introduce a kink of approximately 
26° (Barlow and Thornton, 1988), or can terminate the helical segment by creating 
a tight turn (Nilsson and von Heijne, 1998). Indeed, in folded proteins, a preference 
for prolines in positions from the N-cap to N-cap+2 and C-cap to C-cap+3 has been 
noted (Richardson and Richardson, 1988; Theillet et al., 2014). In IDPs, proline 
residues that flank regions of partially formed residual structure, were found to 
occur more frequently than elsewhere within the IDP (Fuxreiter et al., 2007). 
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Prolines were consequently proposed to be conserved in flanking regions to 
‘preserve levels of disorder in regions with residual structure propensities’ (Theillet 
et al., 2014). Combining this with the view that the level of residual ‘bound-like’ 
structure determines the binding mechanism (Brown et al., 2011; Krieger et al., 
2014), helix-flanking prolines were proposed to act as ‘“switches” that control the 
level of helical content’ and ‘govern the degree of conformational selection by target 
proteins’ (Lee et al., 2014). However, kinetic information is required to determine 
mechanism (Gianni et al., 2014; Shammas et al., 2016).  
 
4.3 Conservation of Helix-Flanking Prolines 
Given its reputation as a helix-breaker, it is easy to imagine that to define helical 
segments, evolution has resulted in prolines maintaining flanking positions. Figure 
4.2 demonstrates the conservation of helix-flanking prolines in six IDPs that 
undergo coupled folding and binding to form α-helicies.  
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Figure 4.2 Position and Conservation of Helix-Flanking Prolines in IDRs. 
Bound structures of IDPs/IDRs, which undergo coupled folding and binding to form 
α-helices that are flanked by prolines. From top to bottom: p53:MDM2 (PDB:1YCR); 
MLL:CBP KIX (PDB:2LXS); c-Myb:CBP KIX (PDB:1SB0); CREB:CBP KIX 
(PDB:1KDX); SHP-1:SF-1 (PDB:1YMT); PGC-1 α:PPARg (PDB:3CS8). Folded 
partner proteins are shown in grey, IDPs/IDRs in red. Helix flanking prolines are 
indicated as cyan spheres. Cyan circles indicate helix-flanking prolines that are not 
present in the structure. N denotes the N-terminus of the IDP/IDR. For each 
IDP/IDR, the sequence from Homo sapiens, Mus musculus, Gallus gallus and Danio 
rerio was aligned using Clutsal Omega (Goujon et al., 2010; Sievers et al., 2014), 
p53 alignment is from Borcherds et al. (2014). The peptide region used in the 
structure is highlighted in grey, with residues that form α-helices upon binding in 
red. Helix-flanking prolines are highlighted. As determined by Clustal Omega, 
positions of full residue conservation are indicated by an asterisk, a colon indicates 
conservation of strongly similar amino acid properties, weakly similar properties 
are specified with a period. 
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4.4 Helix-Flanking Prolines in p53 
To investigate the role of conserved helix-flanking prolines, Borcherds et al. 
investigated proline to alanine mutants in p53. In terms of helix stability, alanine 
is at the other end of the spectrum to proline (Horovitz et al., 1992; O’Neil and 
DeGrado, 1990). Therefore, if proline is acting to reduce helix stability, mutation to 
alanine should provide a large change in observed helicity.  Consistent with the 
idea that conserved helix-flanking prolines control levels of residual structure, 
mutation of the C-terminal helix-flanking proline of p53 to alanine causes a large 
increase in helicity (Borcherds et al., 2014). The 2.5-fold gain in helicity occurs 
within the region that becomes helical upon binding to the structured protein, 
MDM2 (Figure 4.3). Mutation of P12/13 to alanine also increases helicity, however, 
to a far lesser extent (32% peak helicity vs 28% in WT).   
 
 
 
Figure 4.3 Helix-Flanking Prolines Modulate Residual Structure in p53. 
The data represent the difference in per residue fractional helicity between WT p53 
and p53 P27A (Borcherds et al., 2014). Mutation of P27 to alanine increases the 
helicity of p53 within the region that becomes helical upon binding MDM2. Peak 
helicity increases by approximately 40%, while the total helicity across all the 
residues that become helical upon binding increases from 12% in WT p53 to 30% 
in p53 P27A. Helix flanking prolines are highlighted in cyan in both the sequence 
and p53:MDM2 structure (PDB entry 1YCR, p53 in purple, MDM2 in grey). As 
determined from the bound structure, the residues that become helical upon 
binding MDM2 are underlined. Helix-flanking prolines that fall outside of the peptide 
used in the p53:MDM2 structure (residues 15 – 29) are indicated as cyan spheres. 
N denotes the N-terminus of p53.  
 
In terms of the thermodynamics of the p53:MDM2 interaction, the p53 P27A mutant 
has an approximate 10-fold enhancement in binding affinity compared to WT p53 
(Kd = 25 ± 3 nM vs 240 ± 60 nM). Mechanistically, this could either be due to an 
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increase in the rate of association, or a decrease in the rate of dissociation, or a 
combination of the two. If the prolines were acting to govern the degree of 
conformational selection (Lee et al., 2014), then one might predict that an increase 
in kon is responsible for the enhanced affinity i.e. when the P27A mutation is 
present, a greater amount p53 is in a ‘bound-like’ conformation, resulting in an 
increased number of successful collisions and a faster rate of association. To assess 
the kinetic effect of the P27A mutation, Dr Sarah Shammas performed stopped-
flow experiments (Figure 4.4). Despite the 2.5-fold increase in residual ‘bound-like’ 
structure, kon is increased by only 1.23 ± 0.06-fold for the P27A mutant. Clearly, 
an enhanced rate of complex formation is not responsible for the 10-fold gain in 
affinity of p53 P27A for MDM2. Instead, the tighter binding is explained by a 12-
fold decrease in koff (Crabtree et al., 2017).  
 
 
 
Figure 4.4 P27A Enhances p53:MDM2 Affinity by Affecting koff, not kon. 
(A) Pseudo-first order association kinetics for p53 binding to MDM2. The gradient 
of the straight-line fit gives association rate constants of 25 ± 1 µM-1s-1 for WT and 
30.7 ± 0.7 µM-1s-1 for P27A. (B) Observed dissociation rates for p53:MDM2, 
obtained from out competition experiments. The koff is given by the asymptote of 
the fit.  There are 2 dissociation rate constants for the p53 P27A mutant: a ‘fast’ 
rate of 0.37 ± 0.01 s-1 and a ‘slow’ rate of 0.072 ± 0.005 s-1. WT p53 has a single 
koff of 4.40 ± 0.03 s-1.   
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In summary, the conserved helix-flanking prolines in p53 act to restrict the level of 
residual helicity. However, this is not to control the rate of association through 
modulating the level of binding competent p53. Instead, the change in koff 
demonstrates that the influence of the altered helix stability is on the bound 
complex. To determine if this was a common mechanism of action, helix-flanking 
prolines in two further IDRs, the transactivation domains of MLL and c-MYB, were 
investigated. 
 
4.5 Results 
Upon binding to distinct sites on CBP-KIX, both MLL and c-MYB fold and bind to 
form α-helices that are flanked by prolines.  (Figure 4.2). Similar to the p53 study, 
the helix-flanking prolines were mutated to alanine. Both the effects on the residual 
structure and the kinetics and thermodynamics of the interaction with CBP-KIX 
were then monitored. Single and double proline mutants were investigated for both 
MLL (P21A, P9/21A) and c-MYB (P17A, P17/44A). 
 
4.5.1 Helix-Flanking Prolines Reduce Residual Helicity in MLL and 
c-MYB 
By measuring the difference in a protein’s absorbance of right and left handed 
polarised light, circular dichroism can provide structural information. WT and 
mutant peptides were scanned to determine the overall change in residual helicity 
upon helix-flanking proline to alanine mutation. Comparison of the WT peptides 
demonstrated that MLL was mostly disordered (13% estimated helicity), whilst c-
MYB contained some residual helicity (25% estimated helicity) (Figure 4.5). 
Mutation of the C-terminal helix flanking proline in MLL (P21A) results in a small 
increase in helicity (15% estimated helicity). The double mutant (P9/21A) 
demonstrates a further enhancement in helical content (17% estimated helicity). 
Whilst these absolute changes are small, relative to the largely disordered WT 
peptide, the P9/21A mutant represents a 1.3-fold increase in overall helical content 
compared to WT. A similar 1.3-fold change in overall helicity was observed for the 
c-MYB P17A mutant (32% estimated helicity). Mutation of both c-MYB helix-
flanking prolines resulted in a 1.4-fold increase in helicity (35% estimated helicity) 
compared to WT. As the signal from CD is an average across all the peptide bonds, 
these reported changes in helicity represent the change across the entire peptide. 
A residue-level technique is required to locate the changes in helicity.  
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Figure 4.5 Overall Residual Helicity in MLL and c-MYB is Increased upon 
Proline to Alanine Mutation.  
CD data for (A) MLL and (B) c-MYB peptides. A decrease in the MRE at 222 nm is 
indicative of an increase in α-helical content. Data are the mean of three 
independent scans.  
 
To ascertain whether the increases in helicity occurred within the region that 
becomes helical upon binding, NMR was utilised –  NMR can provide residue-specific 
chemical shifts, which can be entered into the δ2D algorithm (Camilloni et al., 
2012) to produce residue-level helicity estimates. The double helix-flanking proline 
to alanine mutants demonstrated the biggest changes in residual structure in the 
CD experiments. Therefore, both WT and the double mutant peptides (MLL P9/21A 
and c-MYB P17/44A) were chosen for further investigation by NMR.   
 
Whilst the NMR-based estimated helicity for c-MYB WT (22% vs 25% from CD) and 
P17/44A (29% vs 35% from CD) matched the CD data reasonably well, a 
substantially lower NMR–based helicity for MLL WT (2% vs 13% from CD) and 
P9/21A (3.5% vs 17% from CD) was observed (Figure 4.6).  
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Figure 4.6 Chemical Shift and Per Residue Helicity for MLL and c-MYB. 
Per-residue helicity for (A) MLL WT (top), MLL P9/21A (bottom), (B) c-MYB WT 
(top) and c-MYB P17/44A (bottom). Chemical shifts were determined from 1H-15N 
HSQC and three-dimensional HNCACB and HNCO experiments. To calculate 
secondary Cα chemical shifts (bars), residue-specific random coil chemical shift 
values were obtained from the ncIDP library (Tamiola et al., 2010) and subtracted 
from the measured chemical shift. Percentage helicity (line) was calculated from 
Cα, CO, Cβ, HN and N secondary chemical shifts using the δ2D algorithm (Camilloni 
et al., 2012). Cyan spheres represent the position of WT proline, or mutant alanine 
residues. Data were collected at 10°C. For c-MYB P17/44A, the chemical shift for 3 
residues could not be observed. This was likely due to the rate of chemical exchange 
at 10°C, as the chemical shifts could be detected at 25°C. Overall helicity was 
similar at 25°C and 10°C for c-MYB WT (23% vs 22%) and c-MYB P17/44A (29% 
vs 28%).  
 
There are a few potential explanations for the discrepancy between CD and NMR 
for MLL. Firstly, the Cα and CO secondary chemical shifts did not match (Figure 
4.7). The Cα shifts were typically positive, indicating that the residues were, at 
least partially, experiencing a helical environment. However, the CO shifts were 
generally lower than those observed for Cα, and the sign of the shift was opposite 
for some residues, especially in WT MLL, indicating a less helical environment. Due 
to the sensitivity of the carbonyl to hydrogen bonding and solvent exposure, 
prediction of helicity from CO secondary chemical shifts can be less reliable than 
using Cα shifts (Wishart and Sykes, 1994). To calculate secondary structure 
content, the δ2D algorithm (Camilloni et al., 2012) utilised Cα, CO, Cβ, HN and N 
secondary chemical shifts. Consequently, the use of the inconsistent CO shifts could 
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have resulted in an underestimation of the helicity. Secondly, whilst the trends are 
similar, the absolute helicity determined from CD is dependent on the method 
chosen. For example, using the method of Chen et al. the estimated helicity for WT 
MLL is 7%, compared to 13% estimated using the method of Muñoz and Serrano 
(Chen et al., 1974; Muñoz and Serrano, 1995). Nevertheless, despite the 
discrepancy in absolute helicity, the total fold change in helicity across the entire 
peptide for MLL (1.5-fold vs 1.3-fold) and c-MYB (1.3-fold vs 1.4-fold) was in 
reasonable agreement with CD data. 
 
 
 
Figure 4.7 Comparison of MLL Cα and CO Secondary Chemical Shifts. 
Cα secondary chemical shifts (grey) were generally higher than CO shifts (black). 
Positive Cα and CO secondary shifts indicate helical secondary structure. A negative 
shift indicates β-sheet structure. The position of WT proline, or mutant alanine 
residues are indicated by cyan spheres.  
 
Similar to p53, the majority of the increase in helicity was observed around the site 
of the proline to alanine mutation (Figure 4.8). Within the region that becomes 
helical upon binding, a 1.5-fold increase in helicity was observed for MLL P9/21A. 
c-MYB P17/44A was increased by 1.2-fold. 
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Figure 4.8 Increase in Helicity Occurs within the Region that Becomes 
Helical upon Binding. 
The change in fractional helicity for (A) MLL and (B) c-MYB upon helix-flanking 
proline to alanine mutation. The change in fraction helicity was calculated by 
subtracting the WT δ2D helicity estimate from the double mutant δ2D helicity 
estimates. For both MLL and c-MYB, 30 residues surrounding the region that 
becomes helical upon binding (underlined) are shown. The position of helix-flanking 
prolines is highlighted in the amino acid sequence. Residues where the chemical 
shift value could not be determined at 10°C are indicated with an x. 
 
4.5.2 The Effect of Helix-Flanking Prolines on Binding Affinity is 
Protein Specific 
An increase in residual p53 structure is correlated with an enhancement in binding 
affinity for MDM2 (Borcherds et al., 2014). Equilibrium binding experiments were 
employed to establish if the enhanced ‘bound-like’ structure of MLL and c-MYB also 
results in an increased affinity for CBP-KIX. In contrast to p53, both MLL and c-MYB 
demonstrated reductions in binding affinity for CBP-KIX (Figure 4.9). The 
equilibrium dissociation constant was shifted by 1.9 ± 0.4-fold for c-MYB P17A and 
1.6 ± 0.1-fold for P17/44A. Whilst the Kd for the single and double proline to alanine 
mutants of c-MYB was similar, the difference in the effect of the MLL P21A and 
P9/21A mutations was stark. Mutation of the C-terminal Helix-flanking proline 
(P21A) had no effect on the observed Kd (0.7 ± 0.1 µM vs 0.66 ± 0.06 µM for WT). 
Whereas, the additional mutation of the N-terminal helix flanking proline (P9/21A) 
resulted in a large, 25 ± 4 fold decrease in affinity.   
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Figure 4.9 Affinity of MLL and c-MYB for CBP-KIX is Reduced by Mutation 
of Helix-Flanking Prolines to Alanines. 
Equilibrium binding curves for (A) MLL and (B) c-MYB binding to CBP-KIX. The 
binding of fluorescent dye-labelled peptide was followed by monitoring the change 
in fluorescence anisotropy. Upon binding, the tumbling of the peptide becomes 
relatively slower, resulting in an increase in anisotropy. Equilibrium dissociation 
constants of 0.66 ± 0.06 µM (MLL WT), 0.7 ± 0.1 µM (MLL P21A), 17 ± 2 µM (MLL 
P9/21A), 0.168 ± 0.009 µM (c-MYB WT), 0.32 ± 0.06 µM (c-MYB P17A) and 0.27 
± 0.02 µM (c-MYB P17/44A) were calculated from the mean of three repeats. Errors 
represent the standard error of the mean.  
 
4.5.3 Reduction in Affinity is Due to an Increase in koff 
Stopped-flow kinetic experiments were utilised to determine whether the changes 
in affinity for MLL and c-MYB were due to alterations in kon or koff.  
 
4.5.3.1 Association Kinetics 
The signal changes observed upon mixing c-MYB peptides, or MLL WT and MLL 
P21A, with KIX were reproducible, fit well to a single exponential and displayed a 
good signal to noise ratio (Figure 4.10). However, upon mixing the MLL P9/21A 
mutant with CBP-KIX, the observed signal changes were relatively small, rapid and 
non-reproducible. This reduction in signal change was at least partly due to the 
increase in Kd. For example, mixing 0.1 µM MLL WT with 1 µM KIX results in 
approximately 66% of the peptide going into complex (calculated using Equation 
3.3). Whereas, for MLL P9/21A, the reduced affinity results in only 5% going into 
complex. Consistent with this hypothesis, the amplitude for MLL P9/21A increased 
when it was mixed with higher concentrations of CBP-KIX. While this improved the 
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signal to noise, the gain was offset by the faster observed rate constant (kobs), 
which approached the detection limit of our stopped-flow apparatus. Consequently, 
it was challenging to extract consistent rates under these conditions of rapid, small 
signal changes. 
 
 
 
Figure 4.10 Variable Signal Changes for Peptides Binding to CBP-KIX. 
Example traces for (A) c-MYB peptides, (B) MLL WT and P21A, and (C) MLL P9/21A  
obtained from fluorescence stopped-flow experiments. Peptide was mixed with an 
excess concentration of CBP-KIX (A = 1 µM), (B = 1.5 µM), (C = 2.5 µM). Data 
were collected under pseudo-first order conditions and are fit to a single exponential 
decay function (Equation 2.25). Traces represent the average of (A) 25, (B) 45 and 
(C) 94 repeats.  
  
Typically, kobs was determined from the mean of multiple traces. However, the 
mean for MLL P9/21A became skewed by the inconsistent traces. One way to 
resolve this issue would have been to manually remove the outlying traces before 
taking the mean. While convenient, this method introduces significant 
experimenter bias and was therefore avoided. Instead, a new data analysis method 
was developed. Individual traces were fit to a single exponential decay function. 
The extracted kobs were put into bins and fit to a Gaussian function (Equation 3.10), 
with limits of 0 s-1 and 1000 s-1. These upper and lower bounds were chosen as 
negative rates have no physical meaning and rates over 1000 s-1 could not be 
detected using our stopped-flow apparatus. This method of clustering the fitted 
data, employing limits and fitting the posterior distribution to a Gaussian function 
is akin to analysing the data using Baye’s theorem. For WT MLL, the distribution of 
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rates was tight (Figure 4.11), and the mean of the Gaussian function was very 
similar to the rate obtained using the typical method of extracting kobs from the 
average trace (e.g. 74.5 s-1 vs 74.2 s-1). On the other hand, the kobs for MLL P9/21A 
were widely distributed between 0 and 2000 s-1. The variation and distribution of 
kobs for MLL P9/21A was dependent on the reaction rate and signal change. 
Discrepancies between the two fitting methods were, consequently, dependent on 
the concentration of CBP-KIX (Figure 4.12). 
 
 
 
Figure 4.11 Example Histograms for the kobs of MLL WT and P9/21A. 
The traces obtained for (A) 2.7 µM CBP-KIX binding to MLL WT, and (B) 2 µM CBP-
KIX binding to MLL P9/21A were individually fit to obtain the kobs. The histogram 
shows the kobs binned into a bin size of 5. There was a large variation in the kobs 
determined for MLL P9/21A, which skewed the kobs obtained from the mean trace. 
For example, averaging all of the traces first and then fitting to a single exponential 
decay function gave a kobs of 310 ± 12 s-1. Whereas, fitting all the traces individually 
and obtaining kobs from the mean of the Gaussian fit gave a rate of 214 ± 56 s-1 
(B). This discrepancy between the two methods was dependent on the variation in 
kobs – for (A) MLL WT, which had a tight distribution, the kobs from each method was 
similar (74.5 s-1 vs 74.2 s-1). To overcome any dependence on bin size, 10 bin sizes, 
from 5 – 50 in increments of 5, were used to produce estimates of kobs from the 
Gaussian mean. The kobs for the reaction was then determined from the mean of 
the Gaussian means. The errors in kobs are the standard deviation of the Gaussian 
fit and therefore represent the distribution of the dataset. 
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Figure 4.12 kobs for MLL P9/21A Obtained from the Gaussian and Mean 
Trace Methods.  
Error bars represent the curve fit error for the kobs obtained from the average fit 
method and the standard deviation for the kobs determined using the Gaussian fit 
method. The errors for the Gaussian kobs therefore indicate the distribution of the 
dataset. 
 
As kobs is a composite of the kon and koff (Equation 3.8), both rate constants can, in 
theory, be extracted from the straight line fit of kobs vs the concentration of excess 
protein (CBP-KIX). While this works well for estimating the kon, the determined koff 
may not be accurate, especially when it is below 1 s-1: a small error in the gradient 
(kon) will result in a relatively large difference in the intercept (koff). For the c-MYB 
peptides, no change in kon was observed when either the N-terminal or both helix-
flanking prolines were mutated to alanine (Figure 4.13). MLL similarly displayed 
little change in the kon for either proline mutant. Indeed, the only difference of more 
than 2-fold for either MLL or c-MYB, was an apparent change in the intercept for 
MLL P9/21A. The data for this mutant were relatively scattered, due to the rapid 
observed rates, but the change in intercept indicated an increase of 22 ± 13-fold 
in the koff.  
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Figure 4.13 Association Rate Constants for c-MYB and MLL Peptides. 
Observed rate constants for (A) MLL and (B) c-MYB were obtained from 
stopped-flow experiments. Dye-labelled peptides were rapidly mixed with an 
excess of CBP-KIX. The change in fluorescence with time was followed and fit to a 
single exponential to obtain kobs. Error bars for MLL P9/21A represent the standard 
deviation of the Gaussian fit. The errors for MLL P9/21A therefore indicate the 
distribution of the dataset. The error of the fit for all other kobs were smaller than 
the data point. A straight-line fit gives a kon (gradient) of 27.7 ± 0.5 µM-1s-1 for c-
MYB WT, 28.1 ± 0.9 µM-1s-1 for c-MYB P17A, 28.8 ± 0.8 µM-1s-1 for c-MYB P17/44A, 
24 ±1 µM-1s-1 for MLL WT, 22.0 ± 0.6 µM-1s-1 for MLL P21A and 21 ± 14 µM-1s-1 for 
MLL P9/21A. Errors in kon represent the error of the fit. The intercept provides an 
estimate of the koff.  
 
4.5.3.2 Dissociation Kinetics 
Association kinetics experiments demonstrated that the helix-flanking proline to 
alanine mutations had little effect on the kon. A change in the intercept was 
observed for MLL P9/21A, indicating an increase in koff. To confirm these changes, 
dissociation kinetics experiments were performed (Figure 4.14). Small fold 
increases of 1.38 ± 0.02 and 1.41 ± 0.01 were observed for both c-MYB P17A and 
P17/44A, respectively. As suggested by the association kinetics experiments, a 
large 15.8 ±0.5-fold increase in koff was determined for MLL P9/21A. The koff for 
MLL P21A (12.22 ± 0.08) was within error of MLL WT (12.4 ± 0.3). 
 
   
A B
0
50
100
150
200
250
300
350
0 1 2 3 4 5 6 7 8
c-MYB WT
c-MYB P17A
c-MYB P17/44A
k o
bs
 (
s-
1 )
[CBP-KIX] (µM)
0
100
200
300
400
500
600
700
0 1 2 3 4 5 6 7 8
MLL WT
MLL P21A
MLL P9/21A
k o
bs
 (
s-
1 )
[CBP-KIX] (µM)
90| Chapter 4 
 
 
Figure 4.14 Dissociation Rate Constants for MLL and c-MYB Peptides. 
Observed rate constants for MLL (A) and c-MYB (B) peptides were obtained from 
stopped-flow experiments. A preformed complex of dye-labelled peptide and 
CBP-KIX was rapidly mixed with an excess of unlabelled peptide. The change in 
fluorescence with time was followed and fit to a single exponential to obtain kobs. 
Error bars for MLL P9/21A represent the standard deviation of the Gaussian fit. The 
errors for MLL P9/21A therefore indicate the distribution of the dataset. The error 
of the fit for all other kobs were smaller than the data point. The asymptote gives a 
koff of 6.38 ± 0.03 s-1 for c-MYB WT, 8.8 ± 0.1 s-1 for c-MYB P17A, 8.96 ± 0.08 s-1 
for c-MYB P17/44A, 12.4 ± 0.3 s-1 for MLL WT, 12.22 ± 0.08 s-1 for MLL P21A and 
196 ± 4 s-1 for MLL P9/21A. Errors in koff represent the error of the fit, except for 
MLL P9/21A, where the error represents the SEM (n = 7). 
 
4.5.4 MLL P9A Alters the Interaction of L8 with CBP-KIX, 
Reducing Binding Affinity 
Generally, mutation of helix-flanking prolines to alanines had little effect on the 
kinetics and thermodynamics of the interaction with CBP-KIX, for either MLL or c-
MYB. Mutation of P9A in MLL was the exception to this generality. Despite an 
apparent increase in residual ‘bound-like’ structure, P9/21A resulted in a decrease 
in binding affinity, compared to both MLL WT and P21A. Inspection of the MLL:CBP-
KIX structure provided insight into this surprising result (Figure 4.15). A leucine 
(L8) immediately N-terminal to P9 appeared to pack into a hydrophobic pocket in 
CBP-KIX in all of the 20 lowest energy NMR structures. CD spectra of the MLL:KIX 
complex indicated that there was a greater gain in helical structure upon MLL 
P9/21A interacting with CBP-KIX, compared to the increase observed with WT MLL. 
Whilst CD is not residue specific and does not provide information on where this 
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gain in structure occurs, it could be hypothesised that the extra gain in structure is 
due to extension of the bound MLL helix: prolines are helix-breakers and mutation 
of the helix-flanking proline could allow extension of the helix. Unfortunately, NMR 
of the bound complex could not be employed, due to the disappearance of peaks. 
Another hint towards MLL P9/21A:CBP-KIX having a different bound structure to 
MLL WT was provided by the equilibrium anisotropy data (Figure 4.9). Anisotropy 
is related to the tumbling of the complex: the slower the tumbling, the higher the 
anisotropy. MLL P9/21A displayed a higher maximal anisotropy than either MLL WT 
or MLL P21A, indicating that the tumbling of the dye was reduced.  
    
 
 
 
Figure 4.15 Structure of the MLL:CBP-KIX Complex. 
(A) The 20 lowest energy NMR structures of the MLL:KIX complex (PDB:2LXS, MLL 
in orange). Helix-flanking prolines are shown as cyan spheres. L8 is shown as a 
pink sphere. (B) The difference in MRE between the mean of free KIX and free MLL, 
and the MRE obtained when the two are mixed, as described in Chapter 3.11.5. 
Spectra are corrected for the proportion of MLL in complex, therefore indicating the 
change in CD spectrum if all MLL was bound to KIX. 
 
Extension of the helix in the bound complex could cause the interaction of MLL L8 
with CBP-KIX to be disrupted. If this was the case, the removal of L8 by mutation 
to alanine would be expected to produce similar kinetic and thermodynamic effects 
to P9A. Mutation of L8A was therefore used as a probe to test the hypothesis that 
P9A disrupts the interaction of L8 with KIX. A 53 ± 8-fold reduction in affinity was 
observed for L8A, compared to the 25 ± 4-fold decrease for MLL P9/21A (Figure 
4.16). Again, the change in Kd was predominantly explained by an apparent 
increase in koff.  
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Figure 4.16 L8A Reduces the Affinity of MLL for CBP-KIX by Increasing koff. 
(A) Equilibrium binding curves for MLL peptides binding to CBP-KIX. The binding of 
fluorescent dye-labelled peptide was followed by monitoring the change in 
fluorescence anisotropy. Upon binding, the tumbling of the peptide becomes 
relatively slower, resulting in an increase in anisotropy. Equilibrium dissociation 
constants of 0.66 ± 0.06 µM (MLL WT), 0.7 ± 0.1 µM (MLL P21A), 17 ± 2 µM (MLL 
P9/21A), 35 ± 4 µM (MLL L8A) were calculated from the mean of three repeats. 
Errors represent the standard error of the mean. (B) Observed rate constants for 
MLL peptides were obtained from stopped-flow experiments. A preformed complex 
of dye-labelled peptide and CBP-KIX was rapidly mixed with an excess of unlabelled 
peptide. The change in fluorescence with time was followed and fit to a single 
exponential to obtain kobs. Error bars for P9/21A and L8A represent the standard 
deviation of the Gaussian fit. The errors for MLL P9/21A and L8A therefore indicate 
the distribution of the dataset. The error of the fit for all other kobs were smaller 
than the data point. The asymptote gives a koff of 12.4 ± 0.3 s-1 for MLL WT, 12.22 
± 0.08 s-1 for MLL P21A, 196 ± 4 s-1 for MLL P9/21A and 173 ± 6 for MLL L8A. 
Errors in koff represent the error of the fit, except for MLL P9/21A and L8A, where 
the error represents the SEM (n = 7 and 4, respectively). 
 
4.6 Discussion 
Proline’s unique chemical features reduce the stability of protein secondary 
structure. Whilst they are commonly found throughout IDPs (Ward et al., 2004), 
their conservation and relative propensity in regions that flank residual helices has 
sparked interest (Lee et al., 2014; Theillet et al., 2014). In line with the idea that 
prolines are helix-breakers, mutation of helix-flanking prolines to alanines in p53 
(Borcherds et al., 2014), MLL and c-MYB increased the residual helical structure. 
However, not all proline mutations had equal effects. Mutation of the p53 N-
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terminal helix-flanking prolines, P12 and P13, have little effect on the residual 
helicity compared to the C-terminal P27A mutation, which increases helicity by 2.5-
fold (Borcherds et al., 2014). On the other hand, mutation of the N-terminal helix-
flanking proline in c-MYB, P17A, increased residual helicity to a greater extent than 
the C-terminal P44A mutation. MLL had similar increases in helicity when either the 
C- (P21A) or N-terminal helix-flanking proline was mutated (Table 4.1).  
 
Increasing the proportion of IDP with a ‘bound-like’ structure has been shown to 
enhance binding affinity (Borcherds et al., 2014; Iešmantavičius et al., 2014; 
Krieger et al., 2014). Given that the IDP looks more like the bound state, it is easy 
to imagine this is due to an enhanced rate of complex formation (Brown et al., 
2011; Krieger et al., 2014). However, this was not the case for p53: only a 1.2-
fold change in kon occurs, despite a 2.5-fold increase in ‘bound-like structure’. 
Instead, the 10-fold shift in Kd for p53 P27A is predominantly due to a 12-fold 
decrease in koff (Crabtree et al., 2017). A link between changes in residual structure 
and dissociation rate constants has also been demonstrated for the IDP PUMA 
binding to MCL-1 (Rogers et al., 2014b), and is consistent with an induced fit 
mechanism of binding.    
 
Both MLL and c-MYB show increases in residual structure upon helix-flanking proline 
to alanine mutation. Yet, the affinity of c-MYB P17A, P17/44A and MLL P9/21A for 
CBP-KIX was reduced. The reduction in affinity for MLL P9/21A was so large that it 
made following the reaction kinetics extremely difficult, and a new method of data 
analysis was required to ascertain the kon and koff. While the data were still 
scattered, especially for the association kinetics, there are reasons to have 
confidence in the determined rate constants. Firstly, the koff from the intercept of 
the association kinetics data (200 ± 40 s-1) and from the dissociation experiment 
(196 ± 4 s-1) were the same. Secondly, the kon calculated by division of the koff by 
the equilibrium Kd (12 ± 1 µM-1s-1), was within error of the kon determined from the 
association kinetics experiment (21 ± 14 µM-1s-1). The kinetic analysis of c-MYB 
and MLL peptides demonstrated that, despite observing a 1.2-fold and 1.5-fold 
increase in ‘bound-like’ structure, no enhancement in kon occurred. Indeed, the 
association rate constant for the MLL mutants were, if anything, slightly slower than 
for WT MLL (Table 4.1). These data are, therefore, inconsistent with the view that 
helix-flanking prolines act as ‘“switches” that control the level of helical content’ 
and ‘govern the degree of conformational selection by target proteins’ (Lee et al., 
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2014). This conclusion is based on the assumption made throughout this Chapter 
- that an increase in residual helicity in the region that becomes helical upon binding 
is equal to an increase in ‘bound-like’ structure. This assertion was made due to 
the observation that a single proline mutation increases the average population 
helicity across a large number of amino acids (both adjacent and up to 13 amino 
acids away from the site of mutation), suggesting that the entire region is more 
helical at the same time in the same molecule. This would be achieved through 
stabilisation of the helical turn where the mutation was made, which subsequently 
makes the rest of the helix more stable due to the cooperative formation of intra-
helical hydrogen bonds. However, while this is the simplest explanation, the 
methods used to probe residual structure are an average of all the examined 
molecules. Consequently, it may be that not all of the increase in helicity is present 
in the same molecule at the same time i.e. if residue i and i+11 have 50% helicity 
by NMR, i may be helical in 50% of the population and unstructured in the rest. 
i+11 could then be helical in the other 50% of the population, with no helicity in 
the population where i is helical. If this was the case, it would mean that the ‘bound-
like’ structure (e.g. a full helix between residues i and i+11) had not increased, as 
only a segment of the region would resemble the bound-state in any given 
molecule. Thus, for a protein that bound via a conformational selection mechanism, 
there would be no increase in the concentration of binding competent species, 
resulting in no increase in the kon. Alternatively, the mutation could have reduced 
the concentration of protein in the ‘correct’ binding conformation, which would 
reduce kon. One way to examine this would be to look at the change in structure of 
a single protein molecule, for example using single molecule FRET or molecular 
dynamics simulations. Despite this caveat, the most likely explanation for the data 
is that the reactions follow an induced fit mechanism; for a conformational selection 
mechanism to still be valid, the mutation would have to result in minimal to no 
change in the concentration of protein in the correct conformation for binding, 
which seems unlikely given the widespread changes in residual structure.  
 
 
When making any point mutation, the amino acid side chain is altered. If the 
interactions with a partner protein are disrupted, the mutation can have significant 
effects on binding affinity. A 25 ± 4-fold reduction in affinity was observed for MLL 
upon mutating P9 to alanine. A simple explanation for this shift in Kd, therefore, is 
that P9 made interactions with CBP-KIX that were lost upon alanine mutation. 
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However, proline residues are known to influence the conformation of the preceding 
residue (MacArthur and Thornton, 1991), and analysis of the bound structure 
indicated that L8 made interactions with CBP-KIX. Removal of the leucine side chain 
by mutation to alanine resulted in a 53 ± 8-fold reduction in affinity, which was 
similar to that observed with the P9A mutant. This was again predominantly due to 
an increase in koff, suggesting that the decrease in affinity of P9A was due to 
disruption of the L8:CBP-KIX interaction. A recent mutational analysis of the 
MLL:KIX interaction found that mutation of the same leucine did not alter the 
binding affinity at pH 4 (Toto and Gianni, 2016). Although, the authors could not 
measure the effects at pH 7.2 and noted that several residues showed different 
behaviours when the pH was altered. The buffer used in this study was at pH 7.4, 
which could explain the differing result. 
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4.7 Summary 
Helix-flanking prolines in three IDPs were found to restrict the level of residual 
structure, but had differing effects on the affinity of the IDP for its partner. For p53, 
the prolines reduce binding affinity, whereas they have little effect for c-MYB and 
enhance the affinity of MLL. Yet, amongst the differing changes in Kd, there was a 
commonality – the changes in binding affinity were predominantly due to a change 
in koff, not kon. Thus, rather than producing their affect through controlling residual 
structure and association rates, helix-flanking prolines were found to influence 
binding affinity through modulating the lifetime of the bound complex.  
 
 
 
Figure 4.17 Fold Changes in Helicity, Rate Constants and Affinities for p53, 
MLL and c-MYB Peptides upon Helix-Flanking Proline to Alanine Mutation. 
Changes in helicity were determined from NMR and represent the fold change within 
the region that becomes helical upon binding. MLL P21A, L8A and c-MYB P17A were 
not investigated by NMR; therefore, helicity data is not shown for these peptides. 
Errors were propagated using standard methods. 
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Chapter 5  
 
5 Modulation of Residual Structure in IDPs 
 
The Genetic Algorithm for Design of Intrinsic Secondary Structure (GADIS) was 
devised and implemented by Tyler Harmon, a PhD student in Professor Rohit 
Pappu’s lab (University of Washington, St. Louis). Peptide sequences were designed 
by Tyler, using GADIS. Kinetic data were collected and analysed together with Dr 
Sarah Shammas.  
 
5.1 Methods to Alter Residual Structure 
One way to address the role of residual structure in IDP coupled folding and binding 
reactions is to alter the level of IDP residual structure, and follow the impact on the 
interaction kinetics and thermodynamics (as described in the previous chapter). 
Various methods are available to modify levels of secondary structure. For example, 
for IDPs that form helices upon binding, mutation of residues - which are solvent 
exposed in the bound structure - to proline can reduce residual helical structure 
(Rogers et al., 2014b).  
 
Enhancing helicity is a little trickier. Chemical stabilisers such as trifluorethanol 
(TFE) or protein modifying strategies such as constraining or stapling can enhance 
IDP helicity (Lau et al., 2015). Stapling techniques involve substituting 2 positions 
on the same side of a helix (e.g. i and i+4) with non-natural amino acids. The side 
chains of the substituting amino acids contain groups that can interact with each 
other, forming a covalent linkage between the 2 positions. By optimising the length 
and position of the linking staple, the sequence between the substituted groups can 
be constrained into a helix. Cooperativity then promotes helix formation in the 
surrounding residues.   
 
While useful, all of these methods have issues. TFE can alter the structure of both 
the IDP and the partner protein. Whereas, proline scanning or constraining the IDP 
by stapling both require mutations to the amino acid sequence, altering the 
composition. This is particularly problematic when the mutation results in a change 
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in net charge: long-range electrostatic interactions can influence association rates, 
confounding any changes that are due to the alteration of residual structure. 
Isolating only the effects of altering residual structure therefore required a new 
method. One that could specifically modulate the helicity of the IDP, without 
altering the amino acid composition.  
 
5.2 GADIS 
Both positively and negatively charges amino acids are overrepresented in IDPs 
(Romero et al., 2001; Theillet et al., 2014; Uversky et al., 2000). Without altering 
the total number of charges, or the sequence composition, these charges can be 
utilised to modulate IDP structure (Das and Pappu, 2013). Arranging the charges 
in a manner where the positive and negative charges are well mixed produces a 
random-coil like structure. Whereas, shuffling the sequence into blocks of 
oppositely charged regions allows long-range electrostatic attraction, creating 
hairpin-like conformations.   
 
When placed in the middle of an alanine host peptide (AAXAA) sequence, each 
amino acid (position X) samples similar, but distinct, phi and psi angles (Towse et 
al., 2016). If the presence of a specific side chain can alter the phi and psi angle 
preferences (Serrano, 1995), then it follows that each amino acid can differentially 
influence structure. An additional layer of complication occurs in proteins, where 
the sequence is more intricate than AAXAA. Interactions between adjacent side 
chains can result in steric clashes and restrictions on side chain rotation, resulting 
in a loss of entropy (Creamer and Rose, 1992; Horovitz et al., 1992; Srinivasan 
and Rose, 1999). Torsion angles that reduce side chain restriction and clashing are 
favoured; however, favourable inter-side chain enthalpic contributions can 
compensate for entropic loses. Taken together, this means that the presence and 
conformation of one amino acid can influence the conformation of neighbouring 
residues (Keskin et al., 2004; Pappu et al., 2000; Zaman et al., 2003).  
 
The Genetic Algorithm for Design of Intrinsic Secondary Structure (GADIS) takes 
advantage of both long-range side chain interactions, and the context dependent 
nature of phi and psi angles. Through changing neighbouring amino acids, the 
algorithm aims to produce protein sequences with specific helicity profiles (Harmon 
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et al., 2016). Unlike mutagenesis, the overall sequence composition is maintained, 
with only the order of amino acids altered.   
  
5.2.1 Altering Residual Helicity in PUMA 
The intrinsically disordered BH3–only protein, PUMA folds upon binding to the 
structured BCL-2-like protein, MCL-1. Proline scanning mutagenesis had been 
previously employed to investigate the role of residual structure in this coupled 
folding and binding reaction (Rogers et al., 2014b). PUMA was therefore an ideal 
protein to study using GADIS, as the effects of altering residual helicity could be 
compared to the previous study.  
 
Altering the position of PUMA residues that form the MCL-1 interaction interface 
could significantly affect the reaction kinetics and complex affinity. To avoid 
disrupting key PUMA:MCL-1 interactions, 7 interface residues (W133, I137, L141, 
I144, A145, L148 and Y152) were kept in their relative WT positions. The remaining 
27 residues were shuffled to create 5 different helicity profiles (Figure 5.1). 
 
 
 
Figure 5.1 Helicity Profiles Targeted Using GADIS. 
To investigate the role of residual helical structure in different regions of the 
protein, PUMA sequences were shuffled in an attempt to produce 5 different target 
helicity profiles. From this point on, the names of the target helicity profiles are 
referred to as SBH (stable broken helix), SMH (stable middle helix), NTH (N-term 
helix), CTH (C-term helix) and UUH (uniformly unstable helix). Figure taken from 
Harmon et al. (2016). 
 
Helicity profiles of the shuffled sequences were determined from all atom ABSINTH-
based simulations (Vitalis and Pappu, 2010) and compared to the target helicity 
Modulation of Residual Structure in IDPs| 101 
 
profile. For each profile, 2 sequences were chosen for experimental analysis (Figure 
5.2). 
 
 
Figure 5.2 Predicted Helicity Profiles for WT PUMA and PUMA Shuffles. 
For each target profile, 2 sequences were produced by GADIS. The helicity profiles 
shown above were predicted from all atom ABSINTH-based simulations (Vitalis and 
Pappu, 2010). WT PUMA resembles a broken helix, with partial helicity between 
residues 3 – 17, and 18 – 29. The other helicity profiles were targeted to reduce all 
helicity (UUH); create a single helix spanning the middle of the sequence (MSH); 
increase helicity between residues 3 – 17 while reducing it between 18 – 29 (NTH); 
increase helicity between residues 18 – 29 while reducing it between 3 – 7 (CTH); 
and maintain a WT profile, but with enhanced helicity (SBH).  
 
5.3 Results 
Many IDPs that undergo coupled folding and binding can sample the ‘bound-like’ 
structure when unbound. A convenient technique to assess the importance of this 
‘bound-like’ structure, is to alter the residual helical content of the IDP, and follow 
the effect on the binding kinetics and affinity. However, methods to alter residual 
structure content are typically either non-specific, or require altering the sequence 
composition through mutagenesis. To further investigate the role of residual helical 
structure in the IDP, PUMA, a new method based on shuffling amino acids was 
developed. The ability of this method to alter residual helical content was assessed 
by ultraviolet-circular dichroism spectroscopy (CD).  
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5.3.1 GADIS Produces PUMA Sequences with Varying Levels of 
Helicity 
As previously noted (Rogers et al., 2013), WT PUMA 34 formed oligomers within 
the µM range. The oligomers were observed in CD experiments, with scans 
performed above 3.5 µM displaying concentration dependent increases in α-helical 
content (Figure 5.3). 
  
 
 
Figure 5.3 Concentration Dependent CD Signal Indicates PUMA 34 
Oligomerisation.   
The CD signal for WT PUMA 34 is concentration dependent, indicating the formation 
of homo-oligomers. Below 3.5 µM, the signal is no longer concentration dependent, 
and the oligomers cannot be detected in CD experiments. For each concentration, 
2 independent samples were scanned. Both scans are shown. MRE indicates the 
mean residual ellipticity. 
 
To determine the success of GADIS, accurate helicity estimates were required. As 
peptide oligomerisation increased the α-helical content of WT PUMA 34, it was 
important to ensure that CD scans were representative of the monomeric peptide. 
Consequently, at least 3 different concentrations were scanned for each shuffled 
sequence (Figure 5.4). The highest concentration scan that did not show 
concentration dependence was then used for further analysis.  
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Figure 5.4 CD Concentration Dependence for PUMA 34 Shuffles. 
Concentration dependent CD scans were only observed for WT (> 3.5 µM) and 
SBH2 (> 5 µM). MRE indicates the mean residual ellipticity. 
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Comparison of the CD spectra indicated that various levels of structure could be 
produced by shuffling the position of 27 out of the 34 PUMA residues (Figure 5.5). 
 
 
 
Figure 5.5 Comparison of the CD Spectra for PUMA shuffles. 
UUH1 and UUH2 display largely disordered CD spectra (characterised by a trough 
at approximately 200 nm). Increases in helicity are indicated by a reduction in the 
mean residual ellipticity (MRE) at 222 nm and a shift in the 200-nm trough towards 
208 nm.  
 
To confirm changes in residual structure, helicity estimates were produced from the 
MRE value at 222 nm. Only NTH2 (39%) showed an increase in total helical content 
compared to WT PUMA (36%). The helicity of the remaining shuffles varied from 
13% (UUH1) to 36% (SHB2). Differences in total helical content were also observed 
within the same target profile, e.g. NTH1 (24%) vs NTH2 (39%).  
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Figure 5.6 Fraction of Helical Content in PUMA Shuffles.  
The fraction of total helical content was calculated for each PUMA shuffle using the 
MRE value at 222 nm and the method of Muñoz and Serrano (1995).  
 
Shuffling the order of amino acids produced proteins with various levels of helicity. 
However, for GADIS to be successful, the changes in helicity need to be predictable. 
While the trends are similar, the absolute estimates of structural content from CD 
are highly dependent on the method used to convert MRE to helicity. Therefore, to 
allow comparison with the helicity obtained from simulations (Figure 5.7), multiple 
methods were used to compute helicity (Chen and Yang, 1971; Chen et al., 1974; 
Greenfield and Fasman, 1969; Morrisett et al., 1973; Muñoz and Serrano, 1995). 
Each method provided a different absolute value for helical content; however, the 
Pearson correlation coefficient, obtained from a straight-line fit of the CD vs 
simulation data, was similar in all cases (0.73 – 0.76).  
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Figure 5.7 Correlation of Fractional Helicity Calculated from CD and 
Simulations.  
Helicity from CD was calculated using the methods of Greenfield et al. (1969) 
(purple); Chen et al. (1971) (red); Morriset et al. (1973) (blue); Chen et al. (1974) 
(yellow); and Muñoz and Serrano (1995) (green). The data are fit to a straight line, 
with the equation and the Pearson correlation coefficient (R) shown. 
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5.3.2 PUMA Shuffles Alter the Interaction with MCL-1 
GADIS successfully produced shuffled sequences with varying levels of helicity. 
Upon binding to MCL-1, WT PUMA folds to form a single contiguous α-helix (Figure 
5.8). By altering the structure of the free peptide, the folding upon binding reaction 
could have been affected, leading to a difference in the structure of the bound 
complex. To check that the altered conformation of the free peptide had not 
disrupted the structure of the PUMA:MCL-1 complex, CD was utilised (Figure 5.9). 
Only CTH1 displayed a spectrum that resembled WT PUMA:MCL-1. All other PUMA 
shuffles either had no change in structure compared to the 2 free proteins (UUH1 
and SBH1), or had an intermediary spectrum, which occurred between WT 
PUMA:MCL-1 and the spectrum that would be expected if there was no change in 
structure upon binding.  
 
 
 
 
Figure 5.8 The Disordered Protein PUMA Undergoes Coupled Folding and 
Binding with its Partner, MCL-1.  
Unbound PUMA (blue) is disordered an exists an ensemble of conformations. Upon 
binding, PUMA forms a single contiguous α-helix. Structures were generated using 
generated using PyMOL (version 1.7.2.1, Schrödinger). MCL-1 (grey) and the 
PUMA:MCL-1 complex are based on PDB code 2ROC. The PUMA peptide used to 
determine the structure was 27 amino acids (residues 130 – 155 with an additional 
C-terminal methionine), compared to the 34-mer peptide investigated in this 
chapter (residues 128 – 161). In the PUMA:MCL-1 complex, the N-terminus of 
PUMA is at the bottom left of the structure.   
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Figure 5.9 Coupled Folding and Binding of PUMA Shuffles Probed by CD. 
Protein solutions used to obtain the PUMA (shuffle) and MCL-1 spectra were mixed 
in a 1:1 volume and concentration ratio. Final concentrations were between 1.75 
and 2.5 µM. The expected spectrum (black, dashed line), if no folding upon binding 
occurred (no CFB), was calculated from the mean of the individual spectra. Spectra 
for PUMA:MCL-1 mixtures (red) gained various amounts of helicity compared to the 
expected spectrum of the free proteins.  
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The differences in the bound spectra indicated that there was a difference in the 
bound complex. Either the structure of the bound state was altered. Or not all of 
the PUMA shuffle had gone into complex with MCL-1. The Kd of WT PUMA:MCL-1 is 
0.1 ± 0.03 nM (Rogers et al., 2013). As both PUMA and MCL-1 were at a 
concentration in the low micro molar range for the CD experiments, to be consistent 
with an explanation relating to unsaturated binding, the Kd for the shuffled peptides 
would have to be shifted by approximately 4 orders of magnitude. This would bring 
the Kd into a range that is easily measureable using a reversible bimolecular kinetic 
experiment (Equation 2.26), where both the kon and Kd can be extracted. For WT 
PUMA, a similar amplitude change was observed when the lowest (0.2 µM) and 
highest concentrations (1 µM) were mixed with 0.2 µM of MCL-1 (Figure 5.10). Only 
the timescale of the reaction was altered. On the other hand, for all of the measured 
PUMA shuffles, an increase in amplitude was observed when the concentration of 
PUMA was increased (e.g. UUH2 in Figure 5.10). Note that no change in intrinsic 
tryptophan fluorescence was observed for some PUMA shuffles (SBH1, CTH2 and 
UUH1). Consequently, the kon and Kd for these three proteins could not be 
determined using the bimolecular reversible association method.  
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Figure 5.10 Examples of Kinetic Traces for PUMA Shuffles. 
Various concentrations of PUMA (0.2 – 1 µM) were rapidly mixed in a 1:1 volume 
ratio with 0.2 µM of MCL-1 using stopped-flow. The change in intrinsic tryptophan 
fluorescence with time was followed and the data were globally fit to a reversible 
bimolecular association model (Equation 2.26). For some proteins, a linear term 
was added to the model, to account for photo-bleaching and/or the presence of 
PUMA oligomers (as described previously in Rogers et al. 2013). To aid comparison 
of the changes in amplitude, the fluorescence at time 0 (obtained from the fit) was 
subtracted from the observed fluorescence. Data for UUH2 demonstrate the 
increase in amplitude observed for the PUMA shuffles. While the kon can be 
determined, the Kd for WT PUMA was shown previously to be 0.1 ± 0.03 nM (Rogers 
et al., 2013), which is too tight to accurately measure using this technique.  
 
As the experiments were performed with a minimum of 0.2 nM of protein, MCL-1 
would be expected to go fully into complex with any shuffles that had a similar Kd 
to WT PUMA. The fluorescence amplitude change would therefore be similar for all 
concentrations of PUMA, as observed for WT. However, when mixed with higher 
concentrations of each PUMA shuffle, the fluorescence amplitude change increased, 
indicating that different amounts MCL-1 were going into complex. Analysis of the 
data indicated that this was due to a reduction in binding affinity (Figure 5.11). As 
suggested by the CD data (Figure 5.9), CTH1 had the tightest binding affinity of all 
the shuffles, although the Kd was still shifted by > 2 orders of magnitude compared 
to WT. At the other end of the spectrum, NTH2 had the lowest affinity for MCL-1, 
with a shift in Kd of > 4 orders of magnitude. 
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Figure 5.11 PUMA Shuffles Have Reduced Affinity for MCL-1. 
The Kd was determined from reversible bimolecular association experiments. Error 
bars represent the error of the fit, except for WT PUMA, where the error bars 
represent the standard error of the mean. Due to a lack of signal change, data were 
not collected for SBH1, CTH2 or UUH1. Data for WT was obtained from Rogers et 
al. (2013).   
 
The experimental set up allows the cause of the shift in Kd to be examined. Apart 
from NTH2, the association rate constant for all the shuffles and WT were 
approximately within the same order of magnitude (106 – 107 M-1s-1) (Figure 5.12). 
Clearly, the 2 to 4 orders of magnitude shift in Kd could not be explained by a 
change in kon. Assuming a 2-state system, the koff could be estimated by multiplying 
the Kd by the kon. WT PUMA has a dissociation rate constant of 0.0016 ± 0.0005 s-
1 (Rogers et al., 2013). In contrast the koff of the slowest dissociating mutant was 
0.360 ± 0.001 s-1 (CTH1), while at the other end of the spectrum, the koff for MSH2 
(30 ± 2 s-1) was shifted by > 4 orders of magnitude. Calculating the koff in this way 
has an issue – it is not a direct measurement, so errors can be compounded. To 
confirm the changes in koff, dissociation rate constants were obtained from out-
competition experiments for 3 of the peptides. These matched the calculated data 
reasonably well. 
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Figure 5.12 Shift in Kd Predominantly Due to a Change in koff. 
(A) Reversible bimolecular association experiments demonstrated that all shuffles, 
except NTH2, bound at a similar rate. The difference in Kd was instead due to 
significant changes in koff (B). koff was determined by multiplying Kd by kon (black 
bars). For 3 shuffles, the calculated koff was compared to the koff determined from 
out competition experiments (grey bars). Due to a lack of signal change, data were 
not collected for SBH1, CTH2 or UUH1. Error bars represent the error of the fit, or 
the standard error of the mean (out competition koff). Data for WT koff was obtained 
from Rogers et al. (2013).   
 
5.3.3 Investigating the Cause of the Shifts in Affinity and koff 
A change in koff indicated that the shuffles were mainly affecting the bound state of 
PUMA:MCL-1, rather than the rate of complex formation. Disruption of the bound 
complex could occur through disturbing PUMA WT-like interactions with MCL-1. 
Although 7 hydrophobic residues were kept in the same position as WT, it was 
possible that some important contacts were lost during the shuffling process, or 
that unfavourable interactions were introduced. Fortunately, the structure of PUMA 
bound to MCL-1 has been solved by NMR (Day et al., 2008). Based on the PDB file, 
contact map analysis allows interacting residues in different protein chains to be 
identified (Sobolev et al., 2005). Utilising this technique, 19 PUMA residues were 
identified to interact with MCL-1 (Figure 5.13). As this was considerably more than 
the 7 that were kept constant in the PUMA shuffles designs, it was possible that the 
altered affinity was due to a loss of some of these 19 contacts. New peptide designs, 
with all 19 contacting residues maintained and the other 15 shuffled, were produced 
to test this hypothesis.  
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Figure 5.13 Contact Map Analysis of PUMA Bound to MCL-1. 
A contact map analysis was produced using the PDB structure, 2ROC and the SPACE 
suite web tool (Sobolev et al., 2005). Contacts were defined as having a contact 
area of > 11 Å2, which was the default setting. In total, 19 contacts were found 
between PUMA (chain B, top) and MCL-1 (chain A, side). Out of these 19, 7 were 
kept in the same relative position in each of the shuffle designs (TRP 133, ILE 137, 
LEU 141, ILE 144, ALA 145, LEU 148 and TYR 152).   
 
The conserved shuffles displayed similar levels of residual helicity, but were all less 
helical than WT PUMA (conserved 1 – 23%; conserved 2 – 26%; conserved 3 – 
22%; and WT – 36% estimated helicity). Conserved shuffle 3 also displayed 
concentration dependent CD spectra above 5 µM, indicating the presence of 
oligomers. Mixtures of the conserved shuffle peptides with MCL-1 all displayed an 
increase in total α-helical content (Figure 5.14).  
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Figure 5.14 CD Spectra for Conserved PUMA Shuffles. 
(A) Concentration dependence for the CD spectra of unbound shuffles. Each shuffle 
has 19 residues that are ‘conserved’ in the same relative position as WT PUMA. 
Conserved shuffle 3 shows a concentration dependent CD spectrum above 5 µM, 
indicating the presence of oligomers. (B) A gain in total α-helical content was 
observed for all 3 conserved shuffles upon binding to MCL-1. The expected 
spectrum (black, dashed line), if no folding upon binding occurred (no CFB), was 
calculated from the mean of the individual spectra. 
 
The affinity of the conserved shuffles for MCL-1 was much closer to WT PUMA than 
to the previous shuffle designs (Figure 5.15). However, the Kd for conserved shuffle 
3 (2.94 ± 0.04 nM) was still shifted by more than an order of magnitude compared 
to WT PUMA (0.1 ± 0.03 nM). The affinity of the other conservative shuffles was 
also reduced by approximately 7-fold compared to WT (conserved 1 Kd = 0.73 ± 
0.02 nM; conserved 2 Kd = 0.75 ± 0.02 nM). Reductions in affinity were not due to 
changes in kon, with all conserved shuffles displaying association rate constants in 
the 10 – 20 µM-1s-1 range (WT kon = 16.19 ± 0.02 µM-1s-1).  
 
A
B
190 200 210 220 230 240 250 260
2.5 µM
5 µM
10 µM 
-2 104
-1 104
0
1 104
2 104
3 104
Wavelength (nm)
Conserved 1
M
R
E 
(d
eg
 c
m
2  
dm
ol
-1
)
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 2
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 3
-4 104
-2 104
0
2 104
4 104
6 104
8 104
190 200 210 220 230 240 250 260
Unbound PUMA
Unbound MCL-1
PUMA:MCL-1 Complex
PUMA:MCL-1 Complex No CFB
M
R
E 
(d
eg
 c
m
2  
dm
ol
-1
)
Wavelength (nm)
Conserved 1
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 2
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 3
-4 104
-2 104
0
2 104
4 104
6 104
8 104
190 200 210 220 230 240 250 260
Unbound PUMA
Unbound MCL-1
PUMA:MCL-1 Complex
PUMA:MCL-1 Complex No CFB
M
R
E 
(d
eg
 c
m
2  
dm
ol
-1
)
W velength (nm)
Conserved 1
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 3
190 200 210 220 230 240 250 260
2.5 µM
5 µM
10 µM 
-2 104
-1 104
0
1 104
2 104
3 104
Wavelength (nm)
Conserved 1
M
R
E 
(d
eg
 c
m
2  
dm
ol
-1
)
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 2
190 200 210 220 230 240 250 260
Wavelength (nm)
Conserved 3
Modulation of Residual Structure in IDPs| 115 
 
 
Figure 5.15 Affinity of Conserved Shuffles for MCL-1 Compared to WT and 
the Previous Shuffle Designs. 
The Kd was determined from reversible bimolecular association experiments. Error 
bars represent the error of the fit, except for WT PUMA, where the error bars 
represent the standard error of the mean. Due to a lack of signal change, data were 
not collected for SBH1, CTH2 or UUH1. Data for WT was obtained from Rogers et 
al. (2013). The experiment also provided association rate constants of 17.68 ± 
0.01 µM-1s-1 for conserved shuffle 1 (CS1), 15.58 ± 0.01 µM-1s-1 for conserved 
shuffle 2 (CS2) and 15.16 ± 0.01 µM-1s-1 for conserved shuffle 3 (CS3). 
 
5.3.3.1 Requirement for a Small Residue in PUMA at Position 138 
Keeping all 19 contacting residues in a fixed position had brought the affinity of the 
PUMA shuffles closer to the WT Kd, suggesting that some contacts may have been 
lost in the original shuffle designs. To investigate whether there were any obvious 
contacts that could have been lost, sequences of WT BH3 containing proteins were 
aligned. Only proteins that bind to MCL-1 with similar affinity to PUMA were chosen 
for analysis. Just 3 residues were identical in all 4 proteins and only an additional 
9 demonstrated strongly or weakly similar properties (Figure 5.16).  Out of the 12 
residues, 5 (including all 3 identical residues) were already kept constant in the 
original shuffles. Of the remaining 7 residues, one stood out. In position 138 in 
PUMA a glycine residue is present that, upon binding, becomes buried into the 
hydrophobic grove of MCL-1. In all of the other 3 BH3 domains, a small residue 
(alanine or glycine) is present in this position. However, in 7/10 of the original 
shuffle designs, this residue was shuffled to a charged residue (either a glutamic 
acid or an arginine) (Figure 3.9). Burying an unpaired charged residue away from 
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the solvent (H2O) can cause a significant energetic penalty upon binding. To 
investigate whether shuffling G138 was the reason for the 2 – 4 orders of 
magnitude reduction in Kd for the original shuffles (Figure 5.11), 2 further peptides 
were designed. The first was based on CTH1, the tightest binding of the shuffles 
(Figure 5.9 and Figure 5.11). In CTH1, G138 was shuffled with a glutamic acid. This 
glutamic acid was swapped back into the position of the glycine, with the glycine 
returning to the WT PUMA position. A second design was based on WT PUMA: a 
glutamic acid (E130) from the N-terminal flanking region was swapped with the 
glycine (Figure 3.10).  
 
 
 
Figure 5.16 Alignment of BH3 Domains from Proteins that Bind with High 
Affinity to MCL-1. 
The BH3 domains from BID, BIM and BAK all bind to MCL-1 with a similar affinity 
to PUMA (Ku et al., 2011). Sequences were aligned using Clutsal Omega (Goujon 
et al., 2010; Sievers et al., 2014). As determined by Clustal Omega, positions of 
full residue conservation are indicated by an asterisk, a colon indicates conservation 
of strongly similar amino acid properties, weakly similar properties are specified 
with a period. Residues that were kept constant in the original shuffles are shown 
in blue. Additional residues that were kept constant in the conserved shuffles are 
shown in green. The conservation of a small residue at PUMA position 138 is 
indicated.  
 
Swapping E130 with G138 in the context of WT PUMA increased the helicity from 
36% to 54% (Figure 5.17). To test if this due to an oligomeric species, the 
concentration dependence of the CD signal was examined. No concentration 
dependence was observed, indicating that either the increased helicity was not due 
to oligomer formation, or that the oligomeric species was more stable and the 
population did not change upon altering the concentration in the micro molar range. 
On the other hand, swapping the glycine back into the WT position in the context 
of the CTH1 sequence had little impact on helicity (20% vs 19% for CTH1 G swap 
and CTH1, respectively). Although the CD spectra for the original CTH1 sequence 
BID ESQEEIIHNIARHLAQIGDEMDHNIQPTLVRQLA 
BAK LEPNSILGQVGRQLALIGDDINRRYDTEFQNLLE 
BIM PEDLRPEIRIAQELRRIGDEFNETYTRRVFANDY 
PUMA VEEEEWAREIGAQLRRIADDLNAQYERRRQEEQH 
  .      .:. .*  *.*:::  
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did not display any concentration dependence (Figure 5.4), oligomerisation was 
observed above 5 µM when the glycine was swapped back to the WT position 
(Figure 5.17). Upon mixing with MCL-1, a gain in α-helical structure was observed 
for both WT G swap and CTH1 G swap.   
 
 
Figure 5.17 CD Spectra for G Swap PUMA Shuffles. 
(A) Concentration dependence for the CD spectra of unbound PUMA G swap 
shuffles. CTH1 G swap shuffle shows a concentration dependent CD spectra above 
5 µM. (B) A gain in total α-helical content was observed for both G swap shuffles 
upon binding to MCL-1. The expected spectrum (black, dashed line), if no folding 
upon binding occurred (no CFB), was calculated from the mean of the individual 
spectra. 
 
Swapping G138 with E130 reduced the affinity for MCL-1 by an order of magnitude 
(Figure 5.18). A similar order of magnitude increase in affinity was observed for 
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CTH1 when the glutamic acid at position 138 was swapped with the naturally 
occurring glycine.  
 
 
Figure 5.18 The Presence of G138 Modulates the Affinity of WT and CTH1. 
The affinity of CTH1 G-swap could not be determined using the reversible 
bimolecular association experiment. Instead, Dr Jeffrey Hollins performed 
isothermal titration calorimetry (ITC) to ascertain the Kd. The affinity of WT G swap 
for MCL-1 was investigated using both methods, which showed good agreement 
(Kd = 3 ± 0.2 nM from ITC and 2.2 ± 0.05 nM from the kinetic experiment). Due 
to a lack of signal change, data were not collected for SBH1, CTH2 or UUH1. Error 
bars represent the error of the fit. Data for WT was obtained from Rogers et al. 
(2013). 
 
5.4 Discussion 
In line with the view that amino acids can influence the conformation of their 
neighbouring residues (Keskin et al., 2004; Pappu et al., 2000; Zaman et al., 
2003), shuffling of the PUMA sequence produced proteins with varying levels of 
helicity. GADIS aims to produce PUMA variants with different, but specific helicity 
profiles. While confirming that the achievement of the target profile requires a 
residue level technique such as NMR, the determined total helical content from CD 
correlated reasonably well with the predicted helicity from simulation. GADIS 
therefore provides a method to alter levels of residual helicity, without altering the 
amino acid composition. This is a distinct advantage over other techniques, such 
as proline scanning or peptide stapling, as changes in amino acid composition can 
alter affinity through mechanisms unrelated to the residual helical content. For 
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example, mutation of a charged residue to a proline can change the protein’s net 
charge, altering long-range electrostatic interactions and the association rate 
constant.  
 
In an attempt to prevent interactions between PUMA and MCL-1 being lost during 
the shuffling procedure, 7 residues were initially kept constant. When the position 
of the remaining 27 residues was shuffled, the affinity of all of the 10 designed 
sequences was reduced by between 2 and 4 orders of magnitude. Aligning the 
sequence of BH3 proteins that bind with high affinity to MCL-1 highlighted the 
conservation of a small residue at the equivalent position of residue 138 in PUMA. 
Upon binding, this residue becomes buried in the hydrophobic grove of MCL-1. 
Typically, during the design process, G138 was swapped with a charged residue 
(e.g. glutamic acid). Burying an unpaired charged residue into a hydrophobic 
environment can destabilise a protein, or a protein:partner interaction, by up to ~4 
kcal mol-1 (Fersht et al., 1985; Tissot et al., 1996). This would match well with the 
2 – 4 orders of magnitude shift in Kd observed with the original shuffle designs. 
However, swapping the G138 with a glutamic acid only produced an approximate 
1 order of magnitude (~ 1.3 kcal mol-1) change in affinity. Clearly other factors 
were involved in the destabilisation of the PUMA shuffle:MCL-1 complex. 
 
Keeping all 19 contacting residues constant indicated that the shift in affinity was 
predominantly due to a loss of contacts; although, the conserved shuffles did not 
regain WT affinity. A difference of up to 1 order of magnitude was still observed. 
This scale of affinity loss is comparable to mutating one of the 7 hydrophobic 
interacting residues (e.g. W133F or I137A) that were kept constant in the original 
shuffle designs (Rogers et al., 2014a). As reported previously for PUMA mutants 
binding MCL-1, the majority of the changes in affinity were due to increases in the 
koff, not kon (Rogers et al., 2014a, 2014b). This was still the case for the conserved 
shuffles. As each one had all 19 contacting residues in the same position, the 
change in affinity should not arise from a loss of contacts. Additionally, the disparity 
between the 3 conserved shuffle sequences reduces the probability that a 
destabilising interaction was introduced in all cases. If neither a loss of stabilising 
interactions, or the introduction of destabilising interactions can completely explain 
the shift in affinity for the conserved shuffles, then what is the cause? An intriguing 
hypothesis can be made – the free energy provided by contacting residues is 
120| Chapter 5 
 
dependent on the context of the surrounding amino acid sequence. This is discussed 
in Chapter 6.   
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Chapter 6  
 
6 Influence of Non-Contacting Residues on Binding 
Affinity 
 
When a protein binds to a partner macromolecule, some of the residues may form 
contacts that contribute a large proportion of the free energy. Others may still make 
contacts, but with a lower energy contribution, or not form any interactions with 
the partner. This raises an interesting question – are the non-contacting residues 
merely linkers that bring the contacting residues together? Or do they influence the 
affinity of the interaction? In the previous chapter, shuffling the non-contacting 
residues in the BH3-only protein, PUMA reduced the affinity for its partner protein, 
MCL-1 by up to an order of magnitude (Chapter 5.3.3). In those experiments, the 
sequence composition of PUMA was kept the same, and the relative position of the 
non-contacting residues was altered.  
 
The BH3-only – BCL-2 like interaction network provides a good system to further 
investigate the role of non-contacting residues. Multiple BH3-only proteins fold into 
a single α-helix upon binding to their partner BCL-2 like protein. Interestingly, 
multiple BH3-only proteins bind with high affinity to MCL-1; however, they share 
only 9% sequence identity (Figure 5.16). This is far fewer than the 55% of residues 
that were maintained in identical positions in the PUMA conserved shuffles (Chapter 
5.3.3). Unlike the PUMA shuffles, the position and identity of functionally important 
non-contacting residues will have been subjected to evolutionary constraints. 
Therefore, multiple options to reach the same goal of high affinity binding could 
have been sampled. Conservation of the contacting residues need not have 
occurred, if mutations of the non-contacting residues compensated for any change 
in binding affinity. In this case, the affinity of the contacting residue would be 
dependent on the identity of the non-contacting residue(s). This raises an intriguing 
question – what would happen if the non-contacting residues of one high affinity 
BH3-only protein were swapped into the same relative position in another BH3-only 
protein? If the affinity of contacting residues were dependent on the sequence 
context (i.e. the position and context of non-contacting residues), the hypothesis 
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would be that swapping the residues would alter the binding affinity. An advantage 
of this method is that the swapped residues would be present in the same relative 
positions that they occupy in the original protein. The experiment is similar to the 
core swap method previously employed to study protein folding mechanisms 
(Billings et al., 2008; Wensley et al., 2012).  
 
When swapping residues from different proteins, it is possible that some of the 
amino acids may be charged. Resultant changes in net charge are therefore 
possible, which could alter the long-range electrostatic interactions, and 
consequently the kon. To determine how the balance of positively and negatively 
charged residues would shift upon swapping the non-contacting residues, a number 
of BH3-only sequences were examined. Aligning with the sequence of PUMA 
indicated that swapping the residues of BIM and BIK would create a charge balance 
of -3. Although the charge of PUMA 34 is -4, PUMA 35 contains an additional 
arginine at the N-terminus (R127), bringing the charge balance to -3. PUMA core 
swaps were thus designed based on the 19 PUMA residues that contact MCL-1 
(Figure 5.13), and the remaining residues from either BIM or BIK (Figure 6.1). 
Reducing the charge of PUMA to -3 would likely reduce the electrostatic repulsion 
between PUMA molecules, promoting the homo-oligomerisation observed for PUMA 
34 (Figure 5.3). To counteract this effect, an I144A mutation, which is known to 
reduce the oligomerisation propensity of PUMA (Rogers et al., 2014b), was 
included.   
 
 
Figure 6.1 Sequences and Charge of BH3-Only Proteins and Core Swaps.  
Sequences were aligned using Clutsal Omega (Goujon et al., 2010; Sievers et al., 
2014). As determined by Clustal Omega, positions of full residue conservation are 
indicated by an asterisk, a colon indicates conservation of strongly similar amino 
acid properties, weakly similar properties are specified with a period. The number 
of negative (N), positive (P) and the difference in charges (overall) are shown. 
Residues from WT PUMA are shown in blue. Residues from BIM and BIK in the core 
swaps are indicated in bold.  
BIK: LMEAVEGRNQVALRLAAIGDEMDLALRSPRLVQLP 5 N, 4 P; overall = -1
BIK Swap: LMEAEEWAREIGLQLRAAADELNLAYESRRLVQLP 7 N, 4 P; overall = -3
PUMA: RVEEEEWAREIGAQLRRAADDLNAQYERRRQEEQH 10 N, 7 P; overall = -3
BIM Swap: EPEDERWAREIGQQLRRAADELNETYERRRFANDY 10 N, 7 P; overall = -3
BIM: EPEDLRPEIRIAQELRRIGDEFNETYTRRVFANDY 9 N, 6 P; overall = -3
*      .:. .*   .*:::         :
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6.1 Results 
The effect of swapping the non-contacting residues of PUMA with residues from BIM 
and BIK was analysed. The swapped peptides were compared both to WT PUMA, 
and to WT BIK and BIM.    
 
6.1.1 Core Swaps Alter Residual Secondary Structure 
The CD spectra of mouse PUMA 35 (29%), BIM (11%) and BIK (11%) indicated 
various levels of residual helicity (Figure 6.2). Keeping the 19 MCL-1 contacting 
residues of PUMA and swapping the equivalent, non-contacting residues of BIM 
resulted in a peptide with intermediate helicity (18%). Surprisingly, when the core 
residues of PUMA were swapped into the BIK sequence, the CD spectrum resembles 
that of an anti-parallel β-sheet. The BIK-swap spectra were concentration 
independent across a range of 2.5 – 10 µM, suggesting that either oligomerisation 
was not a factor, or that the Kd of any oligomeric species was below ~ 25 nM. Tyler 
Harmon produced predicted per residue secondary structure profiles for each of the 
sequences (Figure 6.3). The overall levels of predicted helicity agreed well with the 
CD data – BIK was predicted to be the most disordered, while PUMA was estimated 
to be the most helical. Predictions of the β-sheet content were also produced: 
PUMA, BIM and the BIM-swap showed < 2% β content, whereas both BIK and the 
BIK-swap demonstrated 7% and 6%, respectively. Therefore, although the β-sheet 
content of the BIK-swap was predicted to be higher than either PUMA or BIM, the 
prediction does not match the enhanced β content in the CD spectrum of the BIK-
swap compared to BIK.  
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Figure 6.2 CD Spectra for PUMA, BIM, BIK and PUMA Core Swaps. 
Concentration dependence for the CD spectra of PUMA, BIM, BIK and the PUMA 
core swaps. For the core swaps, all 19 PUMA residues that contact MCL-1 were kept 
in the same position. The residues from BIM (BIM-swap) or BIK (BIK-swap) were 
swapped into the position of the non-contacting residues. All proteins displayed a 
spectrum that was independent of the protein concentration. Each concentration 
was prepared in duplicate and both spectra are shown.   
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Figure 6.3 Predicted Secondary Structure Profiles for PUMA, BIM, BIK and 
Core Swaps. 
Using ABSINTH (Vitalis and Pappu, 2010), Tyler Harmon predicted the secondary 
structure profiles of the peptide sequences. The mean α-helicity across the entire 
sequence was 33% for PUMA, 17% for BIM, 2% for BIK, 15% for the BIM-swap 
and 5% for the BIK-swap. The mean β-sheet content across the entire sequence 
was 0% for PUMA, 1% for BIM, 7% for BIK, 2% for the BIM-swap and 6% for the 
BIK-swap. 
 
To determine if the altered residual structure of the peptides impacted the structure 
when bound to MCL-1, CD was performed on a mixture of the 2 proteins. When 
mixed with MCL-1, an increase in total helical content was observed for all peptides 
(Figure 6.4). MCL-1 was therefore able to interact with all of the peptides. Upon 
binding, the spectrum for each of the peptide:MCL-1 mixtures was similar, 
suggesting that each peptide formed a bound complex that was comparable to 
PUMA:MCL-1 (Figure 5.8).   
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Figure 6.4 Coupled Folding and Binding of PUMA, BIM, BIK and Core Swaps 
Probed by CD.  
A gain in α-helical structure was observed upon mixing each peptide with MCL-1. 
The expected spectrum (black, dashed line), if no folding upon binding occurred 
(no CFB), was calculated from the mean of the individual spectra. 
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6.1.2 Equilibrium Binding Affinity 
The interaction between the 35-mer PUMA peptide and MCL-1 is reported as having 
a Kd of 0.18 ± 0.02 nM (Rogers et al., 2014a). Conventional methods of measuring 
affinity, such as isothermal calorimetry (ITC), are unsuitable for such tight 
complexes. An alternative method to measure the affinity of tight complexes is to 
outcompete another tight binding ligand. For example, a complex between a 
fluorescent dye-labelled peptide and MCL-1 can be outcompeted by addition of 
unlabelled PUMA. The concentration of unlabelled PUMA required to outcompete the 
labelled peptide is dependent on the affinity of MCL-1 for both the labelled peptide 
and the unlabelled PUMA. Therefore, if the affinity of the labelled peptide is known, 
the affinity of the unlabelled peptide can be determined (Nikolovska-Coleska et al., 
2004).  
 
To perform the out-competition experiment, a suitable fluorescent dye-labelled 
peptide is required. A PUMA double mutant (A139G A150G) had been shown 
previously to bind MCL-1 with a Kd 1.7 ± 0.2 nM. This Kd just falls within the range 
that is measurable using fluorescence experiments. Higher affinity interactions 
would require sub-nM concentrations of peptide and MCL-1. At these low 
concentrations, the sticking of proteins to plastic and glassware can significantly 
alter the concentration, reducing the accuracy of the technique.   
 
A 35-mer PUMA A139G A150G peptide with a fluorescence TAMRA dye attached to 
the N-terminus was purchased. Due to the importance of having an accurate Kd, 
both a kinetic and thermodynamic analysis of the interaction with MCL-1 was 
performed (Figure 6.5). A Kd of 1.7 ± 0.2 nM was obtained from equilibrium binding 
experiments, which was identical to the Kd obtained for the unlabelled peptide 
(Rogers et al., 2014a). The affinity was confirmed by taking the ratio of koff over 
kon, which gave a Kd of 2.06 ± 0.01 nM.  
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Figure 6.5 Kinetic and Thermodynamic Characterisation of PUMA A139G 
A150G Binding to MCL-1. 
(A) 50 nM of dye-labelled A139G A150G PUMA was rapidly mixed with various 
excess concentrations of MCL-1. Changes in fluorescence intensity were fit to a 
single exponential function to extract kobs. The gradient of the straight-line fit gave 
an association rate constant of 7.35 ± 0.03 µM-1s-1. (B) A pre-formed complex of 
dye-labelled A139G A150G PUMA and MCL-1 was mixed with various excess 
concentrations of unlabelled WT PUMA. Changes in fluorescence intensity were fit 
to a single exponential function to extract kobs. The mean of the concentration 
independent kobs gave a koff of 0.01518 ± 0.00002 s-1. (C) Various concentrations 
of MCL-1 were incubated with 300 nM of dye-labelled A139G A150G PUMA. A Kd of 
1.7 ± 0.2 nM was extracted by fitting to Equation 3.15. Errors represent the error 
of the fit, except for the koff, where the error represents the standard error of the 
mean.  
 
Once the affinity of the dye-labelled peptide was determined, competition binding 
experiments were performed (Figure 6.6). The midpoint of the titration curve was 
used to calculate an equilibrium constant. As the value is calculated from a 
competition (inhibition) experiment, this is referred to as the Ki. PUMA (0.30 nM 
Ki), BIM (0.26 nM Ki) and the BIM-swap (0.30 nM Ki) all bound with similar affinity. 
BIK and the BIK-swap, on the other hand, had a Ki of 29 nM and 3 nM, respectively. 
Therefore, while swapping the non-contacting residues of BIM into the PUMA 
sequence appeared to have little effect, swapping in the residues from BIK reduced 
the affinity by more than an order of magnitude. Note that the error associated 
with the assay was not determined, as the experiment was performed once for each 
peptide.  
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Figure 6.6 Competition Binding Experiments for PUMA, BIM, BIK and the 
Core Swaps.   
Various concentrations of unlabelled PUMA, BIM, BIK, BIM core swap and BIK core 
swap were incubated with 300 nM of both dye-labelled A139G A150G PUMA and 
MCL-1. As the concentration of competition unlabelled peptide was increased, the 
amount of dye-labelled PUMA bound to MCL-1 decreased.  
 
6.1.3 Change in Affinity is not due to a Difference in kon 
Association kinetics experiments were performed to determine if the altered affinity 
for the BIK core swap was due to a difference in the rate of association to MCL-1. 
Each peptide was rapidly mixed with MCL-1 using stopped-flow. In these 
experiments the proteins were mixed at near equimolar concentrations. The change 
in intrinsic tryptophan fluorescence with time was monitored and fit to a reversible 
bimolecular association model (Equation 2.26), which allows both the kon and the 
Kd to be extracted. PUMA, BIM and the BIM-swap all displayed relatively 
concentration independent amplitude changes (Figure 6.7). Whereas, both BIK and 
the BIK-swap displayed an increase in signal amplitude as their concentrations were 
increased, consistent with a lower affinity for MCL-1 compared to PUMA, BIM and 
the BIM-swap.   
 
At low concentrations of peptide, the bimolecular reversible association model 
appeared to deviate from the data (Figure 6.7). This was especially evident for both 
the BIM-swap and the BIK-swap peptides. One explanation for this deviation could 
be that the peptides did not display 2-state behaviour. However, previous 
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experiments showed that, at least for PUMA, the reaction occurred in a 2-state 
manner (Rogers et al., 2014a, 2014b; Rogers et al., 2013). 
 
Fitting the traces individually rather than globally lead to an improved fit at low 
concentrations for the BIK-swap. However, for the higher concentrations, the Kd 
did not converge and either reported an unphysical negative value, or reached an 
imposed limit. This can occur when the protein concentrations are far above the Kd. 
Unfortunately, this was the case for BIM, PUMA and the BIM-swap, which all bound 
too tightly to be able to determine the Kd using this method.   
 
On the other hand, global fitting reported a Kd of 12.1 ± 0.1 nM for the BIK-swap 
and 44.8 ± 0.1 nM for BIK. These Kd values are consistent with the both the 
equilibrium data (Ki = 3 nM for BIK-swap and 29 nM for BIK) and the increase in 
amplitude observed when the concentration of peptide was increased in the kinetic 
experiment (Figure 6.7). Furthermore, both the global fit and individual fitting 
method gave similar kon values of between 14 and 23 µM-1s-1 for the BIK-swap. 
Fitting the data globally therefore provided an estimate of the Kd, without altering 
the estimate of the kon. Hence, despite resulting in a poorer fit for some traces, the 
global fit method was used to obtaining an estimate of the Kd for BIK and the BIK-
swaps. Sharing the parameters by globally analysing the data should also improve 
the accuracy of the kon estimate.   
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Figure 6.7 Kinetic Traces for PUMA, BIM, BIK and the Core Swaps 
Various concentrations of each peptide were mixed with 0.2 µM of MCL-1. Changes 
in intrinsic tryptophan fluorescence with time were monitored and globally fit to a 
reversible bimolecular association model (Equation 2.26). Individually fitting the 
BIK-swap data (bottom right) resulted in improved residuals compared to the global 
analysis (bottom middle); however, the Kd could not be extracted. Data represent 
the mean of 15 – 20 individual traces.   
The association rate constants for all the peptides were within 3-fold of each other 
(Figure 6.8). With a kon of 3.5 ± 0.02 µM-1s-1, BIK displayed the slowest association 
rate constant. Although not yet examined, it could be hypothesised that this was 
due to the loss of 2 charged residues, reducing the electrostatic steering. At the 
other end of the spectrum, the BIK-swap had the fastest kon of 14.45 ± 0.02 µM-1s-1. 
This was surprising, given that the BIK-swap peptide had β-sheet-like residual 
structure and contained the non-contacting residues of the slowest associating 
peptide (BIK). Similar effects were observed for the BIM-swap peptide, which 
associated almost twice as fast as BIM. Assuming that the peptides displayed 2-
state behaviour, the difference in affinity for the BIK-swap was solely due to an 
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increase in the koff. In contrast, the affinity of BIK was reduced due to a reduction 
in kon and an increase in koff.     
     
 
 
Figure 6.8 Rate Constants for PUMA, BIM, BIK and the Core Swaps.  
(A) Association rate constants were determined as 5.23 ± 0.04 µM-1s-1 for BIM, 
9.01 ± 0.08 µM-1s-1 for the BIM-swap, 11.53 ± 0.01 µM-1s-1 for PUMA, 14.45 ± 0.02 
µM-1s-1 for the BIK-swap and 3.50 ± 0.02 µM-1s-1 for BIK. Errors and error bars 
represent the error of the fit. (B) Dissociation rate constants could be estimated 
from multiplying Ki by kon.    
 
6.2 Discussion 
The influence of non-contacting PUMA residues on the binding affinity for MCL-1 
was probed by swapping non-contacting residues from other BH3-only proteins into 
PUMA. PUMA, BIM and BIK all undergo coupled folding and binding upon interacting 
with MCL-1. In isolation, BIM and BIK displayed a similar, predominantly disordered 
structure, whereas PUMA showed an element of residual helical structure. 
Surprisingly, when the non-contacting residues of BIK were swapped into the same 
relative position in PUMA, the BIK core swap peptide displayed residual β-sheet-
like structure. Swapping the non-contacting residues of BIM into PUMA also 
influenced the residual structure, reducing helicity from 29% in PUMA to 18% in 
the BIM-swap. Despite the change in residual structure, PUMA, the BIM-swap and 
the BIK-swap all bound with similar association rate constants, which is consistent 
with the reported induced fit mechanism of binding for PUMA (Rogers et al., 2014b). 
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Although this work is at a relatively preliminary stage, it is interesting to note that 
the affinity of the BIK-swap was reduced by an order of magnitude compared to 
PUMA. Combined with the data from the conserved shuffles (Chapter 5.3.3), this 
suggests that non-contacting residues have an important role to play in 
determining affinity. This hypothesis is consistent with recently published data, 
showing that when mutations that enhance selectivity of PUMA for A1 are put into 
the context of BIM, they reduce the affinity by more than 3 orders of magnitude 
(Jenson et al., 2017). Thus, the mutations only enhance selectivity in the context 
of the PUMA sequence. When placed into another, tight binding BH3-only protein, 
they have the opposite effect. Furthermore, the importance of the background 
protein sequence has been recently highlighted in antibody binding studies (Boyer 
et al., 2016). Typically, when producing antibodies, a few residues are varied and 
the remaining framework is left constant. Yet, Boyer et al (2016) found that the 
ability to produce selective binders was dependent on the background context of 
the variable residues.  
 
It is too early to conclude why the non-contacting residues appear to influence 
binding affinity; however, a few reasons may be speculated. Firstly, there is an 
enthalpic argument. The specific sequence of non-contacting residues may provide 
a framework that positions the contacting residues in specific places. When the 
sequence is altered, by shuffling or swapping, the position of the contacting 
residues could slightly shift, reducing the interaction energy. Secondly, the other 
component of Gibbs free energy is entropy. Non-contacting residues can influence 
the residual structure of the peptide, which could affect the entropic cost of folding 
and binding. In other words, for a peptide that forms a helix upon binding, reducing 
the residual helicity will require a greater degree of folding upon binding. Thirdly, 
there are other components to entropy other than just considering the structural 
distance between the free, unfolded and bound, folded peptide. For example, a 
certain sequence may provide significantly more side chain steric clashes when 
folding, limiting the position of the side chains and increasing the entopic cost of 
folding. This idea is in line with data showing that phi and psi angles can be 
influenced by neighbouring residues (Creamer and Rose, 1992; Horovitz et al., 
1992; Srinivasan and Rose, 1999). During all this speculation, one point of note 
should be made from the current data. In opposition to the second view, the BIM-
swap bound with >5-fold higher affinity than the conserved shuffles, despite having 
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18% residual helicity compared to 22%, 26% and 23% for conserved shuffle 1, 2 
and 3, respectively.  
 
In summary, while this work is still to be completed, it may prove important for 
drug design, where the focus typically lies on the contacting residues, with little 
heed paid to the rest of the sequence. Engineering the non-contacting could 
enhance binding affinity significantly.   
BCL-2 Family| 135 
 
Chapter 7  
 
7 BCL-2 Family 
 
Equilibrium Chemical denaturation experiments for A1 were collected and analysed 
with Carolina Mendonça. Basile Wicky and Tristan Kwan collected all data related 
to the proteins, BAK and BAX.  
 
7.1 The Role of BCL-2 Family Proteins in Apoptosis 
Evolution dictates that only the fittest, best adapted organisms survive and 
reproduce, passing on their characteristics to the next generation. For unicellular 
organisms, this puts the emphasis on the individual cell’s survival. Benefits can still 
be gained by working with neighbouring organisms; for example, bacterial biofilm 
formation aids the survival of the whole population (Donlan, 2001; Kostakioti et 
al., 2013). However, through competing for nutrients, an individual bacterium still 
prioritises its own survival at the expense of its neighbours. A multicellular 
organism does not carry the same luxury: any cell that is unhealthy or energetically 
costly decreases the organism’s fitness, reducing the likelihood that it will survive 
through evolution. Counterbalancing this disadvantage is the ability to separate 
and optimise specific functions through differentiating cells into tissues and organs. 
Cell differentiation is a relatively irreversible process under standard physiological 
conditions. This creates an issue during an organism’s development, as cells with 
different functions are required at specific times - a differentiated cell or tissue may 
be crucial for early stages of development, but not needed once the organism 
reaches maturity. As maintaining these unnecessary cells requires nutrients, a 
significant evolutionary advantage can be gained by safely disposing of cells that 
provide no functional benefit. Accordingly, apoptosis, the process of controlled cell 
death, has evolved to allow organisms to safely dispose of unhealthy or unwanted 
cells (Ameisen, 2002). For example, during development, 148 out of 1179 cells in 
the round worm, Caenorhabditis elegans, can be visually observed to undergo 
apoptosis (Ellis and Horvitz, 1986).  
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There are two main mechanisms by which apoptosis occurs (Elmore, 2007). In the 
first mechanism, tumour necrosis factor (TNF) cytokines bind to TNF receptors on 
the extracelluar surface of the plasma membrane. Ligand binding triggers a series 
of intracellular interactions that result in apoptosis through the activation of 
caspases (Li and Yuan, 2008). As this mechanism is initiated by the binding of an 
extracellular ligand, this is known as the extrinsic pathway. The second pathway is 
activated by intracellular signals, and is known as the intrinsic pathway. 
Intracellular initiators include the absence of growth factors, hormones or 
cytokines; or the presence of radiation damage, toxins, hypo/hyperthermia, viral 
infections and free radicals (Elmore, 2007). These stimuli activate BH3-only family 
members, which interact with BCL-2 family proteins. The interaction between BH3-
only proteins and the BCL-2 family elicits a response that leads to oligomerisation 
and pore formation in the outer mitochondrial membrane (Figure 7.1). Upon pore 
formation, various factors (e.g. cytochrome-c) are released from the mitochondria, 
and apoptosis is initiated. 
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Figure 7.1 Mechanisms of BCL-2 Family Pore Formation by BH3-Only 
Proteins. 
Proteins in the BCL-2 family are split into 2 functional classes based on whether 
they promote apoptosis through forming pores (pro-apoptotic), or inhibit apoptosis 
(anti-apoptotic). BH3-only proteins can also be separated into 2 categories – those 
that can bind directly to either the pro-apoptotic or anti-apoptotic members 
(activators) or those that can only bind to the anti-apoptotic proteins (sensitisers). 
Anti-apoptotic proteins sequester either BH3-activators (top scheme) or pro-
apoptotic BCL-2 proteins (bottom scheme). BH3-only proteins compete for binding 
to the anti-apoptotic proteins, releasing the sequestration and promoting pore 
formation of the pro-apoptotic proteins (Czabotar et al., 2014; Shamas-din et al., 
2013).     
 
7.2 Members of the BCL-2 Family 
There are 6 anti-apoptotic (BCL-2, MCL-1, A1, BCL-XL, BCL-W and BCL-B) and 3 
pro-apoptotic members (BAK, BAX and BOK) of the BCL-2 family. For the purposes 
of this research, 3 of the anti-apoptotic and 2 of the pro-apoptotic proteins were 
selected for analysis. Mouse MCL-1 had been previously studied by Dr Joe Rogers. 
To allow comparison, mouse A1 and BCL-XL were chosen as the two additional anti-
apoptotic proteins. Human BAK and BAX were utilised, as structures for the mouse 
versions of the pro-apoptotic proteins were not available.  
 
Despite having opposing functions and a sequence identity of < 30%, BAK, BAX, 
MCL-1, A1 and BCL-XL all share a homologous structural fold (Figure 7.2). Helicies 
+
+
+
Pro-apoptoticAnti-apoptoticBH3-activatorBH3-sensitiser
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2 – 5 and 8 form a hydrophobic grove, creating the interaction surface for BH3-
only proteins. 
 
 
 
Figure 7.2 Structure and Sequence Comparison for BCL-2 Family Proteins.    
(A) Structures for the BCL-2 proteins A1 (green; PDB code 2VOI), MCL-1 (grey; 
PDB Code 2ROC), BCL-XL (orange; PDB code 2M04), BAK (blue; PDB code 2M5B) 
and BAX (red; PDB code 1F16) were aligned using PyMOL (version 1.7.2.1, 
Schrödinger). For each protein, only the BCL-2 domain is shown (e.g. for MCL-1 
the N-terminal disordered region was not included in the protein used to determine 
the structure). (B) Sequences for the proteins investigated in this work were 
aligned using Clutsal Omega (Goujon et al., 2010; Sievers et al., 2014) and the 
resultant sequence identities are shown. RMSD values were determined from the 
PyMOL structural alignments of the backbone atoms.  
 
7.2.1 BH3-Only Proteins 
BCL-2 like proteins can contain up to 4 BCL-2 homology (BH) motifs, with all 
members containing at least the BH1 and BH2 motifs. The BH3 motif, consisting of 
the sequence LXXXGDE (where X is any amino acid), is also present in the BH3-
only proteins. BH3-only proteins are typically intrinsically disordered (Czabotar et 
al., 2014; Hinds et al., 2007; Rogers et al., 2013); although, BID is a notable folded 
exception to this generality (McDonnell et al., 1999) (Figure 7.3). Through linking 
the extrinsic and intrinsic apoptosis pathways, BID also displays a unique functional 
role. After activation of the extrinsic pathway, caspase-8 cleaves cytosolic BID, 
90° Rotation
A B
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forming truncated BID (t-BID). t-BID translocates to the mitochondrial membrane, 
where it promotes pore formation of pro-apoptotic BCL-2 proteins (Li et al., 1998).    
 
 
 
Figure 7.3 Folded Structure of Full Length BID. 
The BH3 motif of mouse BID (sticks) forms part of the fold. Upon interacting with 
a BCL-2 member, the leucine (L90) in the BH3 motif becomes buried in the 
hydrophobic grove. In folded BID, this leucine (blue) is buried in the core of the 
protein, and is unavailable for binding. To allow interaction, BID may therefore have 
to unfold before binding. In this work, a 35-residue segment of BID was 
investigated (yellow). During its activation, 60 N-terminal residues of full length 
BID (grey) are cleaved by caspases to form truncated BID (green and yellow; BID 
p15). Other cleavage products of BID also occur, with residues 1 – 75 (BID p13) or 
1 – 98 (BID p11) cleaved  (Wei et al., 2000). Structures were generated using 
PyMOL (version 1.7.2.1, Schrödinger) and are based on PDB code 1DDB.    
  
  
180° Rotation
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7.3 Results 
 
7.3.1 Chemical Denaturant Induced Oligomerisation 
For more than a century and a quarter, the effect of ions on protein stability has 
been noted (Hofmeister, 1888). While the molecular origin of the effect is still not 
well understood, it has been suggested that it is due to interactions of salt ions with 
the protein backbone and charged amino acids (Okur et al., 2017). For ions that 
destabilise 3-dimensional folds, more interaction sites are available when the folded 
protein chain is exposed to the solvent, resulting in stabilisation of the denatured, 
unfolded state. Altering the stability (ΔGD-N) of a protein by titrating destabilising 
ions provides a powerful method to unfold proteins and estimate their stability in 
the absence of denaturant (Myers et al., 1995). Changes in protein structure can 
be monitored by following the CD spectra. Alternatively, fluorescence from intrinsic 
tryptophan residues can be used as a proxy for protein structure: exposure of a 
buried tryptophan to solvent during unfolding typically alters the fluorescence 
intensity and/or the peak emission wavelength.   
 
When exposed to the destabilising chemical denaturants, urea or guanidine 
hydrochloride (GdmCl), members of the BCL-2 family show either one (MCL-1) or 
two (A1, BCL-XL, BAK and BAX) transitions (Figure 7.4). Biphasic unfolding curves 
suggests that a stable species is formed along the unfolding pathway. The 
fluorescence profile for the biphasic curves appeared very similar – the first 
transition was associated with a large increase in fluorescence intensity, the second 
displayed a smaller, reduction in fluorescence intensity. A shift in the emission 
wavelength from ~ 320 nm to ~ 345 nm was observed for the first transition. The 
second transition was associated with a further shift, reaching approximately 360 
nm (Figure 7.5). CD indicated that the first transition was associated with a loss of 
around 30 – 40% of the helicity. The remaining helicity was lost during the second 
transition.    
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Figure 7.4 Equilibrium Chemical Denaturation Curves for BCL-2 like 
Proteins. 
For unfolding experiments, approximately 1 µM of each protein was incubated with 
various concentrations of a chemical denaturant (urea or guanidine hydrochloride). 
Different proteins displayed varying absolute fluorescence intensity and CD values. 
Therefore, to aid comparison, the recorded signal was normalised. The CD signal 
represents the normalised value at 222 nm. Addition of denaturant is associated 
with a loss of total helical structure - the buffer subtracted mdeg values transition 
from a negative value at 0 M denaturant, to close to 0 mdeg at 8 M. Each examined 
BCL-2 like protein contains 3 conserved tryptophan residues (shown as blue sticks 
in the structure). Additional tryptophan and tyrosine residues are also present in 
various, non-conserved positions. CD data was not collected for BCL-XL, as the 
buffer contained both DTT and NaCl, which absorbed light and caused the detector 
voltage to go over range. The structure was generated using PyMOL (version 
1.7.2.1, Schrödinger) and is based on PDB code 2ROC.   
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Figure 7.5 Shift in A1 Peak Emission Wavelength for Each Transition.  
The fluorescence spectra for A1 obtained under 3 different concentrations of urea. 
Each concentration relates to the beginning of the curve (0 M), the peak of the first 
transition (5 M) and the end of the curve (8 M). For clarity, the spectra obtained 
between these concentrations are not shown. A shift in emission wavelength from 
~ 320 nm to ~ 345 nm to ~ 360 nm was observed as the concentration of urea 
was increased. The maximum emission wavelength of a buried and solvent exposed 
tryptophan is typically ~ 320 nm and ~ 360 nm, respectively.    
 
One explanation for biphasic equilibrium unfolding curves could be the presence of 
a partially unfolded intermediate, that, due to having a solvent accessible surface 
area between the folded and unfolded state, becomes the most stable species at a 
given concentration of denaturant. Alternatively, either the formation or 
dissociation of an oligomeric species could explain the presence of 2 transitions. 
Experimentally, these two options can be distinguished by repeating the chemical 
denaturant titrations at different protein concentrations. If the biphasic behaviour 
is due to an intermediate, then the normalised curves should overlay as the process 
is unimolecular and, consequently, independent of the protein concentration. On 
the other hand, the presence of an oligomeric species is at least a bimolecular 
reaction. Any transition relating to the formation or dissociation of an oligomer 
would therefore be dependent on the protein concentration.  
 
Consistent with a unimolecular unfolding process, no change in the single MCL-1 
transition was observed upon increasing the protein concentration (Figure 7.6). 
Anti-apoptotic A1 and pro-apoptotic BAX both showed biphasic behaviour at 1 µM. 
0
200
400
600
800
1000
300 320 340 360 380 400
0 M
5 M
8 M
Fl
uo
re
sc
en
ce
 (
A
.U
.)
Wavelength (nm)
BCL-2 Family| 143 
 
When the protein concentration was reduced, the first and second transitions of A1 
shifted. As the transitions were concentration dependent, the biphasic nature of the 
curves was likely due to oligomers. Analysing the direction of the transition shift 
can provide insight into what process the individual transitions relate to. For lower 
concentrations of A1, the transition at low urea concentrations became less steep 
and shifted to the right, while the transition at high urea concentrations shifted to 
the left and became steeper. This pattern is consistent with the first transition 
indicating monomer to oligomer formation, with the second transition representing 
dissociation of the oligomer into unfolding monomer – at higher protein 
concentrations, oligomer formation would be more favourable, leading to a steeper 
low [urea] transition. The high [urea] transition would shift to the right, as the 
oligomer would be more stable, requiring greater amounts of denaturant to 
dissociate it. In contrast, if the low [urea] transition was an oligomer dissociation 
event, then it should shift to the left with decreasing protein concentration. A similar 
pattern of concentration dependent transitions was also potentially observed for 
BAX, although this needs to be repeated at an additional concentration.  
 
 
 
Figure 7.6 Biphasic Behaviour Due to Formation of an Oligomeric Species.  
Equilibrium chemical denaturation titrations were performed at various 
concentrations of MCL-1, A1 and BAX. To aid comparison, the fluorescence intensity 
signal was normalised. MCL-1 displayed a single transition at both 1 and 10 µM. 
The biphasic behaviour of both A1 and BAX was concentration dependent.  
 
A monophasic unfolding curve was obtained at a low (0.1 µM) concentration of A1 
(Figure 7.6). Either the 2 transitions had merged and could no longer be 
distinguished, or there was no oligomer present and the change in fluorescence 
was reporting solely on the unfolding of monomeric A1.  
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7.4 Discussion 
To trigger controlled cell death, pro-apoptotic BAK and BAX oligomerise, forming 
pores in the mitochondrial membrane and committing the cell to apoptosis (Chi et 
al., 2014). The mechanism for the oligomerisation has been a subject of much 
debate (Bogner et al., 2010; Dewson et al., 2008; Shih et al., 2017). A possible 
mechanism is the insertion of the BH3 motif of one BCL-2 like protein into the 
hydrophobic grove of another, which has been shown to result in homodimers 
(Dewson et al., 2008). In this model, higher order oligomers are then formed via 
interactions between α6 of each protein (Dewson et al., 2009; Shih et al., 2017).  
 
When present, the BH3 motif of BCL-2 like proteins is typically buried and 
inaccessible for binding. Some form of structural rearrangement, or unfolding of 
the protein would therefore be required to allow dimerisation. This could explain 
why adding a chemical denaturant, which destabilises the folded state of the 
protein, can result in the formation of oligomers (Figure 7.6). Consistent with this 
hypothesis of unfolding and binding, the CD data indicated that 30 – 40 % of the 
total helicity was lost upon forming the oligomer (Figure 7.4). Although structural 
data are required to make firm statements about the oligomeric state observed in 
the chemical denaturant assays, the data are consistent with the proposed models 
for the formation of functional, pore-forming oligomers. Consequently, it is 
tempting to speculate that the oligomers observed in the denaturant assays are 
related to either the dimeric or higher order, functional species.  
 
7.4.1 Evolution of the Oligomeric Species 
Of the proteins investigated, only BAK and BAX are reported to form pores in the 
outer mitochondrial membrane (Czabotar et al., 2014).  However, oligomerisation 
in the presence of chemical denaturant was observed for both pro-apoptotic BAK 
and BAX, and the anti-apoptotic BCL-2 like proteins. Not all proteins oligomerised 
to the same extent – MCL-1 appeared to remain monomeric at all concentrations 
examined, whereas A1 showed a concentration dependent formation of oligomers 
in the high nM range. The pro-apoptotic and anti-apoptotic proteins are structurally 
homologous, but share little sequence identity (Figure 7.2). As the pro- and anti-
apoptotic proteins are so structurally homologous, it is interesting to speculate 
which came first. Did the ability to form pores evolve from the anti-apoptotic 
proteins, creating the pro-apoptotic proteins? Or were the less oligomerisation-
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prone, anti-apoptotic proteins evolved from the pore forming pro-apoptotic 
proteins?  
 
In an attempt to answer these questions, it would potentially be extremely 
insightful to reconstruct the evolutionary ancestor of the BCL-2 like proteins (Figure 
7.7). As well as providing information about the functional evolution of the family, 
ancestral reconstruction may also indicate what underlies the differing 
oligomerisation propensities. For example, which residues are key for forming 
intermolecular contacts. Work on reconstructing the evolutionary ancestor of the 
BCL-2 like proteins has begun.  
 
 
 
Figure 7.7 Where do the Evolutionary Ancestors fall on the Oligomerisation 
Propensity Scale? 
(A) To reconstruct the evolutionary ancestor, modern-day protein sequences are 
aligned. A statistical model is then used to track the most likely paths between 
species, and this is used to infer the sequence of the ancestral protein. Both the 
ancient protein and evolutionary intermediates can, in theory, be reconstructed 
(Thornton, 2004). (B) A spectrum of oligomerisation propensity was observed in 
the chemical denaturant experiments. Where do the evolutionary ancestors fall on 
this scale?   
 
Oligomerisation Propensity ??
?
?
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B
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8 Encoding of Coupled Folding and Binding 
Information 
 
For a protein, successfully achieving the correct functional fold poses quite a 
challenge. Each phi and psi angle has the potential to explore a large variety of 
conformations when unfolded, but must be constrained into a relatively fixed 
position in the folded state. To avoid the large potential of forming an incorrect 
structure, proteins follow folding pathways. As demonstrated by Anfinsen’s 
experiments, all of the information required to correctly fold a protein can be 
contained within the amino acid chain (Anfinsen, 1973; Anfinsen et al., 1961). 
Thus, proteins have evolved to act as their own instruction manuals.  
 
As seen in the previous chapters, a subset of intrinsically disordered proteins can 
fold upon binding to a partner macromolecule. In these cases, the folding reaction 
of the IDP occurs in the presence of another protein chain. This raises an interesting 
question – where is the information encoded? Is it contained within the IDP? Or 
does the partner template the folding and binding?  
 
Many pieces of information can be encoded within the amino acid sequence – the 
folded structure; the stability; the rates of folding and unfolding; and the function. 
In terms of encoding the folding reaction, one aspect that is particularly intriguing 
is which residues are involved in committing the protein to folding. In other words, 
which amino acids form interactions at the reaction transition state. These residues, 
which guide protein folding through forming native-like interactions at the transition 
state, can be identified using a method known as φ-value analysis (see Chapter 
1.6.1). 
 
A handful of studies have also applied φ-value analysis to the study of IDP coupled 
folding and binding reactions (Dogan et al., 2013; Giri et al., 2013; Haq et al., 
2012; Hill et al., 2014; Rogers et al., 2014a; Toto et al., 2016, 2014). In one of 
these studies, Rogers et al. (2014) investigated the folding and binding of the IDP, 
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PUMA to the folded protein, MCL-1. An early transition state is observed, with few 
interactions formed and little helical structure. Higher φ-values are present at the 
N-terminal end of PUMA, indicating that this region of the IDP is important in 
stabilising the transition state (Figure 8.1).   
 
 
 
Figure 8.1 φ-Value Analysis for PUMA Binding and Folding to MCL-1 
Higher φ-values are observed towards the N-terminus of PUMA, indicating a greater 
degree of native-like interactions at the transition state in this region. No fully 
native interactions are formed and the transition state occurs early along the 
reaction co-ordinate (generally low φ-values observed). The structure was 
generated using PyMOL (version 1.7.2.1, Schrödinger) and is based on PDB code 
2ROC. Residues that are buried in the hydrophobic grove are shown as spheres. 
Data from Rogers et al. (2014).  
 
As discussed in Chapter 7, the BCL-2 family contains a collection of intrinsically 
disordered BH3-only proteins that fold upon binding to structured, BCL-2-like 
proteins. The bound structures of the BH3-only:BCL-2-like complexes are highly 
homologous, yet each individual protein component shares <26% sequence 
identity (Figure 8.2). Based on Anfinsen’s studies, as both the IDPs and the partner 
proteins have different primary sequences, they could contain different folding and 
binding instructions. Combined with the structural similarity of the bound 
complexes, this makes the BH3-only:BCL-2-like protein interaction network an 
ideal model system to investigate where the coupled folding and binding 
information is encoded. The structural similarity of the bound complex is an 
0.2< φ >0.6 
0< φ >0.2 
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important component to answering this question, as different residues have 
equivalent positions in each structure. Consequently, only the side chain of each 
residue has changed, with the encoded final fold remaining the same. Due to the 
importance of knowing the bound structure, only BH3-only:BCL-2-like protein 
interactions that had experimentally determined structures were considered.  
 
 
 
Figure 8.2 Structural and Sequence Comparison of BH3-Only:BCL-2-Like 
Complexes.  
Sequences for the proteins investigated in this work were aligned using Clutsal 
Omega (Goujon et al., 2010; Sievers et al., 2014) and the resultant sequence 
identities are shown. RMSD values were determined from the PyMOL (version 
1.7.2.1, Schrödinger) structural alignments of the backbone atoms. The N-terminus 
of each protein is indicated with an N.  
 
To allow comparison with the published BH3-only:BCL-2-like transition state 
(Rogers et al., 2014a), complexes that contained either PUMA or MCL-1 were 
sought. Analysis of the Protein Data Bank indicated that the BH3-only protein, BID 
or the BCL-2-like protein, A1 would be good choices. A1 had structures with both 
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BID and PUMA (Smits et al., 2008), while BID had structures with both MCL-1 (Liu 
et al., 2010) and A1 (Figure 8.2). 
 
With the systems chosen, investigation of their coupled folding and binding 
reactions could begin. Specifically, the aim of this work was to determine the 
residues of the IDP that form interactions in the transition state. If the IDP was 
encoding the folding pathway, then the φ-values for PUMA should be the same 
when binding to either MCL-1 or A1. Whereas, if the partner protein contained the 
transition state information, the φ-values should be the same for PUMA and BID 
when binding to MCL-1.  
 
8.1 Results  
 
8.1.1 Purification of A1 
Prior to the work described in this thesis, the expression and purification of A1 had 
not previously been attempted in the lab. A1 was expressed with a GST tag, 
allowing the protein to be pulled down on glutathione sepharose (GS). A TEV 
cleavage site was present between the GST tag and A1, allowing A1 to be cleaved 
off the resin (Figure 8.3). Ion exchange chromatography resulted in pure A1. As a 
final purification step, and to buffer exchange the protein, A1 was passed down a 
Superdex 75 gel filtration column. A1 eluted at a similar volume to MCL-1, another 
BCL-2 like protein of comparable size. The identity of A1 was then confirmed by 
mass spectrometry, which was performed by the Mass Spectrometry Service in the 
Department of Chemistry, Cambridge. Note that by SDS PAGE, A1 runs further than 
would be expected for a protein of its mass.  
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Figure 8.3 Purification of the BCL-2-Like Protein, A1. 
(A) The GST-A1 fusion protein expressed in the soluble fraction. Addition of TEV 
protease resulted in full cleavage of A1 from the GST tag, releasing the protein 
from the glutathione sepharose (GS). Cleaved protein was purified using an anion 
exchange column, producing clean fractions according to SDS PAGE. A1 was buffer 
exchanged and further purified using a Superdex 75 gel filtration column. (B) The 
protein eluted at a similar volume to MCL-1. (C) Mass spectrometry provided a 
mass of 17633 ± 5 Da, which matched the expected mass of 17635 Da for the A1 
construct.    
 
8.1.2 Probing the Reaction by Fluorescence 
The interaction between PUMA and MCL-1 was monitored by following the change 
in intrinsic tryptophan fluorescence of MCL-1 upon binding PUMA (Chapters 5.3 and 
6.1.3). This typically resulted in a large amplitude change of up to ~15% of the 
starting signal. In contrast, upon mixing PUMA with A1, a relatively small signal 
change of only 0.6% was observed (Figure 8.4). A smaller signal results in a smaller 
signal to noise ratio. This can be overcome by averaging more traces, but this is 
more expensive, both in terms of time and protein. Additionally, mutations to the 
protein sequence are investigated during a φ-value analysis. Mutations can affect 
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the fluorescence intensity change, potentially making it unmeasurable, given the 
small signal for WT PUMA.  
 
 
  
Figure 8.4 Fluorescence Intensity Changes Observed Upon Mixing PUMA 
with A1. 
A small change in fluorescence intensity was observed upon rapidly mixing PUMA 
(0.25 µM) with various concentrations of A1. The reaction was performed under 
pseudo-first-order conditions with A1 at concentrations of (A) 2.5 µM, (B) 3.3 µM 
and (C) 4 µM. Changes in fluorescence with time were fit to a single exponential 
function. Data represent the mean of 18 – 27 individual traces.  
 
Another way to improve signal to noise ratios is to use a different probe. 
Conjugation of a fluorescent dye provides a few distinct advantages over intrinsic 
tryptophan fluorescence. Firstly, both protein partners may have fluorescent 
tryptophan or tyrosine residues. This creates a high background fluorescence, 
especially when monitoring the reaction under pseudo-first-order conditions, as 
only a maximum of 10% of the excess protein is able to go into complex and 
contribute to the signal change. In contrast, a fluorescent dye can be specifically 
added to just one of the protein partners, minimising the background fluorescence. 
The reaction can then be set up with the unlabelled protein in excess, resulting in 
up to 100% of the dye-labelled peptide going into complex. The signal change is 
therefore maximised. Secondly, when using a fluorescent dye, both a change in 
fluorescence intensity and fluorescence anisotropy can be measured. Thus, if the 
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fluorescence intensity change is lost upon mutating the protein sequence, the 
reaction can instead be monitored by anisotropy.    
 
Fluorescent dyes can have different properties and different prices. A lack of photo-
bleaching over long-timescales was considered an important requirement, due to 
the relatively slow dissociation rate constants observed for BH3-only:BCL-2-like 
interactions (Chapter 6.1.3). Consequently, TAMRA was chosen as a starting 
candidate because of its reported photo-stability (Dempsey et al., 2011) and 
competitive price.  
 
Addition of TAMRA to the N-terminus of PUMA significantly improved the signal to 
noise ratio (Figure 8.5). As discussed in Chapter 6.1 and Figure 6.5, the presence 
of the dye did not alter the Kd of PUMA binding to MCL-1.  
 
 
 
Figure 8.5 Fluorescence Intensity Changes Obtained Upon Mixing TAMRA-
Labelled PUMA with A1.  
A fluorescence intensity change of 2% of the starting signal was observed upon 
rapidly mixing PUMA (5 nM) with various concentrations of A1. The reaction was 
performed under pseudo-first-order conditions with A1 at concentrations of (A) 0.3 
µM, (B) 0.4 µM and (C) 0.5 µM. Changes in fluorescence with time were fit to a 
single exponential function. Data represent the mean of 26 – 29 individual traces.  
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8.1.3 TAMRA Promotes PUMA Oligomersiation 
Due to the improved signal change, TAMRA appeared to be a good probe of the 
reaction between PUMA and A1. However, TAMRA is hydrophobic. Oligomerisation 
of PUMA 34 (Figure 5.3) was reduced by mutating residue I137A in PUMA 35 (Figure 
6.2). Unfortunately, addition of TAMRA at the N-terminus of PUMA 35 promoted the 
oligomerisation of the peptide. PUMA oligomerisation could be observed by several 
methods: concentration dependent CD spectra, the absorbance ratio at 555 nm 
compared to 523 nm and in kinetics (Figure 8.6). The potential to oligomerise was 
related to the amino acid sequence. Mutations that reduced the net charge of PUMA 
(i.e. negative to neutral mutations such as D147A) increased the oligomerisation 
propensity. This can be rationalised based on the reduced electrostatic repulsion 
upon decreasing the net charge. On the other hand, mutations that reduced helicity 
decreased the propensity to oligomerise (e.g. D147G displayed a reduced 
propensity to oligomersie compared to D147A). 
 
In pseudo-first-order association kinetics experiments, biphasic kinetics were 
observed at certain concentrations of excess A1. The additional phase was relatively 
fast and had an opposite amplitude. The concentration of A1 at which the biphasic 
kinetics were observed was dependent on the oligomerisation propensity of the 
PUMA peptide. For example, D147A displayed biphasic kinetics above 1 µM A1, 
whereas others displayed single exponential kinetics at all concentrations. When 
two phases were detected, the observed rate started to reduce and the 
concentration dependence was no longer linear (Figure 8.7). These kinetic 
signatures indicated that another process was occurring at higher concentrations 
of A1. As the presence of these kinetic signatures was related to the oligomerisation 
propensity of PUMA, Occam’s razor would suggest that the additional rate was due 
to the oligomer. One explanation could be that the oligomer is able to bind rapidly 
to A1 (giving the fast, additional rate), before dissociating and rebinding. The rate 
to reach the final equilibrium (a single PUMA chain bound to a single A1 protein) 
would be rate limited by the dissociation of the bound oligomer, producing the 
rollover in rate observed in Figure 8.7 panel C.  
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Figure 8.6 CD, Absorbance and Kinetic Signatures of PUMA 
Oligomerisation. 
(A) A Concentration dependent CD spectrum is observed for PUMA WT, indicating 
oligomer formation in the low µM range. (B) Peak absorbance of TAMRA was 
observed at 555 nm. The ratio of absorbance at 555:523 nm is concentration 
dependent for PUMA WT (left). Non-oligomerising peptides, such as A139G A150G, 
display a concentration independent 555:523 ratio of ~2.5 (right). The difference 
in 555:523 ratio for D147A, which had the highest propensity to oligomerise, is 
indicated (right). (C) At high concentrations of excess A1 (5 µM; left), pseudo-first-
order kinetic traces did not fit well to a single exponential (red), but were captured 
by a double exponential (blue). At low concentrations of A1 (0.1 µM; right), traces 
fit well to a single exponential.      
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Figure 8.7 Rollover and Amplitude Changes Occur for Oligomerising 
Peptides. 
TAMRA labelled PUMA peptides were rapidly mixed with an excess concentration of 
A1 and the rate to reach equilibrium (kobs) was monitored. (A) A linear dependence 
of kobs on the concentration of excess A1 was observed for A139G A150G, which 
displayed no propensity to oligomerise. (B) At low concentrations, D147A, the 
peptide with the highest oligomerisation propensity, displayed single exponential 
kinetics and a linear dependence of kobs on the concentration of excess A1. (C) At 
higher, micro-molar concentrations of A1, biphasic kinetics were observed for 
D147A. In contrast to the low concentrations (black), kobs was no longer linearly 
dependent on the A1 concentration (red). An increase in amplitude was also 
observed when linearity was lost. This change in amplitude was used as a diagnostic 
test and only traces with a single phase and similar amplitudes were used to 
determine kon.  
 
Monitoring the rate of monomeric PUMA association to A1 was the aim of the 
experiment and a requirement for φ-value analysis. For peptides which displayed 
a propensity to oligomerise, this could be achieved by performing the experiment 
at low concentrations of A1, where single exponential kinetics and a linear 
concentration dependence of the rate were observed. Any traces that showed 
biphasic kinetics, or an amplitude that was dependent on the concentration of A1, 
were excluded. There were a few exceptions to this amplitude exemption rule: 
some mutations reduced the affinity such that different amounts of PUMA went into 
complex with A1. When this occurred, the amplitude increased with the A1 
concentration and the rates were included in the analysis (assuming single 
exponential kinetics were observed).  
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8.1.4 Characterisation of the Interaction Between WT PUMA and 
A1 
Due to the dependence on protein concentrations, errors in protein concentration 
calculation or differences in protein purity could lead to discrepancies in 
determining kon. This would be particularly problematic during a φ-value analysis, 
as mutants are typically characterised with different partner protein stocks. 
Consequently, WT was characterised with two independent stocks of A1. These 
stocks were produced at different times and had their concentrations independently 
measured. Both stocks showed good agreement, indicating that the data were 
reproducible with biological repeats (Figure 8.8).  
 
The observed rate constants (kobs) obtained from pseudo-first-order association 
experiments fit well to a straight-line (Figure 8.8). The gradient provides the kon, 
while the koff can be estimated from the intercept. As the koff for the interaction was 
so slow (5 x 10-4 ± 0.2 x 10-4 s-1), it cannot be accurately determined from the 
intercept. Nevertheless, the intercept (0.1 ± 0.1 s-1) was not inconsistent with the 
koff measured from out-competition experiments. A Kd of 85 ± 4 pM was determined 
from the ratio of koff over kon. Thus, PUMA binds slightly tighter to A1 than MCL-1 
(300 pM Ki; Chapter 6.1.2.).   
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Figure 8.8 Reaction Kinetics for the Interaction Between PUMA and A1. 
(A) Observed rate constants (kobs) were obtained from pseudo-first-order 
association kinetics experiments. Two independent stocks of A1 were used (blue 
and orange). An association rate constant of 5.9 ± 0.2 µM-1 s-1 was obtained from 
the gradient of the straight-line fit. (B) The change in fluorescence observed upon 
mixing a pre-formed complex of A1 and PUMA with an excess of unlabelled PUMA 
was fit to a single exponential to obtain kobs. A dissociation rate constant of 5 x 10-4 
± 0.2 x 10-4 s-1 was determined from the mean of the concentration independent 
kobs. Errors for kobs are smaller than the data points. Errors in kon represent the 
error of the fit, whereas the error in koff represents the standard error of the mean 
(n=4).  
 
8.1.5 Choice of Mutations 
Fundamentally, φ-value analysis measures the contribution of Gibbs free energy 
for each residue at the transition state compared to the final, bound state. This is 
achieved through disrupting the interactions of the residue of interest through 
making a mutation. Mutations must therefore be sufficiently destabilising to allow 
differences between the WT and mutant to be discerned. Typically, the minimum 
change in ΔΔG required between the bound and free states is >0.6 kcal.mol-1 
(Fersht and Sato, 2004). With this in mind, and to match the mutations made in 
the PUMA:MCL-1 φ-value analysis, the hydrophobic residues in PUMA were mutated 
to alanine. These residues become buried into the hydrophobic grove of A1 upon 
binding. Shortening the side chain by mutation to alanine should remove some of 
the hydrophobic interactions with A1, resulting in a loss of binding affinity. 
Interactions with the side chains of residues i±4 can also be affected. These 
mutations therefore probe both intermolecular and intramolecular contacts.  
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The amount of helicity can be specifically probed by mutating residues that are 
solvent exposed and do not make intermolecular contacts in the bound structure. 
Charged residues may be present on the solvent exposed surface. Mutating these 
residues could lead to differences in kon that are at least partially due to changes in 
long-range electrostatic steering. Consequently, analysis of helical content requires 
two mutations. First, the residue is mutated to an alanine. This sequence is used 
as a surrogate WT. Helicity is disrupted by mutating the same residue to glycine. 
Differences in free energy between the surrogate WT and the glycine mutant are 
then used to calculate φ. Six residues were investigated in this manner to probe 
the helix formation of PUMA in the transition state.   
 
Another aspect to choosing mutations is that they should be relatively non-
disruptive. If mutations are too drastic, they could cause significant destabilisation 
of the transition state. This could result in a second, distinct transition state 
becoming lower in energy than the mutated, original transition state. This 
alternative transition state may involve completely different interactions. A 
disruptive mutation would therefore be reporting on a different transition state to 
the one relevant to the WT sequence. To check that destabilising mutations do not 
disrupt the interactions of other residues in the transition state, a double mutant 
can be analysed. The double mutant should contain at least one mutation that alters 
the Gibbs free energy of the transition state. If the two mutations have been 
characterised individually, then the double mutant can be compared to the single 
mutant background. i.e. if a double mutant, A139G A150G, is produced, the φ-
value for A150G in this context can be calculated from the difference in free energy 
between the double mutant and A139G. If the A139G mutation does not alter the 
interaction of A150G in the transition state, then the same φ-value should be 
obtained.       
    
8.1.6 Effect of the Mutations on Residual Helicity 
To ensure that the CD spectrum represented the monomeric peptide, scans were 
performed at low concentrations (≤1 µM) using a 1 cm cuvette. While the long 
path-length cuvette allowed these low concentrations to be measured, 
unfortunately it resulted in a large amount of background absorbance at low 
wavelengths. Consequently, to prevent the detector from exceeding its 
recommended voltage, scans were stopped at 200 nm. At least two concentrations 
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of each PUMA peptide were scanned to determine whether oligomers were present 
(Figure 8.9 and Figure 8.10). Only D147A showed a significant difference in CD 
spectrum between 0.5 and 1 µM (Figure 8.10). To check that the 0.5 µM spectrum 
was representative of the monomer, an additional scan was performed at 0.25 µM. 
This overlaid with the spectrum obtained at 0.5 µM, indicating that the helicity of 
the monomeric peptide could be estimated from the 0.5 µM spectrum.  
  
 
 
Figure 8.9 CD Concentration Dependence for Hydrophobic to Ala Mutations.  
Mutations to alanine were designed to disrupt the interaction of specific 
hydrophobic residues in PUMA with A1. CD was performed to determine the effect 
of the mutation on the residual helicity of PUMA. Peptides were scanned at two 
concentrations (0.5 and 1 µM) to determine the concentration dependence of the 
CD spectrum.  
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Figure 8.10 CD Concentration Dependence for Ala to Gly Mutants. 
Ala to Gly mutations were performed to probe the helicity of PUMA within the 
PUMA:A1 transition state. At least two concentrations (0.5 and 1 µM) were scanned 
for each peptide to determine the concentration dependence of the CD spectrum. 
D147A demonstrated a different CD spectrum at 0.5 and 1 µM. Therefore, an 
additional scan at 0.25 µM was performed, which overlaid with the spectrum 
obtained at 0.5 µM. 
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Estimates of the residual helicity of each peptide were computed using the mean 
residual ellipticity value at 222 nm and the method of Muñoz and Serrano (1995). 
An increase in helicity of was observed for the R143A, D147A and Y152A mutations 
(Figure 8.11). All other mutants displayed similar or reduced helicity compared to 
WT. As expected, the residual helicity of glycine mutants was reduced compared to 
their alanine counterparts. Helicity estimates for the TAMRA labelled PUMA peptides 
investigated in this work generally matched those obtained for the unlabelled 
versions. Addition of the dye, therefore, did not appear to significantly affect the 
residual structural of PUMA. 
 
 
 
 
Figure 8.11 Helicity Estimates for PUMA Peptides. 
Estimates of the helicity were obtained from the MRE at 222 nm. As expected, 
glycine mutants typically reduced the residual helicity compared to the equivalent 
alanine mutant. Grey bars represent the helicity obtained for the TAMRA labelled 
peptides investigated in this work. Black bars represent the helicity obtained by 
Rogers et al. (2014) for the corresponding unlabelled peptides. No previous 
estimate was obtained for R154G. 
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8.1.7 φ-Values 
To determine the Gibbs free energy changes upon mutation, a kinetic analysis of 
the interaction between the PUMA peptides and A1 was undertaken. PUMA and A1 
were rapidly mixed using stopped flow and the change in fluorescence intensity or 
anisotropy with time was monitored. The reactions were set up under pseudo-first-
order conditions, with A1 in excess. Signal changes were fit to a single exponential 
function to obtain the observed rate constant (kobs). To maintain a linear 
dependence of kobs on the concentration of A1, kinetics for WT, E136A, D147A, 
D147G and L148A were performed at low concentrations. Association rate 
constants were obtained from the gradient of the straight-line fit of kobs against the 
concentration of A1 (Figure 8.12 and Figure 8.13). The concentration range used 
to determine the kon affected the error, but did not alter the estimate. For example, 
a kon of 3.1 ± 0.3 µM-1s-1 was obtained for A139G when a concentration range of 
0.1 - 1 µM was used. When the range of concentrations was extended to 10 µM, 
the value of kon was the same within error (3.26 ± 0.05 µM-1s-1).  
 
 
 
Figure 8.12 Association Kinetics for PUMA Hydrophobic to Alanine Mutants. 
PUMA was rapidly mixed with various concentrations of excess A1. Fluorescence 
intensity changes were fit to a single exponential to obtain kobs. The gradient of the 
straight-line fit of kobs against the A1 concentration provides the association rate 
constant (kon). WT is shown in black, mutants are in grey.  
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Figure 8.13 Association Kinetics for PUMA Alanine to Glycine Mutants. 
PUMA was rapidly mixed with various concentrations of excess A1. Fluorescence 
intensity changes were fit to a single exponential to obtain kobs. The gradient of the 
straight-line fit of kobs against the A1 concentration provides the association rate 
constant (kon). WT, or the surrogate alanine WT are shown in black, mutants are in 
grey. A wider concentration range was examined for A139G. The same kon was 
obtained when a concentration range of 0.1 – 1 µM (red line) or 0.1 – 10 µM (grey 
line) was used.  
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Dissociation kinetics were monitored by mixing a pre-formed complex of dye-
labelled PUMA peptide and A1 with an excess of unlabelled WT PUMA. The change 
in fluorescence with time was fit to a single exponential to obtain kobs. When the 
competing peptide concentration was high enough, the kobs became independent of 
the competing peptide concentration (Figure 8.14 and Figure 8.15). The mean 
average of these concentration independent kobs provides the dissociation rate 
constant (koff). In keeping with the interaction between PUMA and MCL-1 (Rogers 
et al., 2014a), mutation of L141A provided the largest change in koff. Combined 
with a reduced kon, this mutation shifted the affinity by almost 4-orders of 
magnitude. For comparison, all other mutations altered the affinity by <3-orders 
of magnitude.  
 
 
 
Figure 8.14 Dissociation Kinetics for PUMA Hydrophobic to Alanine 
Mutants. 
A pre-formed complex of dye-labelled PUMA and A1 was mixed with various excess 
concentrations of unlabelled WT PUMA. Fluorescence intensity changes were fit to 
a single exponential to obtain kobs. Dissociation rate constants were obtained from 
the mean of the concentration independent kobs. 
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Figure 8.15 Dissociation Kinetics for PUMA Alanine to Glycine Mutants. 
A pre-formed complex of dye-labelled PUMA and A1 was mixed with various excess 
concentrations of unlabelled WT PUMA. Fluorescence intensity changes were fit to 
a single exponential to obtain kobs. Dissociation rate constants were obtained from 
the mean of the concentration independent kobs. 
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φ-values can be calculated from the kinetic data using Equation 8.1: 
 
 
φ = #$ %&'()%&'*+,#$ -.*+,-.()                                          (8.1) 
 
 
The Kd in the denominator of Equation 8.1 can be calculated by taking the ratio of 
the koff over the kon (Equation 2.21). This technique of calculating Kd holds as long 
as the reaction is 2-state. To check this assumption, equilibrium binding curves for 
the two most destabilising mutants, L141A and L148A were performed. These 
mutations were chosen as the affinity was shifted to a range that was amenable to 
the assay. Higher affinity interactions would require lower protein concentrations, 
shifting the assay into a regime where proteins sticking to plastic and glassware 
starts to become an issue. Equilibrium dissociation constants of 5.65 ± 0.05 nM for 
L148A and 710 ± 20 nM for L141A were obtained from the mean of two repeats 
(Figure 8.16). These compared well with the values of 7.10 ± 0.09 nM (L148A) and 
735 ± 7 nM (L141A) calculated from kinetics. φ-values for all mutants were 
therefore calculated from the kinetic data (Table 8.1).  
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Figure 8.16 Equilibrium Binding Curves for PUMA L141A and L148A. 
Various concentrations of A1 were incubated with 640 nM of PUMA L141A and 50 
nM of L148A. Two repeats are shown for each binding curve. To aid the eye, one 
repeat is shown with open circles and a dashed line, the other with closed circles 
and an unbroken line. Data were fit to Equation 3.15 to obtain the Kd. 
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E132G was the only mutation that did not satisfy the >0.6 kcal.mol-1 change in 
affinity required to calculate φ-values. All other mutations generated usable φ-
values. Looking at Table 8.1, it is clear that the transition state of PUMA:A1 is 
characterised by generally low phi-values, with few interactions between PUMA and 
A1 formed at this point of highest energy. The higher φ-values that were observed 
were clustered towards the N-terminus, indicating that this region is important for 
guiding the reaction. At the C-terminus, the pattern of φ-values was essentially 0, 
suggesting that this region is not forming native-like interactions at the transition 
state. 
 
Double mutants were produced as a control to ensure that the mutations were not 
causing large scale disruptions at the transition state. Both double mutants gave 
essentially identical φ-values (0.44 ± 0.02 vs 0.48 ± 0.01 for A139G; and 0.12 ± 
0.02 vs 0.11 ± 0.01 for A150G), indicating that destabilisation of the transition 
state by one mutation was not affecting the interactions of other residues.    
 
8.2 Discussion 
Broadly speaking, a similar pattern of φ-values was observed for PUMA binding to 
both A1 and MCL-1. Both transition states were characterised with a lack of high 
φ-values, indicating that few native-like interactions were present. This is 
consistent with the early, largely unstructured transition states observed in the 
majority of other studies of IDPs that undergo coupled folding and binding (Dogan 
et al., 2013; Haq et al., 2012; Rogers et al., 2014a; Toto and Gianni, 2016).   
 
When binding to either A1 or MCL-1, PUMA displayed higher φ-values towards the 
N-terminus. Strikingly, the similarity extends beyond just high or low categories. 
Virtually all the calculated φ-values for PUMA were identical, irrespective of the 
binding partner (Figure 8.17). The consistency of these φ-values indicates that the 
IDP may encode which interactions form in the transition state. If this was the case, 
a different BH3-only peptide, such as BID, should demonstrate a distinct pattern of 
φ-values. Furthermore, if the partner protein has no influence on the transition 
state interactions, the distinct φ-values should be reproduced when binding to 
either MCL-1 or A1. A φ-value analysis of BID was therefore performed to test this 
hypothesis.             
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Figure 8.17 Comparison of PUMA Phi-Values When Binding to A1 or MCL-1. 
Data for PUMA:MCL-1 were taken from Rogers et al. (2014). A φ-value of 0 
indicates that no native-like structure is formed in the transition state, whereas a 
value of 1 indicates that all of the native interactions are formed in the transition 
state. Intermediate φ-values indicate that the residue is either making some, but 
not all, of its native-like interactions in the transition state. Or the residue is making 
all of its native interactions, but with a lower energy than in the bound state. 
 
As PUMA required the addition of a fluorescent dye to follow the reaction kinetics 
with A1, the BH3-only peptide, BID was also purchased with an N-terminal TAMRA 
dye. PUMA and BID were therefore more comparable and the dye provided the 
additional safety net of being able to monitor either fluorescence intensity or 
anisotropy. Fortunately, BID peptides did not display any propensity to oligomerise 
in the concentration ranges examined. After performing the initial characterisation, 
the interactions between BID and MCL-1 and BID and A1 were investigated by 
Quenton Bubb and Carolina Mendonça, respectively.  
 
 
As for PUMA, mutations were chosen on each turn of the helix. Both hydrophobic 
residues that become buried into the grove of A1 and MCL-1, and surface, solvent 
exposed residues were investigated. Only five residues provided a ΔΔG above the 
0.6 kcal.mol-1 typically required to calculate φ-values. All of these mutations were 
to hydrophobic residues that become buried upon binding. Four out of the five 
residues were in equivalent positions to the amino acids investigated in PUMA 
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(Figure 8.18). The additional BID mutant (I83A) was on the same helical turn as 
PUMA W133, but was in the equivalent position of PUMA residue 134. BID I82A was 
investigated, however, the ΔΔG was 0.4 kcal.mol-1 for BID binding to MCL-1 and 
0.5 kcal.mol-1 for BID binding to A1.    
 
 
 
Figure 8.18 Position of Mutated Residues in PUMA and BID. 
(A) Structures of BID (yellow) and PUMA (blue) bound to A1 (green). (B) Each 
mutant is on a separate turn of the helix. For comparison, the hydrophobic mutants 
(orange sticks) are referred to relative to their position in the helix. i.e. the N-
terminal residues W133 (PUMA) and I83 (BID) are indicated at position H1. Note 
that position H4 in PUMA is an alanine and was therefore not investigated. 
 
As predicted, BID displayed a different φ-value pattern to PUMA (Figure 8.19 A). 
Whilst PUMA displayed the highest proportion of native-like interactions at the N-
terminus, BID had a φ-value of 0 for the most N-terminal residue. The φ-values 
for BID were relatively low throughout the entire helix; however, on average, the 
H1 H2 H3 H4 H5 H6
A
B
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central portion displayed slightly higher values. This indicates that the central 
region of BID is important in guiding the reaction to the transition state.  
 
When binding to either MCL-1 or A1, the pattern of BID φ-values were highly 
similar. In contrast, when the partner protein is kept constant and the IDP is 
changed (Figure 8.19 B), it is clear that there is variation in the amount of native 
interactions each residue is making. The results obtained for BID are therefore 
consistent with the hypothesis that was derived from the PUMA MCL-1/A1 φ-value 
comparison. 
 
8.3 Conclusion 
For a unimolecular protein folding reaction, Anfinsen showed that all of the 
information required for folding was contained within the protein sequence 
(Anfinsen, 1973). At the start of this project, the aim was to determine which 
component of a coupled folding and binding reaction encodes the transition state 
information. The comparative φ-value analyses described here are consistent with 
the IDP containing the folding pathway instructions. Thus, analogous to Anfinsen’s 
observation, it is the sequence of the protein that folds which encodes its transition 
state.      
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Figure 8.19 BID Displays a φ-value Pattern that is Distinct from PUMA.  
(A) A similar pattern of φ-values was obtained when either the IDP, BID (left) or 
PUMA (right), is kept constant and the binding partner is changed. (B) In contrast, 
when the partner protein is kept constant and the IDP is changed, the φ-values do 
not match and fall outside of error. Labels on the x-axis relate to the position of 
the residue, as indicated in Figure 8.18. 
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Chapter 9  
 
9 Conclusions, Progress and Future Directions 
 
Since this work began in 2014, the field of intrinsically disordered proteins has 
gathered momentum, expanded and moved forward impressively. A few of the 
developments are described below. The findings of this thesis are then summarised 
and potential future work is discussed. 
 
9.1 Structural Ensembles 
Intrinsically disordered proteins lack a well-defined three-dimensional structure and 
exist as an ensemble of conformations. As discussed in this thesis, a subset of IDPs 
can fold upon binding to a partner macromolecule. At the time of starting this work, 
the link between a structural ensemble and a well-defined folded state raised an 
interesting question: do IDPs bind in an already folded state, following a 
conformational selection mechanism, or is the folding induced by binding? If the 
first mechanism was true, then the folded state should be at least partially 
populated within the structural ensemble of the unbound IDP. Traditional 
techniques to determine protein structures required averaging over many 
molecules. This creates something of an issue if each molecule is transiently 
exploring different structural states (Mittag and Forman-Kay, 2007). To overcome 
these problems, new experimental methods were developed (Aznauryan et al., 
2016; Ozenne et al., 2012), allowing structural populations in IDP ensembles to be 
described. Just as the structures of folded proteins are deposited in the Protein 
Data Bank, a new database was developed for IDP structural ensembles (Varadi et 
al., 2014). So far, 24 entries have been deposited in the protein ensemble data 
base (PED). 
 
9.2 Electrostatics 
Through electrostatic steering, the association of folded proteins can be accelerated 
by 4-orders of magnitude (Schreiber and Fersht, 1996).  Given that IDPs typically 
display an excess of charged residues (Romero et al., 2001; Theillet et al., 2014; 
Uversky et al., 2000), it would be easy to assume that long-range electrostatic 
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interactions may have an even greater influence on the association of complexes 
that involve a disordered component. However, the opposite has been shown to be 
the case (Papadakos et al., 2015). Association of the folded proteins - colicin E3 
rRNase domain and Im3 - is electrostatically enhanced by 3 orders of magnitude 
(Walker et al., 2003). Yet, when the colicin E3 rRNase domain was unfolded by 
mutating a core tyrosine residue to an alanine, the electrostatically driven 
association was largely lost (Papadakos et al., 2015). Only a single order of 
magnitude enhancement remained. This is quite a staggering change, considering 
that the charge composition of the WT and tyrosine to alanine mutant were 
identical. One explanation could be that, to achieve the most efficient rate 
enhancement, defined charged patches are required. While folded proteins can 
achieve a relatively fixed patch, through bringing charged residues together during 
folding, the disordered, dynamic nature of IDPs makes this more difficult. Steering 
between complementary charge patches may therefore be lost in IDPs, explaining 
the reduced electrostatic enhancement. While this is an intriguing hypothesis, 
further analyses of electrostatic contributions to IDP association rates are required 
to support it.  
 
9.3 Sensitivity to Denaturants 
The contribution of electrostatic steering to association rate constants can be 
assessed by measuring kon at different salt concentrations. Typically, the salt of 
choice is either NaCl or KCl. In a recent study, the effects of using other salts to 
screen long-range charge interactions were investigated (Wicky et al., 2017). As 
well as altering kon through modifying electrostatic steering, the salt manipulated 
the residual structure of the IDP. The amount of structural change was dependent 
on the ion-type and followed the Hofmeister series (Hofmeister, 1888). In contrast 
to folded proteins, where the influence of Hofmeister salts on structure is typically 
observed in the molar-range, ion-type specific effects are observed at 
concentrations as low as 10 mM. The lack of structural stability of IDPs therefore 
may make them more susceptible to small changes in environment. Given the 
variation in cell compartment ion composition and the involvement of ions in 
signalling (Clapham, 2007), this sensitivity of IDPs could be of functional relevance.  
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9.4 Allostery and Cooperativity 
Just as IDPs can be induced to fold by partner macromolecules, neighbouring 
domains can influence the folding of disordered proteins. For example, SasG 
(Staphylococcus aureus surface protein G) is composed of two domains, which are 
both predicted to be intrinsically disordered. In isolation, the G5 domain is folded, 
whereas the E domain is disordered (Gruszka et al., 2012). The E domain remains 
unfolded when it is present at the C-terminus of G5. However, when the E domain 
is tandemly expressed at the N-terminus of G5, interactions between the two 
domains induce E to fold. Furthermore, when G5 is destabilised and unfolded by 
mutation, the presence of E at the N-terminus stabilises both domains and results 
in folding (Gruszka et al., 2016).  
 
SasG is expressed on the cell surface of Staphylococcus aureus, where it forms a 
rod-like structure. Interestingly, when force is applied to the multidomain protein, 
the E-domains unfold at lower forces than the G5-domains (Gruszka et al., 2015). 
Thus, the destabilised, disordered nature of the E-domain allows the multidomain 
protein to transition between a rigid rod-like structure and a flexible state under 
mechanical force. This could be a crucial functional advantage to SasG, which is 
exposed to the extracellular environment.  
 
IDPs are over represented in processes such as cell signalling (Ward et al., 2004). 
To prevent disease, signalling processes must be tightly regulated. One example of 
this is in the hypoxic response, which is mediated by the interaction between HIF-
1α and the TAZ1 domain of CBP. The protein complex formed between HIF-1α and 
TAZ1 regulates the transcription of various genes, including CITED2. CITED2 can 
also bind to TAZ1, competing for binding with HIF-1α, and producing a negative 
feedback loop. Although both CITED2 and HIF-1α have almost identical affinities 
for TAZ1, sub-stoichiometric concentrations of CITED2 are able to outcompete HIF-
1α. This apparent enhanced affinity is due to a secondary interaction site for 
CITED2. Upon binding this allosteric site, CITED2 causes a change in HIF-1α koff, 
promoting HIF-1α dissociation (Berlow et al., 2017). Allosteric effects have also 
been observed in other IDP systems (Shammas et al., 2014), and could comprise 
an important regulatory feature of signalling complexes.       
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9.5 Phase Transitions 
Compartmentalisation allows cells to separate and optimise specific cellular 
processes. For example, eukaryotic cells use membrane enclosed nuclei to localise 
the machinery required for DNA and RNA synthesis. In recent years, intrinsically 
disordered proteins have been shown to form liquid-like membrane-less organelles 
(Mitrea and Kriwacki, 2016). Under certain conditions, these IDPs can interact and 
form a phase-separated compartment through de-mixing with the surrounding 
solvent (e.g. the cell cytoplasm) (Brangwynne et al., 2015).  
 
One example of a phase separating protein is Ddx4, which contains a folded DEAD-
box helicase domain surrounded by intrinsically disordered regions (Nott et al., 
2015). Cation-pi interactions, between arginine and phenylalanine residues in the 
disordered N-terminus of Ddx4 molecules, are crucial to overcome the entropic cost 
of de-mixing. Phase separation of Ddx4 is therefore dependent both on the protein 
concentration and the ionic strength of the solvent. Reversible de-mixing can be 
achieved by changing either of these factors, or the temperature. Functionally, the 
Ddx4 liquid droplets can melt double stranded DNA, stabilise single stranded nucleic 
acid structures and selectively absorb or exclude proteins (Nott et al., 2016).  
 
The ability to reversibly form functional membrane-less liquid droplets in response 
to specific stimuli, provides the cell with a distinct advantage. Changes in 
environmental conditions can result in new cellular compartments without the need 
for generating membrane bound organelles. Although the field is relatively new, 
phase transitions represents an exciting new area of intrinsically disordered protein 
research. 
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9.6 Conclusions of this thesis 
 
9.6.1 Changes in Binding Affinity are Predominantly Due to 
Alterations in koff  
The correlation between increases in residual ‘bound-like’ structure and binding 
affinity generated interest in studying the unbound IDP. If coupled folding and 
binding reactions were to be fully understood, characterising the ensemble of 
unbound IDP conformations was thought to be important. However, if the presence 
of a ‘bound-like’ conformation was crucial for the reaction, then altering the residual 
structure should modulate the affinity by changing kon. In this thesis, changes in 
residual structure had a greater impact on the koff, rather than the kon. This was 
irrespective of the method used to alter the conformation (point mutation, shuffling 
or swapping residues). Hence, it was the effect on the bound-state, not the free-
state, that was responsible for changes in affinity.  
 
Whilst it is easy to imagine that changes in the reactant can alter kon, one of the 
main messages from this thesis is that the backwards reaction has to be considered. 
Even if no observable change in structure occurs in the bound complex, changes in 
residual structure can alter the entropic cost of folding. For IDPs with relatively 
early transition states, this will lead to the effect being predominantly on koff. 
Consequently, it is important to consider the effects on the bound complex, rather 
than just interpreting changes in the unbound IDP.  
 
9.6.1.1 Evidence for a Dock and Coalesce Binding Mechanism 
One suggested mechanism for the folding and binding of IDPs is the dock and 
coalesce mechanism (Ou et al., 2017; Zhou et al., 2012). In this scheme, a 
segment of the IDP ‘docks’ with the partner macromolecule. The rest of the IDP 
then folds and ‘coalesces’ to the final bound structure. The rate limiting step for the 
formation of the complex is the IDP segment and partner macromolecule colliding 
and interacting. Conversely, for the complex to dissociate, the intra and 
intermolecular contacts formed during the coalescing stage need to be broken and 
the IDP needs to return to its relatively unfolded state. All of the systems studied 
in this thesis are therefore consistent with this binding mechanism, as any change 
in residual structure influenced koff (the potential coalescing step) more than on kon 
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(the potential docking step). It remains to be seen whether this will prove to be a 
general mechanism for IDP coupled folding and binding.  
 
9.6.2 Non-contacting Residues Alter Binding Affinity 
The prevalence of IDPs in cell signalling makes them attractive targets for drug 
development. Typically, binding affinity is enhanced through engineering the 
binding interface. Investigation of non-interfacial residues led to the development 
of GADIS, which provides a method to adjust the residual structure of IDPs by 
shuffling the sequence order. Biophysical analysis of shuffled IDP sequences 
indicated that non-contacting residues can significantly alter the binding affinity. 
This may be an important consideration when designing peptide inhibitors. 
 
9.6.3 Oligomerisation in the BCL-2 Family 
Although they are not IDPs, the BCL-2-like proteins are important components of 
a signalling system that involves disordered proteins. These proteins are involved 
in apoptosis, with pro-apoptotic members oligomerising to form pores in the 
mitochondrial membrane. Biophysical characterisation of these apoptotic 
arbitrators indicated that both the pro-apoptotic and anti-apoptotic members could 
oligomerise, when the folded structure was destabilised with chemical denaturants. 
A spectrum of oligomerising ability was observed, which could provide clues to the 
functional evolution of these proteins.  
 
9.6.4 Transition State Information is Encoded within the IDP 
When stabilised by a partner macromolecule, IDPs can fold to a stable 3-
dimensional structure. As the stability of this structure is dependent on the partner, 
it is possible that the partner macromolecule templates the folding reaction. In 
opposition to this hypothesis, comparative φ-value analyses revealed that the 
folding pathway for the IDP was found to be encoded within its sequence, rather 
than in the stabilising partner protein.  
 
This produces an intriguing hypothesis relating to the functional advantage of 
disorder. If IDPs can encode both their transition states and their level of residual 
structure, it gives them the ability to evolve specific kinetic profiles. IDPs are 
typically involved in cell signalling, where responses to stimuli may have to occur 
quickly (e.g. activation of a cell surface receptor), or may need to be decisive and 
180| Chapter 9 
 
relatively irreversible (e.g. stimulation of apoptosis). Changing the residual 
structure or encoded transition state provides an accessible method for evolution 
to tune the lifetimes of these complexes, which may be one explanation for the 
evolutionary conservation of disorder. 
 
9.7 Future Directions 
In terms of the work described in this thesis, the most promising piece of ongoing 
work is the oligomerisation of the BCL-2-like proteins. It would be fascinating to 
see whether the ancestor of the modern-day proteins was more, or less, prone to 
oligomerisation.  
 
The comparative φ-value analyses provide another area of work that could be built 
on. Liza Dahal, a PhD student in Clarke Group, is currently investigating how φ-
values for residues on the folded protein, MCL-1, compare when the IDP is changed. 
Secondly, it would be intriguing to study a IDR that can bind in different 
conformations (e.g. the C-terminal domain of p53 that was shown in Figure 1.8). 
How is the transition state encoded when the final structure is distinct? Comparative 
analysis provides a powerful framework to address these fundamental questions.  
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